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ABSTRACT 
 
The use of adult stem cells for applications such as tissue engineering and gene 
therapy is one of the major challenge approaches of regenerative medicine. In the 
field of adult stem cells, bone marrow stromal cells (BMSCs) are very promising 
candidates.  
The ability to move forward the use of these cells in therapy depends on the 
setting up of mammalian models, necessary to evaluate pre-clinical efficacy and 
standardize procedures. Precisely, murine BMSCs (mBMSCs) characterization is 
a major breakthrough that can benefit from numerous established genetic models 
of human diseases now available in this organism. In particular, C57Bl/6 strain is 
frequently used to prepare transgenic mice because it produces a large number of 
high-quality embryos and super-ovulate in response to hormone injections. 
However, the BMSC is a cell type better studied and characterized in humans than 
in mouse and, although in the last few years numerous protocols have been 
developed to isolate these cells, some problems still remain. 
In the present study, I define, for the first time, conditions for optimizing the 
yields of cultures enriched for specific progenitors of bone marrow. I isolated four 
different sub-populations of mBMSCs using four distinct culture conditions, 
supernatants from culture of bone fragments, marrow stroma cell line MS-5, 
embryonic fibroblast cell line NIH3T3 and a cocktail of epidermal growth factor 
(EGF) and platelet-derived growth factor (PDGF). These cells show very 
interesting features in immunophenotype, self-renewal ability and differentiation 
potency. In particular, using NIH3T3 conditioned medium, we obtained cells that 
show impairment in osteogenic and chondrogenic differentiation, whereas 
retaining a very high adipogenic potential during passages. These results indicate 
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that the choice of the medium used for isolation and expansion of mBMSCs is 
extremely relevant in order to enrich the culture of desired specific progenitors.  
A common characteristic among these sub-populations of mBMSCs was the 
expression of a well known marker of undifferentiated embryonic stem cells, 
namely Nanog. Recent studies have demonstrated the expression of Nanog in 
BMSCs and its effect on proliferation and osteogenic and chondrogenic abilities, 
however its role in these cells is still unknown.  
During a six- month period as visitor in the laboratory coordinated by Dr Nicole 
Horwood, at Imperial College (London, UK), I have generated vectors expressing 
Nanog sense and antisense in order to analyze the effect of over-expression and 
down-regulation of Nanog on migration, senescence, apoptosis and tumorigenesis 
in BMSCs. Preliminary data suggest that over-expression of Nanog does not seem 
to efficiently reduce the number of senescent cells; however, Nanog over-
expressing cells showed a decrease in the expression of p53, a well known tumor-
suppressor gene and acquired the ability to grow in soft agar, an in vitro hallmark 
of tumorigenic cells. On the other hand, down-regulation of Nanog in BMSCs 
enhances migration ability, and induces an increase in the expression of CCL5 
(Rantes) and CXCL10 (IP10, interferon γ inducible protein-10), which have been 
reported to enhance motility, invasion and metastasis of breast cancer cells and to 
have a potent thymus-dependent antitumoral effect. 
This work suggest that defined levels of Nanog could affect BMSCs properties 
and indicate a further need of a better understanding of the biology of these cells 
which are already being used in several clinical trials. 
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INTRODUCTION 
Chapter 1  
The bone marrow system 
 
The bone marrow consists on three main cellular systems, haematopoietic, 
endothelial and stromal. This organ has traditionally been seen as composed of 
two main distinct lineages, the haematopoietic one, proper able to give rising to 
the blood lineage cells and the mesenchymal lineage. This includes the non 
haematopoietic cells of mesenchymal origin that support haematopoiesis, as well 
as the mesenchymal stem cell and its progeny, such as osteocytes, chondrocytes 
and adipocytes (Figure 1).  
This chapter describes bone marrow stromal cells (BMSCs) from their discovery 
to the recent advances in their characterization. 
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Figure 1 The Bone Marrow system 
The bone marrow is the source of two distinct lineages, the haematopoietic and the 
mesenchymal lineage. From the haematopoietic lineage derive blood cells; from the 
mesenchymal stem cells derive the supporting stromal cells, osteocytes, chondrocytes and 
adipocytes. Adapted from http:stemcells.nih.gov. 
Maria Teresa Esposito                                                                                                                                            PhD Thesis 
18 
1.1 In vitro characterization of bone marrow stromal cells 
(BMSCs) 
The discovery of the stromal system was one of the major discoveries in the field 
of stem cells. Alexander Friedenstein, Maureen Owen, and their co-workers were 
the first to utilize in vitro culture and transplantation in laboratory animals, to 
characterize cells that compose the physical stroma of bone marrow (Friedenstein 
et al. 1966; Friedenstein et al. 1970; Owen 1988).  After mechanical dissociation 
of the bone marrow, they obtained a single-cell suspension which they plated in 
culture at low density. In these conditions they were able to observe that little, 
spindle shaped cells, the bone marrow stromal cells, rapidly adhered to the plastic 
surface, whereas the non-adherent haematopoietic cells could be removed by 
repeated washing. With appropriate culture conditions, distinct colonies were 
formed, each of which was derived from a single precursor cell, the Colony 
forming fibroblastic unit (CFU-F, Figure 2). Under optimal conditions, these 
colonies can undergo over 25 passages in vitro (more than 50 cell doublings), 
demonstrating a high capacity for self-replication. Therefore, billions of BMSCs 
can be generated from a limited amount of starting material, such as 1 ml of a 
bone marrow aspirate. Thus, these cells were referred as rapidly adherent, 
clonogenic, and capable of extended proliferation. 
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Figure 2 Colony forming fibroblastic unit (CFU-F assay). 
Examples of CFU-F obtained from murine bone marrow stromal cells culture. Original 
magnification 50X (panel A), 100X (panel B) and 125X (panel C). Adapted from StemCell 
Technologies. 
 
1.2 Definition of BMSCs  
Since the identification of the bone marrow stromal stem cell by Friedestein and 
co-workers (Friedenstein et al. 1966; Friedenstein et al. 1970; Owen 1988), many 
researchers have tried to isolate and better characterize this population. The first 
detailed functional description of the tri-lineage differentiation potential of 
BMSCs was provided by Pittenger and colleagues in 1999 (Pittenger et al. 1999). 
They isolated populations of human BMSCs from the bone marrow taken from 
the iliac crests with a frequency ranging from 1 out of 10.000- 100.000, analyzing 
their immunophenotype and the in vitro differentiation potential. They showed 
that some of the clones, which they obtained, were able to differentiate in 
osteoblast, chondroblasts and adipocytes, pointing out a multipotent ability for 
these clones (Figure 3). Not every clone retained these abilities. Out of six 
colonies analyzed, all of them were able to differentiate in osteoblasts, five were 
able to differentiate in chondrocytes and only two were able to differentiate in 
adipocytes, confirming that these populations were very heterogeneous and made 
up of multipotent stem cells and progenitors already committed towards a specific 
cell lineage (Pittenger et al. 1999). 
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After the publication of this article, these cells have been identified as plastic-
adherent multipotent cells, capable of differentiating into bone, cartilage and fat 
cells (Figure 3) and referred to by different names. The original term “colony 
forming unit-fibroblast” (CFU-F) or “marrow stromal fibroblasts” (MSF, Castro-
Malaspina et al. 1980; Friedenstein et al. 1982; Kuznetsov et al. 1997) has been 
gradually abandoned and replaced by diverse, still indistinct denominations like 
“marrow stromal cells” (MSC,  Prockop 1997; Digirolamo et al. 1999), 
“mesenchymal stem cells” (MSC, Caplan 1991; Pittenger et al. 1999; Baddoo et 
al. 2003; Meirelles Lda et al. 2003; Tropel et al. 2004; Wang et al. 2006), “bone 
marrow stromal cells” (BMSC, Phinney et al. 1999; Bianco et al. 2001; Short et 
al. 2001; Sun et al. 2003; Peister et al. 2004), “recycling stem cells” (RS, Colter et 
al. 2000; Colter et al. 2001), “multipotent adult progenitor cells” (MAPC, Reyes 
et al. 2001; Jiang et al. 2002) and “marrow isolated adult multilineage inducible 
cells” (MIAMI, D'Ippolito et al. 2004).  Table 1 summarises the definitions used 
to different populations of cells isolated from human and murine bone marrow.   
A lot of new sources of stromal cells have been identified so far. They have been 
isolated from adipose tissue (Zuk et al. 2001; Schaffler et al. 2007),  cord blood 
(Gang et al. 2004), placenta (Fukuchi et al. 2004) and periferical blood (Rochefort 
et al. 2006; He et al. 2007). However, even if isolated by density-gradient 
fractionation, they remain a heterogeneous mixture of cells with varying 
proliferation, differentiation potentials and different denominations that contribute 
to generate a deep confusion in this field.  
Although acceptable for cell-based therapeutic applications, a rigorous 
understanding of the BMSC requires a better definition of what a BMSC is.  
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Many laboratories have employed different methods to isolate BMSCs, in both 
serum and serum deprived conditions, and have developed novel approaches to 
isolate purified populations of BMSCs.  
These advances have furthered our understanding of BMSC biology but have also 
created differences in terminology and read-out measures (i.e., based on 
morphology, phenotype, gene expression, and combinations thereof) for 
describing the fibroblast-like cells derived from bone marrow and adult tissue 
(Table 1). Although none of these terms can accurately account for both the 
developmental origin and differentiation capacity of these cells, the term bone 
marrow stromal cell is often employed, because it applies not only to the stem cell 
per se, but to a vast repertoire of committed progenitors exhibiting at least more 
than one differentiation potential and described to be present in the bone marrow.  
 
 
 
Figure 3 “Bone marrow stromal cell” functional definition 
Culture-expanded BMSCs exhibit a spindle-shaped fibroblastic morphology following 
culture expansion ex vivo (panel A). Under appropriate inducing conditions, the culture 
will demonstrate osteogenesis as seen by calcium conditions (panel B), adipogenic 
differentiation evidenced by fat globules (panel c) or chondrogenic differentiation as 
measured by staining for type II collagen. Adapted from Deans R., Experimental 
Haematology 2000. 
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Table 1 
Representative examples of denominations used for bone marrow stromal 
cells 
Term Cell type identified Animal sources/references 
Colony forming unit- 
fibroblast (CFU-F) 
Colonies of fibroblastic 
cells, with the occasional 
monocyte/macrophage 
present 
• Human (Castro-
Malaspina et al. 1980)  
• Mouse (Friedenstein et 
al. 1982)  
Mesenchymal stem 
cells (MSCs) 
Cells defined by their 
selective attachment to a 
solid surface 
• Human (Caplan 1991; 
Pittenger et al. 1999)  
• Mouse (Baddoo et al. 
2003; Meirelles Lda et 
al. 2003; Tropel et al. 
2004; Wang et al. 
2006)  
Marrow stromal cells 
(MSCs) 
Adherent cells of bone 
marrow that include 
and/or adherent fibroblast-
like cells, endothelial 
cells and colonies 
monocytes/macrophage 
• Human (Digirolamo et 
al. 1999) 
• Mouse (Prockop 1997) 
Bone marrow stromal 
stem cells (BMSSCs) 
and/or Stromal 
precursors cells (SPCs) 
Non-haematopoietic cells of 
mesenchymal origin, 
displaying fibroblastic 
morphology 
• Human (Bianco et al. 
2001) 
• Mouse (Phinney et al. 
1999; Short et al. 
2001; Sun et al. 2003; 
Peister et al. 2004)  
RS-1, RS-2, mMSCs 
(RS:Recycling stem 
cell) (m: mature) 
RS-1: thin, spindle-shaped 
cells RS-2: moderately 
thin, spindle-shaped cells 
mMSCs: wider, 
spindle-shaped cells 
• Human (Colter et al. 
2000; Colter et al. 
2001) 
Multipotent adult 
progenitor 
cells (MAPCs) 
Culture-derived bone 
marrow progenitor cells able 
to differentiate in 
neuroectodermic and 
endodermic derivates 
• Human (Reyes et al. 
2001) 
•  Murine (Jiang et al. 
2002)    
Marrow isolated adult 
multilineage inducible 
cells (MIAMI) 
Culture-derived bone 
marrow-derived progenitor 
cells able to differentiate in 
vitro into mature-like cells 
from all three germ layers. 
• Human (D'Ippolito et 
al. 2004) 
Pluripotent 
unrestricted somatic 
stem cells (USSCs) 
Culture derived cord blood 
cells able to differentiate in 
vitro into osteoblasts, 
chondrocytes, adipocytes, 
and neural progenitors. 
• Human (Kogler et al. 
2006) 
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1.3  BMSC immunophenotype 
Several laboratories have developed monoclonal antibodies using BMSCs as 
immunogen in order to identify one or more markers suitable for identification 
and sorting of stromal cell preparations. Hpwever, to date, the isolation of a 
“pure” population of multipotent marrow stromal stem cells remains elusive and 
the immunophenotypical identification of BMSC is still based on a combination 
of negative and positive markers, rather than on a precise and specific subset of 
antigens. 
There is a consensus that both human and murine BMSCs do not express CD45, 
marker of all haematopoietic cells,  glycophorin-A, an erythroid lineage marker,  
or CD11b, an immune cell marker (Lai et al. 1998; Deans et al. 2000).  CD34, the 
primitive haematopoietic stem cell (HSC) marker, is rarely expressed in human 
BMSCs, although can be positive in mice (Peister et al. 2004). CD31, expressed 
on endothelial and haematopoietic cells, and CD117, a haematopoietic 
stem/progenitor cell marker, are almost always absent on human BMSCs 
(Pittenger et al. 1999; Colter et al. 2001), whereas they are present on murine 
(Baddoo et al. 2003). 
In particular, some antigens have had particular relevance and have been used for 
positive selection of BMSCs, such as Stro-1 (Simmons et al. 1991), CD105 and 
CD73 (Haynesworth et al. 1992), CD271 (Quirici et al. 2002), SSEA-1 and 
SSEA-4 (Anjos-Afonso et al. 2007; Gang et al. 2007) and, more recently, CD146, 
which is the only one identified on BMSCs in vitro and in vivo (Sacchetti et al. 
2007). 
Stro-1 is by far the best-known BMSC marker (Simmons et al. 1991). The cell 
population negative for Stro-1 is not capable of forming colonies, whereas Stro-1- 
positive cells can become HSC-supporting fibroblasts, smooth muscle cells, 
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adipocytes, osteoblasts, and chondrocytes (Gronthos et al. 1994), which is 
consistent with the functional role of BMSCs.  
However, Stro-1 is unlikely to be a general BMSC marker, for, at least, three 
reasons: 
- there is no known mouse counterpart of Stro-1 
- Stro-1 expression is not exclusive to BMSCs 
- Stro-1 expression in BMSCs is gradually lost during culture 
expansion limiting the use of Stro-1 labelling to the isolation of 
BMSCs and/or their identification during early passages. 
In the 17 years since Stro-1’s discovery, no consensus has emerged regarding its 
use to purify BMSCs. This is due particularly to the fact that other investigators 
have failed to detect this antigen on BMSCs.  
In the laboratory of Caplan  some  monoclonal antibodies against CD105 (SH-2), 
or CD73 (SH-3 and SH-4) were developed (Haynesworth et al. 1992). These 
antibodies react against CD105, endoglin, a 5′-nucleotidase, regulatory 
component of the TGF-beta receptor complex, or CD73, which is the lymphocyte-
vascular adhesion protein 2. Although these antigens were also expressed on 
many other cell types, these antibodies were developed with specificity for 
mesenchymal tissue-derived cells, providing a new tool in BMSC isolation 
(Haynesworth et al. 1992).  
Several years later, Thomson et al. identified expression of CD271, the low 
affinity receptor for nerve growth factor (NGF) on BMSCs (Thomson et al. 1988). 
Although its function is still unknown, CD271 is highly expressed on directly 
isolated BMSCs (10% of total bone marrow cells), is maintained in un-stimulated 
in vitro cultures and is rapidly down-regulated upon differentiation. These 
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characteristics made this antigen a good target for antibodies to be employed in 
positive selection (Quirici et al. 2002). 
Very recently it has been reported the identification, isolation, and detailed 
characterization of a primitive mesenchymal progenitor cells in the adult murine 
and human bone marrow, based on the expression of stage-specific embryonic 
antigen–1 (SSEA-1) and stage-specific embryonic antigen–3/4 respectively 
(Anjos-Afonso et al. 2007; Gang et al. 2007). These antigens have been 
characterized as overlapping carbohydrate epitopes on globo- and lacto-series 
glycolipids (Kannagi et al. 1983; Henderson et al. 2002). Human ES cell lines 
retain the earlier globo-series pathway and are SSEA-3/4 + SSEA-1- (Henderson et 
al. 2002), whereas mouse ES cell lines use the lacto-series pathway and are 
SSEA-3/4- SSEA-1+ (Henderson et al. 2002). With the exception of certain highly 
specialized cell types, the globo-series ganglioside synthesis pathway has been 
thought restricted to the pre-implantation embryo and not available to somatic cell 
types (Kannagi et al. 1983). Although the function of these carbohydrate antigens 
is still unknown, it is intriguing that in addition to pluripotent ES and EC cells, 
they are also present on the surface of multipotent BMSCs. Although the evidence 
associating these markers with a “stemness” state is correlative, it suggests some 
overlap in specialized metabolic pathways between pluripotent ES cells and 
multipotent BMSCs (Anjos-Afonso et al. 2007; Gang et al. 2007).  
Importantly, two years ago, Sacchetti et al. demonstrated that self-renewing 
osteoprogenitors isolated from human bone marrow and able to regenerate bone 
and stroma, and organize a haematopoietic microenvironment in vivo are 
CD146High (a melanoma associated cell adhesion molecule), possibly providing a 
positive selectable marker for BMSCs in fresh tissue (Sacchetti et al. 2007). 
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Chapter 2 
Reaching a balance between self-renewal and 
differentiation 
Stem cells share the defining characteristics of self-renewal, which maintains or 
expands the stem-cell pool, and multi-lineage differentiation, which generates and 
re-generates tissues. These processes are influenced by the convergence of 
intrinsic cellular signals and extrinsic micro-environmental cues from the 
surrounding stem-cell niche, but the specific signals involved remain largely 
unknown (Watt et al. 2000, Figure 4).  
Recently, several studies based on genomic array have sought to identify the 
genetic mechanisms that underlie the stem-cell phenotype. It has been postulated 
that, although each unique stem cell can be characterized by the expression of a 
specific set of genes, the defining self-renewal and multi-lineage differentiation 
characteristics of stem cells are encoded by a shared set of genes that are 
expressed by all distinct stem-cell populations, and that therefore represents a 
conserved stem-cell molecular signature (Ivanova et al. 2002; Ramalho-Santos et 
al. 2002; Fortunel et al. 2003). Several studies have examined the gene-expression 
pattern of both embryonic and adult stem-cell populations, such as bone marrow 
stromal cells. In particular, some candidate gene and proteomic approaches have 
provided interesting data on pathways involved in BMSCs self-renewal (Roche et 
al. 2006; Song et al. 2006; Jaishankar et al. 2008), however, there are 
inconsistencies in the resultant lists of ‘stemness’ genes and mechanisms involved 
in BMSC self-renewal, differentiation and maintenance of the niche are still 
unknown. In this chapter, I report new advances on self-renewal and regulation of 
specific lineage differentiation of BMSCs.  
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Figure 4  Bone marrow niche 
Quiescent stem cells are anchored in the centre of the niche, whereas self-renewing stem 
cells are located close to the border separating the niche from the non-niche 
microenvironment. At this interface, niche signals (differentiation and/or division 
repression) and non-niche microenvironment signals (differentiation and/or division 
induction) form a signalling centre. The appearance of a stem cell at the niche edge 
would expose it to proliferative and anti-adhesive signals emanating from the non-niche 
microenvironment. At the onset of cell division, one daughter cell would transit the 
interface towards the non-niche microenvironment to initiate differentiation, while the 
other would remain in the niche as a self-renewing stem cell, thereby achieving 
asymmetric division by environmental asymmetry. Alternatively, signals from the 
periphery might induce asymmetric division of a formerly quiescent stem cell by 
polarization of determinants (right). Attachment of stem cells to niche cells (and possibly 
signals exchanged between them) would maintain stem-cell fate, while the budding 
daughter cell would initiate differentiation. Adapted from Wilson A. Nature Immunology 
Review 2006. 
 
2.1 Niche-External signals 
The external signals that control stem cell fate collectively make up the stem cell 
micro-environment, or niche. A complex interplay of short- and long-range 
signals between stem cells, their differentiating daughters, and neighbouring cells 
are involved in the niche maintenance (Figure 4). Soluble factors, cell-cell 
interaction and cell-extra-cellular matrix interaction seem to contribute to the self-
renewal of different type of stem cells (Watt et al. 2000; Moore et al. 2006; 
Wilson et al. 2006). The most important signals implicated in BMSC ‘stemness’ 
maintenance are some cytokines such as leukaemia inhibitory factor (LIF, Jiang et 
al. 2002; Metcalf 2003), fibroblast growth factors (FGFs, Bianchi et al. 2003; 
Zaragosi et al. 2006; Choi et al. 2008) and  mammalian homologues of 
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Drosophila wingless (Wnts, Boland et al. 2004; Etheridge et al. 2004; Kleber et 
al. 2004; Ling et al. 2008). These factors have drawn particular focus because of 
their demonstrated role in the self-renewal of other stem cell types, in the 
maintenance of undifferentiated embryonic mesenchymal tissue, and/or in de-
differentiation programs, including tumorigenesis (Figure 5).  
 
 
 
Figure 5 BMSC self renewal and cytodifferentiation 
In this theoretical model, BMSCs have the capacity to differentiate into all connective 
tissue cell types, including bone, cartilage and adipose tissue. Furthermore, BMSCs have 
the potential for self-renewal and proliferation and, under defined environmental cues, 
can commit to a particular differentiation pathway. The lineage-committed cell 
progresses through several stages of maturation prior to the onset of terminal 
differentiation, which is marked by the cessation of proliferative capacity and shift 
toward synthesis of tissue-specific markers, including components of the extra cellular 
matrix. 
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2.1.1 Leukaemia inhibitory factor (LIF) 
LIF, a pleiotropic cytokine, is secreted by BMSCs (Kim et al. 2005) and maintains 
the stem state of BMSCs (Jiang et al. 2002) and other stem cells (Metcalf 2003; 
Ying et al. 2003). LIF also has been considered as a cytokine of neuroimmune 
system with the particular characteristic of stimulation and repression  on 
osteoblast and osteoclast activities (Metcalf 2003) and responsible for blocking 
osteoblast maturation at late differentiation stages and redirect these cells toward 
the adipogenic pathway (Falconi et al. 2007; Falconi et al. 2007). These data 
suggest that the cellular environment and the developmental stage of the target 
cell influence its differential responses to LIF. Mechanisms of LIF action in 
BMSC self-renewal are unknown but may involve paracrine crosstalk with 
neighbouring cells (Metcalf 2003). 
 
2.1.2 Fibroblast growth factor 2  
FGF2 maintains the stem state of BMSCs from a variety of species by prolonging 
their viability in culture and maintaining their differentiation potential at least for 
50 population doublings (Bianchi et al. 2003; Choi et al. 2008) and suppressing 
the cellular senescence (Ito et al. 2007). The underlying mechanism and the target 
genes of FGF responsible of these effects are not known. It is has been proposed 
that this could be  a cell-autonomous mechanism (Zaragosi et al. 2006) and that it 
could be based on the activation of the ERK1/2 and PI3K-Akt signalling pathways 
(Choi et al. 2008). Very recent data based on gene expression profiling provided 
new insights in FGF targets in BMSCs (Ng et al. 2008). 
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2.1.3 Wnt  
Wnt signalling has been implicated in the control over various types of stem cells 
and may act as a niche factor to maintain stem cells in a self-renewing state 
(Kleber et al. 2004) . Wnt3a treatment increases adult MSC proliferation and 
decreases the apoptosis, an effect that is consistent with the mitogenic role of 
Wnts in haematopoietic stem cells (Reya et al. 2003; Boland et al. 2004).  
 
2.2 Niche-Intrinsic signals 
Intrinsic regulators of self-renewal include the proteins responsible for setting up 
cell divisions, nuclear factors controlling gene expression and chromosomal 
modifications and telomere length (Watt et al. 2000).  
 
2.2.1 Transcription factors  
Embryonic stem (ES) cells maintain pluripotency by a transcriptional program 
that suppresses differentiation; this property is regulated by a small number of ES 
cell specific transcription factors such as Nanog, Oct-4 and Sox-2, whose 
expression is down regulated early during embryogenesis (Boiani et al. 2005). In 
the last two years several groups have shown the expression of Oct-4, Nanog and 
Sox2 in  BMSCs (Jiang et al. 2002; Anjos-Afonso et al. 2007; Beltrami et al. 
2007; Gonzalez et al. 2007; Greco et al. 2007; Kobayashi et al. 2008) and other 
adult stem cells (Battula et al. 2007; Beltrami et al. 2007; Nadri et al. 2008). 
Indeed, recent chromatin immunoprecipitation on chromatin immunoprecipitation 
array (Chip on Chip) studies suggest that some Polycomb chromatin-associated 
proteins are involved globally in maintaining the repression of differentiation 
Maria Teresa Esposito                                                                                                                                            PhD Thesis 
31 
genes (Boyer et al. 2006). Thus, Polycomb proteins may indirectly maintain Oct-
4, Sox-2, and Rex-1 activation in BMSCs. 
 
2.2.1.1 Oct4  
The octamer-bonding transcription factor 4 gene encodes a nuclear protein (Oct-
4, also known as Pou5F1 and Oct3/4) that belongs to a family of transcription 
factors containing the POU DNA- binding domain and which is expressed in 
embryonic stem cells and plays a critical role in maintaining pluripotency and 
self-renewal (Scholer et al. 1990). Deficiency of Oct-4 in ES cells by knock-out or 
knock-down procedures, abolish both self-renewal and pluripotency and results in 
differentiation to trophoectoderm lineage (Nichols et al. 1998). Oct-4 has 
therefore been viewed as being involved in preventing trophectoderm and perhaps 
somatic-cell differentiation from the inner cell mass, as well as being crucial for 
maintaining the pluripotent state during embryonic development. 
Several authors tried to identify the role of Oct-4 in BMSCs, starting from the 
expression of this protein in their cultures. Greco et al. demonstrated that Oct-4 
provides similar regulatory circuitries in human BMSCs and ESCs and that Oct-4 
promote the expression of BMSC-specific genes and regulate BMSCs cell cycle 
progression (Greco et al. 2007); however very recent papers  dispute the role of 
Oct-4 as stemness marker and its expression in BMSCs. Liedtke et al. raise the 
issue of six known Oct-4 pseudogenes as a source of confusion in stem cell 
research (Liedtke et al. 2007; Liedtke et al. 2008). Kotoula et al. demonstrate that 
the second isoform of hOct-4, hOct-4B, which is related neither to stemness nor 
pluripotency, can account for much of misinterpretation of experimental data 
(Kotoula et al. 2008); Cantz T. et al. demonstrated highly methylated regions in 
Oct-4 promoter of somatic tumor cell lines (Cantz et al. 2008). In addition, 
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Lengner et al. demonstrated, using a recombination approach to achieve specific 
inactivation of Oct-4 in bone marrow, that the absence of Oct-4 protein does not 
interfere with BMSCs self-renewal or differentiation (Lengner et al. 2007). 
 
2.2.1.2 Sox-2  
Sox-2 is a member of the HMG-domain DNA-binding-protein family that is 
implicated in the regulation of transcription and chromatin architecture (Pevny et 
al. 1997). Sox-2 forms a ternary complex with either Oct-4 or the ubiquitous Oct-
1 protein on the enhancer DNA sequences of Fgf-4. This allows Sox-2 to 
participate in the regulation of the inner cell mass and its progeny or derivative 
cells. Consistent with this role, Sox-2 is expressed in ES cells, but it is also 
expressed in neural stem cells (Episkopou 2005). When gene targeting has been 
used to inactivate Sox2 gene, the primitive ectoderm was defective (Avilion et al. 
2003). Very recently the expression of Sox-2 has been reported in BMSCs 
(Beltrami et al. 2007; Gonzalez et al. 2007; Kobayashi et al. 2008). Go et al., in a 
gain of function study, observed that Sox-2-expressing BMSCs showed much 
higher expansion potential than control cells in both high and low serum 
conditions and higher osteogenic differentiation abilities (Go et al. 2008). 
 
2.2.1.3 Rex-1 
The Rex-1 (Zfp-42) gene encodes a zinc finger family transcription factor which is 
highly expressed in mouse and human embryonic stem cells involved in DNA 
repair process (Cenkci et al. 2003). A recent papers dispute its role as stem cell 
marker for ES cells (Masui et al. 2008). Its expression has been reported in 
BMSCs (Beltrami et al. 2007) and MAPC (Jiang et al. 2002), although it has 
never correlated with a specific function. 
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2.2.1.4 Nanog 
Nanog is a transcription factor expressed in ES cells and is thought to be a key 
factor in maintaining pluripotency, as, when over expressed, it enhances ES cell 
self-renewal efficiency to the point of LIF-independence (Chambers et al. 2003; 
Mitsui et al. 2003). Conversely, deficiency of Nanog in ES cells by knock-out or 
knock-down procedures, abolish both self-renewal and pluripotency and results in 
differentiation to extra embryonic endoderm (Mitsui et al. 2003).  
Similar to Oct-4, it has been proposed that Nanog might regulate differentiation 
through the transcriptional repression of genes that promote differentiation, a 
proposal that was based on the presence of Nanog-binding sites in the control 
regions of Oct-4, Sox-2 as well as that of Rex1/Zfp42 (Mitsui et al. 2003). Thus 
negative regulation of Nanog is required to promote differentiation during 
embryonic development. Transcriptional activator and tumour suppressor p53 
binds to the promoter of Nanog, thereby enabling p53-dependent suppression of 
Nanog expression (Lin et al. 2005). Loss of p53 results in inefficient Nanog 
suppression during ES cell differentiation and in a 100-fold increase in 
susceptibility to testicular teratoma (Lam et al. 2003). Cues or agents that induce 
DNA damage also down regulate Nanog and this has been shown to maintain 
genetic stability in ES cells by inducing their differentiation into other cell types. 
Very poor data are available about the role of Nanog in adult stem cells, although 
in the last years many groups have reported Nanog expression in BMSCs (Jiang et 
al. 2002; Anjos-Afonso et al. 2007; Beltrami et al. 2007; Gonzalez et al. 2007; 
Greco et al. 2007; Kobayashi et al. 2008) and other adult stem cells (Battula et al. 
2007; Beltrami et al. 2007; Nadri et al. 2008). Very recently it has been 
demonstrated that that Nanog-expressing BMSCs show much higher expansion 
potential, higher osteogenic differentiation abilities and higher chondrogenic 
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differentiation abilities (Go et al. 2008; Liu et al. 2008), however the role of 
Nanog in adult stem cells as well as BMSCs is still disputed. 
 
2.2.2 Telomeres length  
A second potential clock mechanism is the telomere length. In somatic cells, 
telomere length is progressively shortened with each cell division both in vivo and 
in vitro due to the inability of the DNA polymerase complex to synthesize the 
very 5' end of the lagging strand (Harley et al. 1990). It has been suggested that 
telomeres protect chromosome ends since damaged chromosomes lacking 
telomeres undergo fusion, rearrangement and translocation. As  telomerase 
activity has been shown to be specifically expressed in immortal cells, cancer, 
germ cells and embryonic stem cells (Kim et al. 1994), progressive shortening of 
telomeres could act as a mitotic clock, counting off divisions before senescence. 
In BMSC, expression of telomerase is disputed; some studies did not find 
telomerase activity (Simonsen et al. 2002; Stenderup et al. 2003), but others did 
(Pittenger et al. 1999; Miura et al. 2006). Such differences may arise from 
different sensitivity of measurement and differing standards regarding which 
amount of telomerase activity can be referred to as telomerase-negative. 
 
2.3 Differentiation Potential  
The identification of specific signalling networks and ‘master’ regulatory genes 
that govern unique BMSC differentiation lineages remains a challenge. 
Information provided by various studies based on gene expression profiling (Song 
et al. 2006; Liu et al. 2007; Ng et al. 2008) or RNA interference (Zhao et al. 
2007), allowed to draw a model for the regulation of  adult stem cells 
differentiation, based on two continuous and distinct compartments (Figure 6). In 
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the first compartment (MSC compartment), BMSCs undergo transcriptional 
modification, generating precursor cells which continue to divide symmetrically, 
generating more tripotent and bipotent precursor cells. These tripotent and 
bipotent precursor cells are morphologically similar to the multipotent BMSCs, 
but differ in their gene transcription repertoire, and therefore, still reside in the 
stem cell compartment. Gene repression and induction have thought to be the 
principal mechanism involved in the maintenance of the niche (Quesenberry et al. 
2002). Upon stimulation, multipotent, uncommitted BMSCs undergo asymmetric 
division, giving rise to two daughter cells, one being the exact replica of the 
mother cell and maintaining multilineage potential, and the other daughter cell 
becoming a precursor cell, with a restricted developmental program (Quesenberry 
et al. 2002). At the present, what is not fully understood is the mechanism that 
governs the transit of uncommitted stem cells to partially committed precursor or 
progenitor cells, and then to fully differentiated cells (Figure 6). 
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Figure 6 The stromal system 
In the BMSC compartment the stem cells and progenitor cells express different “Gene 
Set” within a nucleus. This indicates the potential to differentiate in a specific cell type. 
When they live the niche different external stimuli can induce the differentiation; in this 
way these cells can acquire the phenotypic expression of the different lineage pathway as 
showed by the different cytoplasmic colours. Adapted from Dennis J.E. Stem Cells 2002. 
 
2.3.1 Osteogenesis 
During osteogenesis, multipotent BMSCs undergo asymmetric division and 
generate osteoprecursors, which then progress to form osteoprogenitors, pre-
osteoblasts, functional osteoblasts and osteocytes. This progression from one 
differentiation stage to the next is accompanied by the activation and subsequent 
inactivation of transcription factors, i.e., Cbfa1/Runx2, Msx2, Dlx5, Osx, and 
expression of bone-related marker genes, i.e., osteopontin, collagen type I, 
alkaline phosphatase, bone sialoprotein, and osteocalcin (Karsenty et al. 2002; 
Harada et al. 2003) (Figure 7).  
The BMPs pathway has a well known role in promoting osteogenesis (Chen et al. 
2004). Other cytokines, such as members of Wnt family have recently shown a 
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role in osteogenesis (Hartmann 2006), however different members can have 
dramatically different effects (Boland et al. 2004). 
The targets of osteogenic pathways are the two master genes, CbfaI/Runx2 and 
Osterix. CbfaI/Runx2 is a member of Runt family of transcription factors; it has 
an essential role in the differentiation of mesenchymal progenitors in osteoblasts 
in both the endochondral and membranous skeletons.  Besides its role in 
osteogenesis, it is also required for hypertrophic chondrocyte differentiation 
(Ducy et al. 1997). Osterix is a zinc finger–containing transcription factor that is 
expressed in osteoblasts of all endochondral and membranous bones. In osterix 
null mutants no endochondral and no intramembranous bone formation occur. 
Arrest in osteoblast differentiation occurs at later step than in Runx2/Cbfa I null 
mice, suggesting that this factor is down stream of CbfaI/Runx2 (Nakashima et al. 
2002). It has been proposed that osterix might be a dominant negative regulator of 
Sox-9 and Sox-5 expression preventing bi-potential progenitors from choosing a 
chondrocyte differentiation pathway (Nakashima et al. 2002, Figure 7). 
 
2.3.2 Chondrogenesis 
Chondrogenic differentiation of BMSCs in vitro mimics that of cartilage 
development in vivo. The transcription factor Sox-9 is considered the master gene 
of chondrogenesis and is responsible for the expression of  extra cellular matrix 
(ECM) genes such as collagen types II and IX, aggrecan, biglycan, decorin, and 
cartilage oligomeric matrix protein (Goldring et al. 2006, Figure 7). However, the 
specific signalling pathways that induce the expression of these benchmark 
chondrogenic genes remain generally unknown. Naturally occurring human 
mutations and molecular genetic studies have identified several instructive 
signalling molecules, including various transforming growth factor-β (TGF-β) 
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(Massague et al. 2000), bone morphogenetic protein (BMP), growth and 
differentiation factor (GDF, Chen et al. 2004) and Wnt ligands (Hartmann 2006). 
 
2.3.3 Adipogenesis 
The nuclear hormone receptor peroxisome proliferators activated receptor γ 
(PPARγ) is a critical adipogenic regulator promoting BMSC adipogenesis while 
repressing osteogenesis (Rosen et al. 2006) (Figure 7). The binding of PPAR γ to 
various ligands, including long chain fatty acids and thiazolidinedione 
compounds, induces the transactivation and transrepression of PPARγ. The 
bipotent co regulator TAZ was recently discovered to function as a coactivator of 
Runx2 and as a co repressor of PPARγ, thus promoting osteogenesis while 
blocking adipogenesis (Hong et al. 2005). A similar role is played by Wnt 
signalling. As discussed above, some  members of Wnt family have recently 
shown a positive role in osteogenesis (Hartmann 2006); on the other hand  
suppression of Wnt signalling is required for the cells to undergo adipogenesis 
(Liu et al. 2004).  
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Figure 7 Molecular regulation of BMSC differentiation 
BMSC is the precursor of osteoblasts, adipocytes and chondroblasts. Expression of 
specific master genes is essential to drive BMSC towards osteo-, chondro- or adipogenic 
differentiation. These processes involve different intermediate stages and the expression 
of different markers. 
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Chapter 3 
Senescence and transformation 
Most, if not all, human adult cells can undergo 50–60 divisions before they 
become senescent. This limited replicative capacity is also known as the ‘Hayflick 
limit’, according to its discoverer Leonard Hayflick (Hayflick 1965) and it is 
thought to be determined by chromosomal telomere shortening after each cell 
division. It is well known that cells can escape this process in vitro by acquiring 
mutations in specific genes in a process called transformation. Functional 
mutations that provide a growth or survival advantage produce positive selection 
for the mutant stem cell clone, with full fledged cancer resulting from the 
accumulation of multiple cancer-promoting events. To offset this possibility, stem 
cells appear to have evolved multiple reinforcing mechanisms that are aimed at 
maintaining genomic integrity (reviewed by Pelicci et al. 2004 and Sharpless et al. 
2004). When mutations occur, despite these error prevention capacities, potent 
tumor suppressor mechanisms such as senescence and apoptosis are activated to 
sense damaged stem cells genomes with malignant potential and limit replicative 
ability of such clones (Figure 8). 
Due to the huge number of clinical trials employing BMSCs (Le Blanc et al. 
2005; Giordano et al. 2007), a careful consideration about the factors involved in 
senescence and tumorigenic potential of this population is necessary. 
 
 
 
 
 
Maria Teresa Esposito                                                                                                                                            PhD Thesis 
41 
 
Figure 8 Fates of damaged stem cells 
A limited number of outcomes appear to be possible for stem cells with heritable DNA 
damage. Although it is likely that many mutational events do not lead to any alteration of 
stem-cell function, significant damage is expected to induce apoptosis, senescence, 
transformation or dysfunction. Examples of DNA lesions associated with each outcome 
are indicated. Mutations in RAS and the tumour-suppressor p53 are associated with 
transformation, unrepaired double-strand DNA breaks (DSBs) and telomere dysfunctions 
induce apoptosis and senescence, respectively. SA- SP, senescence-associated secretory 
phenotype. Adapted from Sharpless N. Nature Review Molecular Cell Biology 2007. 
 
 
3.1 Defining senescence  
Senescence, according the definition of Campisi, is “an essentially irreversible 
arrest of cell division” (Campisi 2000).  
The most accredited hypothesis is that accumulation of senescent cells contributes 
to an ‘aging’ phenotype in vivo. In this contest, the process of senescence 
represents a means to eliminate cells that acquired DNA damage and/or became 
transformed, that compromise organismal integrity (reviewed by Sharpless et al. 
2007). The processes involved in BMSCs senescence are poorly understood. One 
of the most common observation in a large number of papers is that culture-
expanded hBMSC usually stop proliferating before or at 40 population doublings 
(PD's; at least 60 for mBMSC, see Tropelet al. 2004), at which time the cells lose 
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spindle-shaped fibroblastic morphology and become bigger and more flattened 
(Bruder et al. 1997; Stenderup et al. 2003). A phenomenon largely associated with 
senescence in vitro (Hayflick 1965; Dimri et al. 1995). Indeed, several studied 
reported a dramatic change in differentiation potential during the in vitro culture 
(Digirolamo et al. 1999; Pittenger et al. 1999).  
Many kinds of oncogenic or stressful stimuli can induce a senescence response. In 
the BMSCs field it has been reported that DNA damage (Galderisi et al. 2008), 
shortening of telomere length (Baxter et al. 2004; Bonab et al. 2006; Guillot et al. 
2007) and epigenetic changes to chromatin organizations (Di Bernardo et al. 
2008) seems to be the principal inducing factors (Sethe et al. 2006). Indeed, very 
recently, some micro-array studies have provided new insights in the 
understanding of molecular pathway involved in BMSC senescence (Ryu et al. 
2008; Wagner et al. 2008). 
 
3.1.1 DNA damage  
DNA is subjected to spontaneous and extrinsic mutational events on daily basis, 
and despite a formidable capacity for repair, some damaged DNA appears to 
evade repair and accumulates over time. Evidences in support of the notion that 
DNA damage attenuates BMSCs function have been provided by recent studies 
(Galderisi et al. 2008; Wagner et al. 2008). 
Galderis U. et al. demonstrated that during in vitro culture of rat BMSCs, these 
cells showed an increased growth doubling time, lost telomerase activity and 
expressed senescence associated beta-galactosidase (SA-β-Gal) (Dimri et al. 
1995; Galderisi et al. 2008). This phenotype was accompanied by down-
regulation of several genes involved in stem cell self-renewal (Nanog, Sox-2, 
KLF-4 and Bmi1) and DNA repair (especially genes involved in base excision, 
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nucleotide excision and mismatch repair). These data confirmed the importance of 
DNA repair in the maintenance of BMSCs genomic integrity, and that activation 
or response to DNA damage is essential to overcome senescence. 
 
3.1.2 Telomere length  
One of the mechanisms underlying cell senescence is loss of telomere length. A 
number of studies have measured telomere length of BMSCs, with varied results. 
Baxter et al. described in an in vitro culture system,  a progressive loss of 
telomere length with each cell division and found that hBMSCs stop dividing 
when telomere length reaches about 10 kb (Baxter et al. 2004). Several groups 
documented telomere loss of up to 1.5–2 kb upon passage in vitro (Bonab et al. 
2006; Guillot et al. 2007).  
As mentioned in the Chapter 2, section 2.2.2, expression of telomerase is still 
disputed in BMSCs. Some studies find no telomerase activity (Simonsen et al. 
2002; Stenderup et al. 2003), but in others a certain activity is detected (Pittenger 
et al. 1999; Miura et al. 2006; Galderisi et al. 2008). In order to understand the 
role of telomerase activity in BMSCs senescence, several groups have tested 
whether forced expression of telomerase reverse-transcriptase (TERT) would 
extend the lifespan of hBMSC. 
hTERT-transduced hBMSC have prolonged replicative capacity in vitro, as they 
undergo more than 260 PDs, whereas they retained adipo-, chondro- and 
osteogenic differentiation potential in vitro and osteogenic potential in vivo (Shi et 
al. 2002; Simonsen et al. 2002; Ryu et al. 2008). 
According to these studies, the ectopic expression of hTERT can maintain the 
proliferative and differentiation  ability of human BMSC, without altering the 
karyotype and without providing a tumorigenic potential (Shi et al. 2002; 
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Simonsen et al. 2002); evidence that is not confirmed by several other studies 
(Serakinci et al. 2004; Rubio et al. 2005; Miura et al. 2006).  
 
3.2 Molecular pathways involved in senescence 
Although diverse stimuli can induce a senescence response, they appear to 
converge on either or both of two pathways that establish and maintain senescence 
and growth arrest.  This arrest is primarily caused by the expression of cell-cycle 
inhibitors. Among these, two are often expressed by senescent cells: the cyclin-
dependent kinase inhibitors p21CIP1 and p16INK4A. These proteins are key 
components of tumor suppressor pathways that are governed by p53 and pRB 
(Campisi et al. 2007; Serrano et al. 2007; Sharpless et al. 2007, Figure 9). 
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Figure 9 Roles of p53 and p16RB pathways in senescence response 
p53 activity is predominantly regulated at the protein level. In the unstressed state, p53 is 
rapidly degraded by MDM2; a process which is inhibited by ARF. Also, p53 can be 
stabilized by N-terminal serine phosphorylation in response to genotoxic stresses, and 
this phosphorylation inhibits its interaction with MDM2. p53 activation potently induces 
either growth arrest or apoptosis depending on cellular context. The antiproliferative 
activity of p53 in part results from p21 expression, which is a p53 transcriptional target. 
Rb is inactivated by phosphorylation as a result of the cyclin-dependent kinases CDK4 
and CDK6. Hypophosphorylated Rb binds E2F and represses proliferation. CDK activity 
is inhibited by  p19ARF. 
 
3.2.1 p19ARF/p53 pathway 
p53 is a crucial mediator of cellular responses to DNA damage, including the 
senescence response (Campisi et al. 2007; Serrano et al. 2007; Sharpless et al. 
2007). 
In normal cells p53 is usually inactive, bound to the protein MDM2, which 
prevents its action and promotes its degradation by acting as ubiquitin ligase. At 
least in some cells, the induction of senescence by DNA damage, telomere 
dysfunction, and possibly oncogene over-expression can cause activation of p53 
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through ATM or p19ARF (p14ARF in human cells). p19ARF phosphorylate p53 
at sites that are close to or within the MDM2-binding region, blocking the 
degradation MDM2 dependent and binds directly to and sequesters MDM2, 
inhibiting the capacity of MDM2 to induce degradation of the p53 tumor 
suppressor protein. This loss of MDM2 function, in turn, results in the 
stabilization of p53 and activation of p53-mediated growth arrest or apoptosis 
(Sherr et al. 2000, Figure 9). Once activated p53 activates expression of several 
genes including one encoding for p21, that interacts with the G1-S/CDK and 
S/CDK complexes (molecules important for the G1/S transition in the cell cycle) 
inhibiting their activity (Campisi et al. 2007; Serrano et al. 2007; Sharpless et al. 
2007). 
The role of p53 in BMSC senescence is still not clear. Some studies report the up-
regulation of p53 during the cellular senescence (Ito et al. 2007; Rubio et al. 2008) 
and others do not report any significative changes (Galderisi et al. 2008). 
 
3.2.2 p16/pRB pathway 
Although the p53 inactivation reverses the senescence arrest in some cells, it fails 
to do in others (Beausejour et al. 2003).  
p16 is a positive regulator of pRB and a tumor suppressor in its on right (Campisi 
et al. 2007; Serrano et al. 2007; Sharpless et al. 2007). 
It is induced by varied stressful stimuli, including over-expression of oncogenes. 
Some cells spontaneously reduce or silence p16 expression, often by promoter 
methylation and activate its expression during long-term culture and upon 
replicative senescence, as reported in hBMSCs by Shibata et al. (Shibata et al. 
2007). Thus, the p16 tumor suppression and the pRB pathway provide a 
formidable barrier to cell proliferation, which cannot be overcome by loss of p53 
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function. The mechanisms involved in the implementation of senescence by 
p16/RB pathway are not completely understood, however pRB seems to be 
involved in a reorganization of chromatin (Narita et al. 2003). Briefly, replicative 
senescent cells develop dense foci of heterochromatin which coincides with pRB- 
dependent heterochromatic repression of genes encoding cyclins and other 
positive cell cycle regulators (Narita et al. 2003).  
Up- regulation of 16INK4A seems to be the principal mechanism involved in BMSC 
senescence (Ito et al. 2007; Shibata et al. 2007; Galderisi et al. 2008). 
 
3.3 Overcoming the cell crisis: from senescence to spontaneous 
transformation 
As above described, after 20-40 population doublings in vitro, BMSCs enter a 
senescence phase, which they are able to bypass at a high frequency. These cells 
then continue to divide until they reach a crisis phase, characterized by 
generalized chromosome instability that provokes mass apoptosis (Campisi 2000; 
Sharpless et al. 2004; Serrano et al. 2007; Sharpless et al. 2007). Only some cells 
are able to escape from this crisis phase spontaneously, but those that do have 
undergone tumorigenic transformation. This phenomenon has been well described 
in the studies of Rubio (Rubio et al. 2005; Rubio et al. 2008). In these studies the 
authors propose a two stage model, immortalization and transformation, in which 
BMSCs become tumor cell (Figure 10). In the first step the cells bypass the 
senescence. This phase is accompanied by c-myc over-expression and p16 
repression; many DNA repair proteins are subsequently down-regulated, whereas 
the cells are forced to proliferate. Consequently, the shortening of telomere length 
provokes the cell crisis phase in which they undergo stringent selection. In the last 
phase the cells up-regulate many DNA repair proteins, which may be necessary 
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for crisis bypass. Finally, escape from crisis is associated with telomere 
stabilization, Rb hyperphosphorylation and p16 deletion that seems to be essential 
to promote transformation (Sharpless et al. 2004). These essential steps in BMSC 
transformation have been confirmed by very recent papers (Miura et al. 2006; Li 
et al. 2007; Tolar et al. 2007; Rubio et al. 2008), leading to the application of 
“cancer stem cells” hypothesis for BMSCs.  
 
 
 
Figure 10 Model of spontaneous BMSC transformation 
In the model proposed by Rubio et al published on Plos One in 2008, bypass of 
senescence is the first step required to lead to transformation. Escape from crisis is 
associated with telomere stabilization, Rb hyperphosphorylation and p16 deletion that 
seems to be essential to promote transformation. Black and blue boxes represent 
chromosomes, orange boxes represent telomeres. 
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MATERIALS AND METHODS 
Chapter 4 
4.1 Mice 
C57BL/6 (H-2Kb) and nude mice (Foxn1nu/Foxn1) were obtained from Harlan 
Sprague Dawley Inc. All the experiments in this study are performed following all 
regulations protecting animals used for research purposes, including those of the 
DL 116/92. 
 
4.2 Cell cultures  
4.2.1 mBMSCs isolation and expansion 
C57Bl/6 mice were euthanized with carbon dioxide vapours. Using aseptic 
technique, skin were peeled from the top of each hind leg and down over the foot. 
Muscles were removed from legs and femurs and tibias were dislocated, removed 
and carefully cleaned of adherent soft tissue. Marrows were harvested by flushing 
bones three times with alpha-modified minimal essential medium (α-MEM) 
(Cambrex Bio Science) using a 26 gauge syringe. Cells were centrifuged 10 min 
at 500 g at room temperature. Supernatant were discarded and cell pellet were 
suspended in 10 ml of α-MEM. A little aliquot of cell suspension was diluted 
1:1000 with NH4Cl (StemCell Technologies) and incubated at 4°C for 15 minutes 
to lyse erythrocytes. I counted the number of viable cells of this aliquot with 
Trypan blue (Sigma-Aldrich) in a Burker chamber and then I suspended the cells 
in α-MEM supplemented with 10% selected FBS (HyClone), 2 mM L-Glutamine 
(Gibco, Invitrogen) and 10 U/ml penicillin-10 μg/ml streptomycin (Gibco, 
Maria Teresa Esposito                                                                                                                                            PhD Thesis 
50 
Invitrogen) (complete medium) to a final concentration of 5x106 viable nucleated 
cells per ml. I initially seeded 2x106 nucleated cells/cm2 in complete medium 
without any supplements in a six -well tissue culture dishes (TPP Techno Plastic 
Products). After three days I removed the non-adherent cells and waited for a sub-
confluent culture. Unfortunately, the cells failed to reach confluence and they 
formed only a little colony in the centre of the well. I tried to subculture this 
colony but the cells didn’t expand. I decided to change the medium in DMem and 
IMDM. In both these conditions, I obtained larger colonies: however, when I  
tried to subculture these colonies, the cells did not expand. When I added 20% 
bone marrow conditioned medium to the complete medium, as reported by Sun, 
the cells became confluent in 10-17 days (Sun et al. 2003). At that time they were 
washed twice with Ca2+Mg2+- free phosphate buffered saline (PBS, Gibco 
Invitrogen), detached with accutase (Innovative Cell Technologies) at 37°C for 10 
minutes and then suspended in 50% culture supernatant and 50% complete 
medium with the addition of: a) 20% bone marrow conditioned medium (Sun et 
al. 2003) (BF mBMSC), b) 20 ng/ml mEGF and 20 ng/ml PDGF-AA (Sigma-
Aldrich) after two weeks of culture in condition a (EP mBMSC) c) 20% MS5 
conditioned medium (Issaad et al. 1993) (M mBMSC) or d) 20% NIH3T3 
conditioned medium (Burroughs et al. 1994) (N mBMSC). The resulting 
suspensions were split 1:3. 50% of the culture medium was changed every 3-4 
days until the cultures became confluent, when they were washed twice with 
Ca2+Mg2+- free PBS, detached and split 1:2. At passage 4-5, cultures were 
transferred to 75 cm2 flasks or frozen at 2x106 cell/vial in 10% Dimethyl sulfoxide 
(DMSO) (Sigma-Aldrich ) and 90% FBS. 
Analogous protocol was used to isolate mBMSCs from Balb/c mice (B BMSCs) 
in the laboratory of Dr Nicole Horwood at Kennedy Institute of Rheumatology, 
Maria Teresa Esposito                                                                                                                                            PhD Thesis 
51 
Imperial College of London. B BMSCs were expanded in Mesencult (StemCell 
technologies). 
 
4.2.2 Preparation of bone-marrow conditioned medium  
The bone marrow conditioned medium has been prepared following the procedure 
described in the work of Sun  (Sun et al. 2003). Briefly, after flushing the bone 
marrows out of femur and tibia, fragments from these bones were cultured in α-
MEM supplemented with 20% FBS at 37°C in humidified atmosphere containing 
5% CO2 for three days. Then the incubation medium was collected by 
centrifugation at 2500 rpm for ten minutes and filtered through a 0.22 μm filter. 
MS-5 and NIH3T3 cell lines, obtained from DSMZ, were cultured in complete 
medium at 37°C in humidified atmosphere containing 5% CO2. Cells were sub-
cultured every three-four days and conditioned media were collected from each 
cell line, centrifuged at 2.500 rpm for ten minutes and then filtered through a 0.22 
μm filter. 
 
4.2.3 Culture of cell lines  
MC3T3-E1 sub4, C3H10T1/2, 293 and A549 cell lines were obtained from ATCC 
(American Type Culture Collection); ATDC5 cell line was obtained from ECACC 
(European Collection of Cell Culture). MC3T3-E1 sub4 cell line was cultured in 
IMDM (Sigma- Aldrich) supplemented with 10% selected FBS, 2 mM L-
Glutamine, 1 mM sodium pyruvate. For the osteogenic differentiation, cells were 
plated at 2x104 cell/cm2  and cultured in α MEM supplemented with 10% selected 
FBS, 2 mM L-Glutamine, 0.05 mM ascorbic acid 2-phosphate (Sigma-Adrich) 
and 10 mM β-glicerophosphate (Sigma-Adrich), changing the medium every 3 
days for 10 days (Wang et al. 1999). 
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293, A549 and C3H10T1/2 cell lines were cultured in complete medium. For the 
adipogenic differentiation of C3H10T1/2, the cells were allowed to reach 90% 
confluence and then cultured in α-MEM supplemented with 10% selected FBS, 2 
mM L-Glutamine, 10-6 M dexamethasone (Sigma-Adrich), 5 μg/ml insulin 
(Sigma-Adrich), 0.5 μM 3-Isobutyl- 1-methylxanthine (Sigma-Adrich)  and 50 
μM indomethacin (Sigma-Adrich)  changing medium every 3-4 days for 14 days 
(Cho et al. 2004). 
ATDC-5 cell line was cultured in DMEM/HamF12 (Sigma-Adrich)  
supplemented with 5% selected FBS and 2 mM L-Glutamine (Chen et al. 2005). 
Total RNA from MC3T3-E1, C3H10T1/2 and ATDC-5 was extracted from the 
cells using TriReagent (Sigma-Adrich) as described below. 
 
4.2.4 Culture of murine embryonic stem (mES) cells 
Mouse ES cell line E14 tg 2A (BayGenomics) was maintained in GMEM (Sigma-
Aldrich) supplemented with 10% FBS, 0.1 mM β-mercaptoethanol (Sigma-
Aldrich), 1 mM sodium pyruvate (Invitrogen), 1X non essential aminoacids 
(Invitrogen), 2 mM glutamine, 10 U/ml penicillin-10 μg/ml streptomycin and 
103U/ml leukaemia inhibitory factor (LIF) (Chemicon International) (ES complete 
medium). ES cells were routinely split every 2 days, and the medium was changed 
on alternated days. To analyze the expression of LIF in NIH3T3 supernatant, I 
plated mES cells at 10 cell/cm2 density in ES complete medium. After 24 hours I 
changed the medium and maintained cells in ES complete medium (positive 
control), in ES complete medium without LIF (negative control), in supernatant 
NIH3T3, supplemented with 10% FBS, 0.1 mM β-mercaptoethanol, 1 mM 
sodium pyruvate, 1X non essential aminoacids, 2 mM glutamine, 10 U/ml 
penicillin-10 μg/ml streptomycin in absence or presence of blocking anti-LIF 
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antibody (Chemicon International), according to the manufacture’s instructions. 
The medium was changed every day. After six days we analyzed the formation of 
alkaline phosphatase positive colonies. 
 
4.3 Flow cytometry analysis  
Cells were detached with accutase at 37°C for 10 minutes and suspended in 
complete medium. The fraction to be analyzed (2x105/tube) was centrifuged, 
suspended in PBS supplemented with 2% FBS and incubated for 30 minutes at 
4°C with a panel of monoclonal antibodies directly coupled with Phycoerythrin 
(PE) or Fluorescein isothyocyanate (FITC) including Ly-1 (CD5), CD19, Ly-5 
(CD45) , CD34 (Santa Cruz Biotechnology), Ly-24 (CD44), CD117 (c-kit) , 
CD13, Ly-6A/E (Sca I) and MHC-I (H2-k b) (BD Biosciences). 
Excess antibodies were removed by washing with PBS. At least 10,000 events 
were collected and analyzed with FACS Canto II (BD Biosciences). 
 
4.4 Cumulative duplication number and doubling time 
measurement  
Cumulative population doublings were calculated from the initial number of 
mBMSCs at the first passage and the number of mBMSCs harvested at each of the 
following passage. This procedure provides a theoretical growth curve that is 
directly proportional to the cell number (Meirelles Lda et al. 2003). 
Doubling time measurement was obtained dividing the number of cells harvested 
after each passage by number of days in culture. 
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4.5 Cell cycle analysis  
For each assay, 2x106 cells were collected, suspended in PBS and fixed in 70% 
ethanol. After re-hydration with PBS and centrifugation at 500g for five minutes, 
the cell pellets were incubated with 500 μg/ml propidium iodide solution (Sigma-
Aldrich) at the dark for 30 minutes at 37°C. Samples were analyzed by FACS 
Canto II (BD Biosciences Pharmingen). DNA peaks were analyzed by ModFit 
LT. 
 
4.6 Senescence associated Beta Galactosidase (SA-B-Gal) staining  
Cells were fixed for 10 minutes with 2% formaldehyde/0.2% glutaraldehyde 
(Sigma-Adrich). Cells were washed with PBS and then incubated at 37°C for at 
least two hours with a staining solution (30mM Citric Acid/Phosphate buffer, 5 
mM K4Fe(CN)6, 5 mM K3Fe(CN)6, 150 mM NaCl 2mM MgCl2, 1mg/ml X-gal 
solution) (all reagents from Sigma-Adrich) (Dimri et al. 1995). Cells were 
counted in at least 12 fields for each well. The number of senescent cells was 
calculated by the mean of blue cell number (β galactosidase positive cells) out of 
three wells. 
 
4.7 Telomeric Repeat Amplification protocol (TRAP) Assay  
Telomerase activity products of mBMSCs were analyzed according the guidelines 
of TRAPeze ELISA detection kit (Chemicon International). Reaction consists on 
TRAP extension/amplification followed by results analysis by PAGE and ELISA. 
Briefly, cells were detached with accutase at 37°C for 10 minutes and suspended 
in complete medium. The fraction to be analyzed (1x106) was spun down, washed 
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in PBS and suspended in 200 µl of 1X CHAPS lysis buffer. Determination of 
protein concentration was obtained by Bradford Assay. 
1.5 µg of each extract was used in a PCR reaction (incubation at 30°C for 30 
minutes, followed by a two-step PCR at 94°C for 30 seconds, 55°C for 30 sec and 
72°C 30 sec for 36 cycles). TRAP products were analyzed on a 12% native 
polyacrylamide gel electrophoresis (PAGE) and, after electrophoresis, the gel was 
stained with ethidium bromide to visualize the TRAP ladder. As the TRAP 
products were tagged with biotin and DNP residues, they were also detected by 
ELISA. 
 
4.8 In vivo tumorigenicity: transplantation of mBMSCs into nude 
mice  
2x106 mBMSCs were suspended in a 1:1 mixture of PBS and injected 
subcutaneously in five nude mice (Foxn1nu/Foxn1+, 6-8 weeks of age from Harlan 
Sprague Dawley). As a positive tumor cell control, five mice received mES cells 
subcutaneously (2x106 cells/site). The mice that received mES cells were 
sacrificed 4 weeks post-transplantation, as, at this time, they formed a visible 
tumor on the neck. The other mice were sacrificed 10 weeks post-transplantation. 
Sites of injection were analyzed macroscopically and histologically; tissues were 
dehydrated through ascending concentrations of ethanol, embedded in paraffin 
and sectioned at 5 μm thicknesses. After deparaffinization, sections were stained 
with hematossilin and eosin (Bio-Optica). 
 
4.9 Immunofluorescence for Nanog detection  
Cells were fixed in 4% paraformaldehyde and permeabilized with 0.2% TX-100 
in 10% normal goat serum /1% BSA (Sigma-Aldrich) in PBS for 15 min at room 
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temperature. The samples were incubated with primary antibodies anti-Nanog 
(1:100 dilutions, R&D Systems) and then with an anti-goat IgG conjugated with 
Alexa Fluor 488 (Molecular Probes). Images were captured with an inverted 
microscope (DMI4000, Leica Microsystems). 
 
4.10 Differentiation Assay  
4.10.1 Osteogenic differentiation  
Cells were allowed to grow to 70-90% confluence and then cultured for 3 weeks 
in α-MEM supplemented with 10% FBS, 2 mM L-Glutamine, 10 U/ml penicillin -
10 μg/ml streptomycin,10-8 M dexamethasone, 0.05 mM ascorbic acid 2-
phosphate and 10 mM β-glicerophosphate, changing the medium every 3-4 days 
(Phinney et al. 1999).  
 
4.10.2 Chondrogenic differentiation  
Cells were trypsinized and suspended in DMEM/Ham's F12 medium 
supplemented with 10% FBS, 2 mM L-Glutamine, 10 U/ml penicillin -10 μg/ml 
streptomycin at a concentration of 107 cell/ml. A 10 μl drop was plated at the 
centre of well of 24 well-plate. Cells were allowed to adhere for 2-3 h at 37° C 
and 5% CO2, then the culture was flooded with 1 ml medium containing α-MEM 
supplemented with 1% FBS, 2mM L-glutamine, 10 U/ml penicillin -10 μg/ml 
streptomycin, 6.25 μg/ml insulin, 50 nM ascorbic acid 2-Phosphate, 10 ng/ml 
TGF-β1 (Sigma-Aldrich) and 12.5 μg/ml poly-Lysine (Sigma-Aldrich) very 
gently to not detach the cells nodules and  changing medium every 3-4 days (Sun 
et al. 2003). 
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Pellet cultures were used for functional study in chondrogenesis. Briefly, 2.5x105 
BMSCs were placed in a 15 ml polypropylene tube (Corning Costar) and 
centrifuged. The resulting pellets were cultured at 37°C with 5% CO2 in 500 µl of 
chondrogenic media that contained 10 ng/ml TGF-β1, 10-7 M dexamethasone, 50 
μg/ml ascorbate-2-phosphate, 100 μg/ml sodium piruvate and 1X ITS+1 (Sigma-
Aldrich). The medium was replaced every 3–4 days for 21 days (Mackay et al. 
1998). 
 
4.10.3 Adipogenic differentiation  
Cells were allowed to grow to 90-95% confluence and then cultured for 2 weeks 
in α-MEM supplemented with 10% FBS, 10% Horse Serum (Gibco Invitrogen), 2 
mM L-Glutamine, 10 U/ml penicillin-10 μg/ml streptomycin, 10-6 M 
dexamethasone, 5 μg/ml insulin, 0.5 μM 3-Isobutyl- 1-methylxanthine (IBMX ) 
and 50 μM indomethacin changing medium every 3-4 days (Digirolamo et al. 
1999).  
 
4.11 Histochemical analysis   
4.11.1 Alkaline Phosphatase (ALP) staining and activity assay  
Cells were washed with PBS and fixed in 10% cold Neutral Formalin Buffer 
(10% formalin, 0.1 M Na2HPO4, 0.029 M NaH2PO4.H2O) (Sigma-Aldrich) for 15 
min. After being rinsed with distilled water, cells were stained with substrate 
solution [2.4x10-4 M naphtol AS MX-PO4 (Sigma-Aldrich), 0.4% N,N 
Dimethylformamide  (Sigma-Aldrich), 1.6 μM red violet LB salt (Sigma-Aldrich)   
in 0.2 M Tris-HCl pH 8.3 (Carlo Erba Reagenti)] for 45 minutes. Excess staining 
was removed by washing twice with distilled water and then with 2.5% silver 
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nitrate (Sigma-Aldrich) for 30 min. The cells were washed again with distilled 
water and examined.   
For the determination of ALP activity, cells were washed twice with Tyrode’s 
balanced salt solution (50 mM Tris-HCl pH 7.4, 0.15 M NaCl) and then incubated 
with 5mM p-nitrophenol phosphate (Sigma-Aldrich) in 50 mM glycine (Sigma-
Aldrich), 1mM MgCl2 pH 10.5 at 37°C for 5-20 minutes.  The reaction was 
stopped adding 3M NaOH each well. Optical density (OD) was measured at 405 
nm (Bruder et al. 1997). 
 
4.11.2 Alizarin Red S staining  
Cells were washed with PBS and fixed in 10% formaldehyde for 1 hour; after 
rinsing with distilled water, they were incubated with 2% alizarin red s (Sigma-
Aldrich) pH 4.1 with gentle shaking for 10 minutes. Excess staining was removed 
by washing twice with PBS (Digirolamo et al. 1999). Dye was extracted by 
overnight incubation with 4M guanidine-HCl (Sigma-Aldrich) at room 
temperature. Absorbance at 490 nm of a ten- fold dilution of the resulting 
supernatant was used for quantitative mineralization determination. 
 
4.11.3 Von Kossa Staining 
Cells were washed with PBS and fixed in 10% formaldehyde for 1 hour; after 
rinsing with distilled water, they were incubated with 5% Aqueous Silver Nitrate 
Solution (Sigma-Aldrich) under UV light for 45 minutes. Excess staining was 
removed by incubation with 5% Sodium Thiosulfate (Sigma-Aldrich) for 1 
minute.  
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4.11.4 Alcian Blue staining  
Cells were fixed with 4% paraformaldheyde for 15 min at room temperature. 
After rinsing with PBS, they were stained with 1% alcian blue (Sigma-Aldrich) in 
0.1 N HCl pH 1.0 (Carlo Erba Reagenti) overnight. Cells were then dried, washed 
with 0.1 M HCl for 5 minutes to remove excess staining and washed again with 
distilled water (Denker et al. 1995). 
 
4.11.5 Oil Red O staining 
Cells were washed with PBS and fixed in 10% formaldehyde for 10 minutes. 
After rinsing with distilled water, they were stained with 0.5% oil red-o working 
solution prepared by vigorously mixing 3 parts of a stock solution (0.5% Oil Red-
O in isopropanol) (Sigma-Aldrich) with 2 parts of water for 5 minutes and 
filtering through a 0.4 μm filter. Excess staining was removed by washing twice 
with PBS. Cells were then counterstained with hematossilin for 3 minutes and 
then washed with distilled water (Digirolamo et al. 1999). Dye was extracted by 
isopropanol incubation for 15 min at room temperature. Quantitative assessment 
was obtained by absorbance of a ten-fold dilution of the extracted dye at 550 nm.  
 
4.12 Reverse Transcription Polymerase Chain Reaction (RT-
PCR)  
Total RNA was extracted from mBMSCs cultured in control or inductive media at 
different time points using TriReagent (Sigma-Aldrich), and then treated with 
DNase I (Ambion). RT-PCR was performed using M-MuLV Reverse 
Transcriptase (New England BioLabs) according to the manufacturer’s 
instructions. A twenty five-fold dilution of each sample was PCR amplified using 
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primers and conditions listed in Table 2. Amplified DNA fragments were 
separated on a 1% agarose gel containing 0.1 μg/μl ethidium bromide and 
visualized under UV light. 
 
Table 2: Specific primers for PCR  
 
 
Marker Forward Reverse cycle 
number 
size Ta Control 
Oct3/4 GCAGGAG
CACGAGTG
GAAAGCA
AC 
CAAGGC
CTCGAA
GCGACA
GATG 
30 269 65 mES 
 
Sox2 CGAGATA
AACATGGC
AATCAAAT
G 
AACGTTT
GCCTTAA
ACAAGA
CCAC 
30 232 61 mES 
Nanog ATGAAGTG
CAAGCGGT
GGCAGAA
A 
CCTGGTG
GAGTCA
CAGAGT
AGTTC 
30 464 60 mES 
Rex 1 TGACAAA
GGGGACG
AAGCAAG
AG 
GCCATC
AAAAGG
ACACAC
AAAG 
30 418 62 mES 
Cbfa 
1/runx2 
CCGCACGA
CAACCGCA
CCAT 
CGCTCCG
GCCCAC
AAATCTC
30 289 60 MC3T3 
Osterix CTGGGGA
AAGGAGG
CACAAAG
AAG 
GGGTTA
AGGGGA
GCAAAG
TCAGAT 
29 496 60 MC3T3  
Collagen I GAAGTCA
GCTGCATA
CAC 
AGGAAG
TCCAGG
CTGTCC 
30 313 50 MC3T3 
Osteopontin TCACCATT
CGGATGA
GTCTG 
ACTTGTG
GCTCTGA
TGTTCC 
30 437 50 Differentiated 
MC3T3  
Bone sialo 
protein 
CAAGCGTC
ACTGAAGC
AGGTG 
CATGCCC
CTTGTAG
TAGCTGT
ATT 
30 296 60 Differentiated 
MC3T3  
Osteocalcin TCTGCTCA
CTCTGCTG
AC 
GGAGCT
GCTGTG
ACATCC 
30 388 50 Differentiated 
MC3T3  
PPAR γ2 GCTGTTAT
GGGTGAA
ACTCTG 
 
ATAAGG
TGGAGA
TGCAGG
TTC 
30 351 54 Differentiated 
C3H10T1/2 
LPL GAAGGGA
AAGGACTC
ATCAGA
AGACAT
30 312 54 Differentiated 
C3H10T1/2 
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AGCAG 
 
CAGGCA
GG 
FABP-
4/aP2 
GGGATTTG
GTCACCAT
CCG 
CCAGCTT
GTCACC
ATCTCG 
30 204 54 Differentiated 
C3H10T1/2 
Adipsin CTGCTGGA
CGAGCAGT
GG 
GATGAC
ACTCGG
GTATAG
ACGC 
30 569 54 Differentiated 
C3H10T1/2 
Sox9 ATCGGTGA
ACTGAGCA
GCGAC 
GCCTGCT
GCTTCGA
CATCCA 
30 199 60 ATDC5  
Aggrecan TGGAGCAT
GCTAGAAC
CCTCG 
GCGACA
AGAAGA
CACCAT
GTG 
30 324 60 ATDC5  
Collagen XI GGAAAGA
TGGGCTAC
CAGGACA 
GGACGT
CCTGGC
AAACCA
ATTG 
30 412 60 ATDC5  
Collagen X GTGAGGTA
CAGCCTAC
CAGTTTT 
CTTTGTG
TGCCTTT
CAATCG 
30 157 50 ATDC5  
Actin GGTTCCGA
TGCCCTGA
GGCTC 
ACTTGCG
GTGCAC
GATGGA
GG 
26 370 62  
GAPDH GTATGACT
CCACTCAC
GGCAAA 
CTAAGC
AGTTGGT
GGTGCA
G 
26 400 60  
 
LIF  ACCTGTGC
CATACGCC
AC 
CTTCTGG
TCCCGG
GTGAT 
30 275 57  
 
 
4.13 Quantitative Real time PCR  
Quantitative real time PCR was performed with QuantiFast SYBR Green RT-PCR 
(Quiagen) according to the manufacturer in a Corbett machine. Briefly, 0.03 μg of 
total RNA was converted to cDNA  and used as template in a quantitative RT-
PCR reaction, following these conditions:  10 min at 50°C (reverse transcription), 
5min at 95°C (denaturation step), followed by  35 cycles of PCR (95°C for 10 s, 
60°C for 30 sec) by using 5 μl of 2x QuantiFast SYBR Green RT-PCR Master 
Mix, 1 µM forward primer, 1 µM reverse primerand  0.1μl of QuantiFast RT Mix. 
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The expression of murine GAPDH was used to normalize gene expression levels. 
Primers sequence in Table 3. 
 
Table 3: Specific primers for Real time-PCR  
 
 
Marker Forward Reverse 
Osteocalcin GACCTCACAGATGCCAAGC
C 
TTATTGCCCTCCTGCTTGGA 
Nanog TCAGAAGGGCTCAGCACCA GCGTTCACCAGATAGCCCTG 
Sox 2 CTGCAGTACAACTCCATGAC
CAG 
GGACTTGACCACAGAGCCCAT 
Oct4 AACCTTCAGGAGATATGCA
AATCG 
AACCTTCAGGAGATATGCAAA
TCG 
p53 CTCTCCCCCGCAAAAGAAA
AA 
CGGAACATCTCGAAGCGTTTA 
pRB ACAACCCAGCAGTGCGTTAT
C 
ACCAGGTCATCTTCCATCTGT 
CCL5 GCTGCTTTGCCTACCTCTCC TCGAGTGACAAACACGACTGC 
CXCL10 CCAAGTGCTGCCGTCATTTT
C 
GGCTCGCAGGGATGATTTCAA 
GAPDH GTATGACTCCACTCACGGCA
AA 
TTCCCATTCTCGGCCTTG 
c-myc GAGCTCCTCGAGCTGTTTGA
A 
CATCGTCGTGGCTGTCTGC 
TERT GCACTTTGGTTGCCCAATG GCACGTTTCTCTCGTTGCG 
 
 
4.14 Cell transfection  
4.14.1 Transfection with lipofectamine 2000  
Transfection with Lipofectamine 2000 (Invitrogen) was performed following the 
producer’s guidelines. Initially, cells were plated in 96 well- plates at 5x103 cells/ 
well and allowed to grow overnight to achieve 70%– 80% confluence. Cells were 
transfected at different DNA: lipofectamine 2000 ratio ranging from 0.07-1.5 µl 
of lipofectamine 2000 and 0.05-0.4 µg of DNA. The reagent/DNA mixture was 
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added to the OptiMem medium (Invitrogen) and the cells incubated for 6 hours, 
whereupon they were washed once with PBS and changed to standard medium.  
 
4.14.2 Nucleofection Technology  
Nucleofection of mBMSCs was performed according to the optimized protocols 
provided by the manufacturer (Amaxa Biosystem). Briefly, cells were gently 
suspended in 100 µl of V Solution (Amaxa Biosystem), mixed with DNA 
plasmid, and pulsed with program U-23. Immediately after, cells were transferred 
into pre-warmed fresh medium in six-well plates.  
 
4.14.3 Calcium Phosphate transfection  
Transfection of 293 cell line was performed using Profection mammalian system 
according to the optimized protocols provided by the manufacturer (Promega). 
Briefly, 1.6x106 cells were plated in 60 mm dish and allowed to attach overnight. 
10 µg of DNA were precipitated with 0.3 M Sodium Acetate pH 5.2 and 2.2 V/V 
of 100% cold ethanol. The day after, DNA was mixed with 0.25 M CaCl2 and 
then added drop wise to HBS solution in a ratio 1:1. The solution was incubated at 
room temperature for 30 minutes and then added to the cells. After 6 hours the 
medium was changed.  
 
 
4.15 Analysis of Green fluorescent protein (GFP) expression  
Analysis of GFP expression in mBMSCs was performed by fluorescence 
microscopy and flow cytometry.  
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For visualization of mBMSCs under fluorescence microscopy, GFP positive  cells 
were observed at 10X original magnification with a Zeiss Axiovert 10 inverted 
microscope equipped with an epifluorescent condenser HBO 100W/2 (lamp 
excitation range, 450 to 490 nm); micrographs were recorded with a Nikon 
Coolpix digital image system. 
For flow cytometry, cells were detached from culture flasks by incubation with 
0.25% Trypsin-EDTA for 5 minutes, recovered by centrifugation, and washed in 
flow cytometry buffer consisting of 2% BSA and 0.1% sodium azide (Sigma- 
Aldrich) in PBS. Non specific fluorescence was determined using mBMSCs 
transfected with no DNA. Samples were analyzed counting 10,000 events on 
FACS Canto II (BD Biosciences). 
 
4.16 Cell proliferation assay  
2.5x103 were seeded in each well of a 96 well-plates and cultured for 2, 4 and 7 
days in maintenance media. At nominated time-points, cell number was evaluated 
using CellTiter-Glo Luminescent Cell Viability Assay (Promega). 
To determine the effect of Nanog over-expression on mBMSCs proliferation rate, 
1x104 cells  were seeded in each well of a six well-plates in triplicate. Cell number 
was evaluated by counting cells with a hematometer in triplicate at day 3, 6 and 
10 days after seeding.  
4.17 Construction of expression plasmids  
Some clonings were done in order to generate pCAGGS-NSNS IRES-GFP 
WPRE, carrying the chicken β actin (CAG) promoter and Citomegalovirus 
(CMV) enhancer. 
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As these promoters did not drive the expression of GFP in mBMSCs, I cloned the 
CMV promoter in place of CAG promoter. 
pCAGGS-NSN was generated from the pCAGG vector (Addgene) by insertion of 
a polylinker XbaI/NheI/ScaI/NotI/XhoI. Briefly 5µg of oligos NSN were annealed 
and ligated with 50 ng of pCAGGS, previously digested with XbaI and XhoI. 
Ligation product was transformed in Xl-10 gold Escherichia Coli cells 
(Stratagene) and sequence verified. The resulting vector (pCAGGS-NSN) was 
further modified by insertion of a polylinker HindIII/SalI/HindIII, using the same 
ligation protocol used in the generation of pCAGGS-NSN. The resulting vector 
was pCAGGS-NSNS. 
pIRES-GFP (Applied Biosystem) was modified by insertion of a polylinker 
XhoI/NotI/BamHI using the same ligation protocol used in the generation of 
pCAGGS-NSN. The resulting vector was pIRES2-GFP-N. 
In order to clone IRES2GFP in pCAGGS-NSNS, pIRES2GFP-N- was digested 
with NotI and the insert was cloned in pCAGGS-NSNS, previously treated with 
NotI. Ligation product was transformed in Xl-10 gold Escherichia Coli cells and 
sequence verified. The resulting vector was pCAGGS-NSNS-IRESGFP. 
WPRE element  was amplified from p#277CCLSIN-S-PPT-hPGK-GFP-pre (a gift 
from Luigi Naldini’s lab) using the Pfx Taq DNA polymerase (Invitrogen) and 
adopting the following PCR conditions: 2 minutes of initial denaturation at 95°C, 
3 cycles of 15 s denaturation at 96°C and 30 s annealing at 56°C, followed by 3 s 
polymerization at 68°C. The 5’ region of all the primers contained sequences 
(underlined letters) recognized by the restriction enzyme XhoI, so that the 
amplification product contained restriction sites near to both ends. Amplicons 
were directly cloned into the vector pCAGGS-NSN-IRESGFP treated with XhoI. 
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The cloned inserts were transformed into XL10 gold Escherichia coli cells and 
sequence-verified.  
CMV promoter was amplified from pCMVGFP (Addgene) by PCR. The 5’ region 
of forward primer contained a sequence (underlined letters) recognized by the 
restriction enzyme SpeI, whereas the reverse primer contained a sequence 
(underlined letters) recognized by the restriction enzyme NheI,  so that the 
amplification product contained restriction sites near to both ends. Amplicons 
were directly cloned into the vector pCAGGS-NSN-IRESGFP-WPRE treated 
with XhoI. The cloned inserts were transformed into XL10 gold Escherichia coli 
cells and sequence-verified.  
Murine Nanog cDNA was obtained from Geneservice and amplified by PCR. The 
5’ region of all the primers contained sequences (uppercase letters) recognized by 
the restriction enzyme NheI, so that the amplification product contained restriction 
sites near to both ends. Amplicons were directly cloned into the vector pCMV-
IRESGFP-WPRE treated with XhoI. The cloned inserts were transformed into 
XL10 gold Escherichia coli cells and sequence-verified to distinguish between 
pCMVNanogIRES-GFP-WPRE and pCMVantiNanogIRES-GFP-WPRE. Primers 
are listed in Table 4. 
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Table 4 Primers used in molecular clonings 
Oligo name  Forward Reverse   Ta 
(°C) 
XbaI/NheI/
ScaI/NotI/ 
XhoI 
CTAgAAATTgCTAgCTAg
ATCgATAgTACTCgACTTg
CggCCgCAATCTAAC 
TCgAgTTAgATTgCggCCgC
AAgTCgAgTACTATCgATC
TAgCTAgcAATTT 
 
HindIII/Sal
I/HindIII 
AgCTTCggATAgTCgACAA
CgTC 
AgCTTgACgTTgTCgACTA
TCCTA 
 
XhoI/NotI/
BamHI 
TCgAgCgATCCAgCggCCg
CAACTgg 
gATCCCAgTTgCggCCgCTg
gATCgC 
 
WPRE gggCTCGAGATCGACAAT
CAACCTCTGGAT 
gggCTCGAGCAGGCGGGG
AGGCGGCCC 
63 
CMV 
promoter 
gggACTAGTTAGTTATTA
ATAGTAATCAATTACG 
gggGCTAGCCCGCGGGAT
CTGACGGTTCACTAAAC 
52 
Nanog ggggCTAgCTACCGCGGGC
CCGGGATCCATGAGTG 
cccgCTAGCGTCGCGGCC
GCTCATATTTCACCTG 
66 
 
4.18 Western blot analysis  
Cells were collected by centrifugation and cell pellet was suspended in lysis 
buffer (1mM EDTA, 50 mM Tris-HCl pH 7.5, 70 mM NaCl, 1% Triton, 50 mM 
NaF) containing 1X proteinase inhibitors (Roche) and incubated on ice for 30 
min. Following centrifugation at 16000 g for 15 min at 4°C, the supernatant 
containing total cell extract was collected and kept at -80°C. Proteins from cell 
extracts were quantified using Bradford assay. 
10 µg of cell extracts were loaded on a 12% polyacrylamide gel and then 
electrophoretically transferred onto a Hybond-PVDF membrane (GE Healthcare). 
The membrane was incubated for 1h at room temperature in blocking buffer 
(TBS-T containing 8% skim milk) to block non specific protein binding and then 
incubated at 4°C overnight with the primary antibody rabbit anti murine Nanog 
(CalbioChem) diluted 1:500 in blocking buffer or mouse anti murine GAPDH 
(Santacruz) diluted 1:100 in blocking buffer. Following four washes with TBS-T, 
the membrane was incubated for 1 hour with the HPR-conjugated antibody, goat 
anti rabbit (Dako) diluted (1:3000) in blocking buffer or sheep anti mouse (Ge 
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Healthcare) 1:5000. Antibody binding was visualized with an ECL Western 
blotting detection system (GE Healthcare).  
 
4.19 Migration assay  
BMSCs were suspended (5×104 cells per ml) in DMEM without FBS. Two 
hundred μl (1x104 cells) were added to the migration chamber (8-μm pore size) 
(BD Bioscience). The lower chamber contained 1 ml of DMEM containing 20% 
FBS. The plates were incubated at 37°C, 5% CO2 for 12 hours. After incubation, 
cells suspended in media in the migration chamber were gently removed by 
flipping out the medium. The cells adhering to the topside of the membrane were 
removed by scratching with a cotton applicator. 
The migration chamber plate was then stained with 1% Crystal violet (Sigma- 
Aldrich) and the cells analyzed under an inverted microscope. Cells were counted 
in at least 12 fields for each chamber plate. 
 
4.20 Soft agar assay  
A549, no DNA, GFP and Nanog transfected BMSCs were suspended at density 
105cell/ 0.5 ml  in a solution 1:1 of DMem 2X (Sigma-Aldrich) supplemented 
with 20% FBS and 0.6% low melting agarose, in order to obtain a final 
concentration of 0.3%. The suspension was layered as 0.5 ml each well of 6 well- 
plates, on 0.5% agarose. The cells were fed twice a week and after two weeks they 
were stained with 1% crystal violet. 
 
4.21 Statistical analysis  
All the experiments were analyzed using two two-way Student’s t-Test. p-values 
less than 0.05 were considered statistically significant. 
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RESULTS 
Chapter 5  
Establishment of mBMSC long term culture and 
morphologic characterization 
5.1 Background  
BMSC is a cell type better studied and characterized in humans than in mouse 
and, although in the last few years numerous protocols have been developed to 
isolate these cells, some problems still remain (Dobson et al. 1999; Phinney et al. 
1999; Baddoo et al. 2003; Meirelles Lda et al. 2003; Sun et al. 2003; Peister et al. 
2004; Tropel et al. 2004; Wang et al. 2006). The standard method, widely used for 
the purification of human BMSCs, based on the adherence to plastic substrate 
does not allow the isolation of homogeneous populations of mBMSCs. Using 
alternative methods based on immunodepletion (Baddoo et al. 2003) or 
centrifugation (Dobson et al. 1999; Short et al. 2001; Peister et al. 2004), different 
populations of mBMSCs have been isolated; however, they expand poorly, 
probably because of either the loss of relevant cell-cell contacts or the absence of 
specific cytokines necessary in the early phases of expansion. Moreover, no data 
are available concerning an exhaustive characterization of the stemness, 
differentiation potential and acquisition of transformed phenotype of the isolated 
cells during passages. 
Starting from the observation that use of bone fragment-conditioned medium 
favours BMSCs growth (Sun et al. 2003), I hypothesized that specific conditioned 
media, obtained from different microenvironments, may contribute to the self-
renewal of BMSCs and could be critical in the early phases of mBMSCs 
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expansion. Therefore I analyzed the effect of supernatants from culture of bone 
fragments, mouse marrow stroma cell line MS-5, mouse embryonic fibroblast cell 
line NIH3T3 and a cocktail of epidermal growth factor (EGF) and platelet-derived 
growth factor (PDGF) on  mBMSC expansion. 
 
5.2 Isolation of mBMSCs from adult mouse bone marrow  
In this study nine animals have been sacrificed to isolate mBMSCs from bone 
marrow of tibias and femurs. Different factors resulted to be very important in 
order to allow the isolation of a homogeneous population of mBMSC without 
haematopoietic or macrophage contaminants and, as a result, for the establishment 
of a long term culture. 
By the surgical procedure used, the total number of collected marrow nucleated 
cells was 1.36x107 ± 3.2x106 per femur and 8.10x106 ± 1.17x106 per tibia; these 
results are comparable to StemCell Technology procedure, whose expected cell 
recovery was 1 - 2 x 107 per femur and 6 x 106 per tibia. 
One of the most important factors to determine the establishment of a long term 
culture of mBMSC was the density of the starting culture. As mentioned in 
Chapter 4, section 4.2.1, mBMSCs were seeded at 2x106 nucleated cells/cm2 and 
then allowed to attach to the surface of the plates for three days at which time I 
removed the non-adherent cells and waited for a sub confluent culture; the 
cultures underwent an initial lag phase of about 10-17 days during which the 
colonies were seen to arise from single cells and then they became confluent 
(Figure 11).  
Starting from the observation of published data on mBMSCs (Dobson et al. 1999; 
Phinney et al. 1999; Baddoo et al. 2003; Meirelles Lda et al. 2003; Sun et al. 
2003; Peister et al. 2004; Tropel et al. 2004; Wang et al. 2006), I considered the 
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composition of the medium used for the isolation and expansion of BMSCs, 
determining to obtain a long- term culture. For this reason I decided to split our 
culture in four conditions:  
- EP mBMSC: treated for  2 weeks with complete medium supplemented 
with 20% bone fragments conditioned medium and then with complete 
medium supplemented with 20 ng/ml mEGF  and 20 ng/ml hPDGF BB 
(Colter et al. 2001; Tropel et al. 2004; Kratchmarova et al. 2005; Figure 
11, panel C). 
- BF mBMSC: treated for  2 weeks with complete medium supplemented 
with 20% bone fragments conditioned medium  and then with complete 
medium without this (Sun et al. 2003; Figure 11, panel D). 
- M mBMSC: treated with complete medium supplemented with 20% MS5 
conditioned medium (Issaad et al. 1993; Figure 11, panel E). 
- N mBMSC: treated with complete medium supplemented  with 20% 
NIH3T3 conditioned medium (Burroughs et al. 1994; Figure 11, panel F). 
In the conditions described above, initially, the cells were very heterogeneous 
presenting round, flattened and spindle-shaped cells. The round non adherent 
cells, the haematopoietic cells, were lost during medium changes; the round 
adherent cells, which seemed to be macrophage or granulocytic precursors, 
adhered very strongly to the plate and were not detached easily from the plate, for 
this reason these cells were lost during the passages (Figure 11).  
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Figure 11 Morphology of mBMSCs varies according to culture conditions 
Morphology of BMSCs 72 hours after plating (panel A) and after 10-17 days of culture 
(panel B). Cells were subdivided and cultured respectively in: complete medium with 
20% bone marrow-conditioned medium and, subsequently, in complete medium with 20 
ng/ml mEGF and 20 ng/ml PDGF-AA (mBMSC EP, panel C); complete medium with 
20% bone marrow conditioned medium (mBMSC BF, panel D); complete medium with 
20% MS5 conditioned medium (mBMSC M, panel E) and complete medium with 20% 
NIH3T3 conditioned medium (mBMSC N, panel F). Magnifications 10X. 
 
5.3 Immunophenotypical characterization 
In order to characterize the types of cells present in the different culture 
conditions, I analyzed a panel of surface antigens by flow cytometry. To avoid the 
presence of macrophage/granulocytic contamination and to allow the cells to 
stabilize under the different culture conditions, I analyzed the mBMSCs 
subpopulations after 10 passages. We observed that mBMSCs in different culture 
conditions exhibited different morphological features (forward scatter x side 
scatter) and immunophenotype (Table 5 and Figure 12), however, in all cases the 
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immunophenotype showed a markers profile strictly compatible with BMSCs (Lai 
et al. 1998; Deans et al. 2000), without the expression of any haematopoietic cell 
markers, such as CD45, CD34, CD5, and CD19. 
BMSCs from all conditions were positive to Sca I, the hallmark of haematopoietic 
and mesenchymal progenitor cells (Holmes et al. 2007), and to CD44 which 
bridges cells to hyaluronan and osteopontin and is involved in niche maintenance 
(Avigdor et al. 2004). In particular, the EP mBMSCs presented a subset of cells 
highly positive to CD13, whereas BF and M mBMSCs were negative to H-2kb, 
the major hystocompatibility complex of class I, so suggesting a typical feature of 
very early progenitors known as mMAPC (Jiang et al. 2002). 
 
Table 5 Variations in culture conditions allow selection of different 
mesenchymal progenitors. 
Antigen  EP mBMSC  BF mBMSC  M mBMSC  N mBMSC 
CD 45 - - - - 
CD 34 - - - - 
CD 5 - - - - 
CD19 - - - - 
CD 117 (c-kit) + - - + 
Sca-I ++ + + + 
CD 44 +++ ++ ++ +++ 
CD 13 + - + + 
H2-k b + - - + 
 
- indicates that mBMSC type does not express the specific antigen. +, ++ and +++ 
indicate, a partial overlapping, no overlapping and a big difference between the plot of 
isotype control and the plot of staining profile, respectively.  
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Figure 12 FACS analysis of mBMSC populations 
Plot shows specific antibody staining profile for CD117, H2-kb, ScaI and CD13 (filled 
histograms). The lines in horizontal and vertical positions indicate the boundaries 
between isotype control and the specific staining profile (EP, BF, M and N BMSCs panel 
A, B, C and D, respectively). 
 
5.4 Growth kinetic of mBMSCs during 30 passages 
I  cultured all four BMSC subpopulations for more than 30 passages determining 
the population doubling potential, progression to senescence and proliferative 
activity. In order to exclude the acquisition of a tumorigenic potential I analyzed 
the DNA content of our subcultures, the expression of telomerase and the ability 
to form tumor in mice under local injection. 
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5.4.1 Cumulative duplication number and doubling measurement 
Cumulative population doublings were calculated from the initial number of 
mBMSCs at the first passage and the number of mBMSCs harvested at each of the 
following passage (Figure 13). This procedure provides a theoretical growth 
curve that is directly proportional to the cell number. At the last analyzed passage, 
the mean cumulative population doublings were 83 for the EP group, 109 for BF, 
70 for M and 90 for N, suggesting that progenitors selected in the different 
conditions have different doublings times. I calculated doubling times ad reported 
in Chapter 4 section 4.4. As expected, small differences were found in their 
doubling time, which was 58 hours for the EP group, 40 for BF, 57 for M and 44 
for N. 
 
 
Figure 13 Growth kinetic of mBMSCs 
Cumulative population doublings were calculated from the initial number of mBMSCs at 
the first detachment from plastic tissue culture and the number of mBMSCs harvested at 
following passage, as reported in Chapter 4, section 4.4. Different culture conditions are 
indicated as follows: EP ■, BF ◊, M ▲, N * mBMSCs. 
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5.4.2 Cell cycle analysis  
I confirmed the growth kinetic data, analyzing the cell cycle (Figure 14). As 
reported in Chapter 4, section 4.5, cells were detached from the culture dish, 
fixed, stained for DNA with Propidium Iodide (PI), and analyzed by flow 
cytometry. All the subcultures were euploid after 10-15 passages, as demonstrated 
by the same PI intensity among the lymphocytes and the mBMSCs.  
A small difference in the percentage of cells in G1, S or G2 phase, was shown 
according to the differences in doubling time (panel F).  
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Figure 14 Cell cycle analysis of mBMSCs 
Histograms show DNA content of lymphocytes (panel A), EP (panel B), BF (panel C), M 
(panel D) and N (panel E) mBMSCs (y-axis, cell count; x-axis, PI intensity). The 
percentage of cells in G1, S and G2 phase are summarized in panel F. 
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5.4.3 Senescence Associated Beta Galactosidase expression  
Senescent cells induce cell growth arrest in the G1 phase and usually this is 
accompanied in a change in morphology and metabolism. Such an example the 
cellular enlargement and the expression of senescence associated beta 
galactosidase (SA- β- Gal) represent two of the most common features of 
senescent cells (Dimri et al. 1995; Sethe et al. 2006) (Figure 15).  
I did not observe any particular changes in cellular morphology during the in vitro 
culture, so, to follow up the appearance of senescence, the cultures were assayed 
for SA- β- Galactosidase expression.  
Number of SA-β-Gal positive mBMSCs did not increase during the passages 
indicating that mBMSCs did not show signs of cellular senescence during in vitro 
culture (Figure 15). These data were very surprising as an increase in the number 
of senescent cells, assessed by SA- β- Gal staining was reported for human (Ito et 
al. 2007; Shibata et al. 2007; Ryu et al. 2008; Wagner et al. 2008) and rat BMSCs 
(Galderisi et al. 2008). As the cellular senescence is one the tumor suppressor  
functions of normal cells (Sharpless et al. 2007), to further investigate the 
characteristics of these subcultures and exclude the acquisition of a tumorigenic 
potential, I analyzed their  DNA content, the expression of telomerase and the 
ability to form tumor in mice under local injection after 30 passages in culture.  
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Figure 15 Senescence Associated Beta Galactosidase (SA-B-Gal) expression in 
mBMSCs 
SA- Beta-Gal staining in mBMSC at early passages (EP, BF, M and N mBMSCs panel A, 
C, E and G respectively) and late passages (EP, BF, M and N panel B, D, F and H 
respectively. Original magnification 10X). 
 
5.4.4 Cell cycle analysis at late passages  
I repeated the cell cycle and DNA content analysis after 35-40 passages. As 
reported in Figure 16 and Figure 17,  a slight increase in the number of cells in 
G1 phase and a decrease in S phase were observed for EP and BF mBMSCs. This 
result confirmed that, in spite of the lack in the increase of SA- β- Gal cells, these 
cells slow down the progression in the cell cycle over a period of 35-40 passages.  
Different results were obtained for M and N BMSCs. 
No differences in terms of cells in G1, S or G2 phase were observed between 
early (10-15) and late (35-40) passages in N BMSCs, suggesting that the NIH3T3 
conditioned medium could contain cytokines involved in the suppression of 
cellular senescence and maintenance. The results obtained for EP, NF and N 
BMSCs confirm the maintenance of a euploid karyotype over a period of 30 
passages. 
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I observed an aneuployd karyotype in M BMSCs at late passages. As shown in 
Figure 16, after 35-40 passages this population is made up of two different sub-
populations. One of this has a G1 peak, which has the same PI intensity of 
lymphocytes, confirming the euployd content of DNA of this sub-populations; the 
other one has a double PI intensity compared to lymphocytes, suggesting a double 
content of DNA. 
Chromosomal alterations in BMSCs are very often associated with the activation 
of telomerase activity in vitro (Serakinci et al. 2004; Rubio et al. 2005; Miura et 
al. 2006; Rubio et al. 2008) and tumorigenic potential in vivo (Serakinci et al. 
2004; Rubio et al. 2005; Miura et al. 2006; Zhou et al. 2006; Rubio et al. 2008). 
For these reasons I analyzed mBMSCs for the expression of telomerase and the 
ability to form tumor in vivo. 
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Figure 16  Cell cycle analysis of mBMSCs after 30 passages in vitro 
Histograms show DNA content of EP (panel A), BF (panel B), M (panel C) and N (panel 
D) mBMSCs (y-axis, cell count; x-axis, PI intensity). 
 
 
Figure 17 Cell cycle comparison between mBMSCs at early and late passages 
Summary of the percentage of cells in G1, S and G2 phase after early and late passages. 
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5.4.5 Assesment of telomerase activity 
In order to verify whether cells growing under these experimental conditions 
possessed telomerase activity, I measured telomerase activity by a primer 
extension assay in which telomerase reverse transcriptase (TERT) synthesizes 
telomeric repeats onto oligonucleotide primers (TRAP assay; Kim et al. 1994; 
Colter et al. 2000). TRAP products were analyzed on a 12% native 
polyacrylamide gel electrophoresis (PAGE), and then by ELISA according to 
manufacturer’s instructions (see Chapter 4, section 4.7; Figure 18). As reported 
in Figure 18 panel A, I did not observe 6-bp periodicity, as in the two positive 
controls +1 and +2, suggesting that these subcultures did not possess telomerase 
activity, even at late passages. PCR products were also analyzed by ELISA, 
confirming the same results (panel B).  These findings confirmed that EP, BF and 
N BMSC subcultures, even without showing dramatic changes in proliferative 
activity or cellular metabolism, do not activate telomerase expression in vitro. The 
absence of expression of telomerase led me to hypothesize that chromosomal 
alterations observed in M BMSCs were not transforming events. In order to 
exclude that these subpopulations contained transformed cells I tested their 
tumorigenicity in vivo.  
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Figure 18  Telomerase activity assessment in mBMSCs 
Polyacrylamide gel electrophoresis of TRAP assay products obtained from mBMSCs at 
early and late passages (panel A). e: early passages BMSCs. l: late passages BMSCs. S: 
test extract. H: heat-treated test extract. +1:  telomerase-positive control, cell extract 
provided by the Chemicon kit. +2: PCR/ELISA positive control, a synthetic 
oligonucleotide with 8 telomeric repeats that works as a template of the PCR reaction. -: 
minus telomerase control, CHAPS lysis buffer. M: DNA ladder. Black arrow: TRAP 
internal control (panel A). ELISA analysis of TRAP products (panel B).   
 
5.4.6 Tumorigenicity in vivo  
I tested in vivo tumorigenicity, by subcutaneous injection of 2x106 mBMSCs in 
immunodeficient mice. I did not observe any tumor formation, as determined by 
macroscopic and histological analysis 10 weeks after inoculum (n=5; Figure 19), 
confirming that these sub-populations were essentially free of tumorigenic cells. 
As a positive for tumor formation control, five mice received at the same site mES 
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cells (2x106cells/ site). All animals inoculated with mES cells developed large 
tumors (1.28± 0.49 cm in diameter) at the injected sites within 3-4 weeks (Figure 
20). 
 
 
Figure 19 mBMSCs do not transform in tumorigenic cells 
mBMSCs at 35p  showed no tumor formation when transplanted into 
immunocompromised mice (EP mBMSCs panel A and E, BF mBMSCs panel B and F, M 
mBMSCs panel C and G, N mBMSCs panel D and H; magnification 2.5X for panel A-D, 
10X for panel E-H; hematossilin and eosin staining). 
 
 
 
 
 
Figure 20 Teratocarcinoma development in mice injected with mES cells 
Mice inoculated with mES cells developed large tumors at the injected sites within 3-4 
weeks. 
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5.5 Stemness expression in mBMSCs  
I evaluated whether transcription factors essential for pluripotency and self-
renewal in murine embryonic stem (mES) cells, such as Oct 4, Nanog, Sox-2 and 
Rex-1, were present in mBMSCs and could account for the differences in 
proliferative ability observed (Boiani et al. 2005).  
As mBMSCs are able to spontaneously differentiate along mesenchymal lineages, 
I analyzed the expression of transcription factors in cells kept in control medium 
for one and twenty one day. Among the above-mentioned transcription factors 
only Nanog was expressed in the sub-cultures, as evidenced by RT-PCR, at time 0 
and after 21 days of culture in EP mBMSCs, and at time 0 in BF, M and N 
mBMSCs (Figure 21). Immunofluorescence data confirmed the localization of 
Nanog in the nucleus of mBMSCs EP (71.8% ± 16.6%), BF (61% ± 20%), M 
(48.4% ± 19.2%) and N (47.9% ± 17.5%) as shown in Figure 22. t-Test analysis 
showed that the differences in percentage of Nanog expressing cells among EP 
and M BMSCs or EP and N BMSCs are statistically  significant (Table 6). Since 
Nanog is a stemness marker for mES cells and its expression is usually lost as 
soon as the cells begins to differentiate and lose self-renewal potential (Chambers 
et al. 2003; Mitsui et al. 2003), I determined its expression also in mBMSCs at 
high passage number. After 30-40 passages the percentage of Nanog positive cells 
was reduced for mBMSCs EP (71.8% ± 16.6% to 31% ±19.1%), mBMSCs BF 
(61% ± 20% to 24% ± 20%) and M (48.4% ± 19.2% to 28.3% ± 22.7%). On the 
contrary, the reduction of percentage of Nanog-positive cells was not significant 
for mBMSCs N (47.9% ± 17.5% to 42.6% ± 11%) (Figure 22, panel B). t-Test 
analysis suggests that the differences in Nanog expressing cells, among the four 
culture conditions used, are significant only in the early phases of expansion and 
that this percentage reaches the same value after many passages (Table 6). 
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Figure 21 Stemness factors expression in BMSCs 
Expression of stemness markers was analyzed by RT-PCR immediately after cell 
purification (0) and after 21 days in the different culture conditions. GAPDH as shown as 
control of RNA quality. PC: positive control, RNA extracted from mES cells. 
 
 
 
Figure 22 mBMSCs express Nanog 
Expression of Nanog was confirmed in all the subpopulations by immunostaining with an 
anti-Nanog antibody conjugated with FITC counterstained with DAPI (panel A, 
magnification 63X). Quantization of the percentage of Nanog positive cells in the 
different subpopulations at early and late passages (panel B). 
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Table 6: Percentage of Nanog expressing BMSCs, t-Test result 
 
Matrix t-Test result 
e.p. EP BMSCs vs e.p. BF BMSCs  p> 0.05 
e.p. EP BMSCs vs e.p. M BMSCs p< 0.005 
e.p.EP BMSCs vs e.p. N BMSCs p< 0.005 
e.p. BF BMSCs vs e.p. M BMSCs p> 0.05 
e.p. BF BMSCs vs e.p. N BMSCs p> 0.05 
e.p. M BMSCs vs e.p. N BMSCs p> 0.05 
l.p.EP BMSCs vs l.p.BF BMSCs p> 0.05 
l.p. EP BMSCs vs l.p. M BMSCs p> 0.05 
l.p.EP BMSCs vs l.p. N BMSCs p> 0.05 
l.p. BF BMSCs vs l.p. M BMSCs p> 0.05 
l.p. BF BMSCs vs l.p. N BMSCs p< 0.05 
l.p. M BMSCs vs l.p. N BMSCs p> 0.05 
 
e.p.: early passages; l.p.: late passages; vs: versus 
 
5.6 Differentiation abilities of BMSCs 
In order to evaluate whether culture conditions could select subpopulations 
different not only in the immunophenotype and proliferation ability but also in 
differentiation potency, I performed osteogenic, chondrogenic and adipogenic 
differentiation assays. 
 
5.6.1 Osteogenesis  
mBMSCs were incubated to confluence in their medium and then transferred to 
osteogenic medium for time indicated as described in Chapter 4, section 4.10.1.  
In the first time I analyzed alkaline phosphatase (ALP) as an osteoblastic 
differentiation marker. After 6 days of osteogenic induction, 80% of EP, M and 
Maria Teresa Esposito                                                                                                                                            PhD Thesis 
88 
BF mBMSCs underwent a dramatic change in cellular morphology and were 
alkaline phosphatase (ALP)-positive (Figure 23). Control cultures in regular 
growth media expressed a variable and significant background level of ALP-
positive staining (Table 7), in agreement with previously described results both in 
human (Jaiswal et al. 1997) and in murine BMSCs (Fromigue et al. 2008). ALP 
activity of differentiated cells increased during the first week of induction for EP, 
BF and M mBMSCs reaching a plateau phase,  a phenomenon correlated with the 
increased extensive mineralization occurred throughout the differentiated cultures 
(Jaiswal et al. 1997). By contrast, the ALP activity of differentiated N mBMSCs 
increased during the time, but it did not reach the level of the other 
subpopulations, suggesting a delay or impairment in osteogenic differentiation 
(Figure 23).  
 In order to evaluate the ability of our mesenchymal progenitors to reach 
osteoblastic terminal differentiation, I analyzed the calcium deposition in the extra 
cellular matrix after 21 days of differentiation. In the EP, BF, M and N mBMSCs 
grown in control medium I did not observe detectable calcium deposits 
throughout all the experiment, as measured by Alizarin Red S staining. By 
contrast, in BMSCs grown with osteogenic medium I observed a mineralized 
matrix at day 21 (Figure 24). Alizarin Red S staining confirmed a difference in 
the osteogenic ability of EP, BF and M compared to N BMSCs.  EP, BF and M 
BMSCs, produce a well mineralized matrix which is distributed uniformly 
throughout the culture dish. As expected, the mineralization pattern of N 
mBMSCs was localized to few discrete foci, probably correlated with focal areas 
of high ALP activity, rather than throughout the culture dish. These data were 
corroborated by the quantification of mineralization deposits by extraction of 
bound Alizarin Red S, as reported in Chapter 4, section 4.10.1 (Figure 24, panel 
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B). These data confirmed a significative difference between calcium content of 
mBMSC grown in control medium and in differentiation medium. 
These results were also corroborated by Von Kossa staining (Figure 25). 
To confirm the differentiation status of our subcultures, I analyzed expression of 
osteoblast-specific markers before and after treatment with the inductive medium 
by RT-PCR. The results confirmed that the mBMSCs constitutively express some 
osteoblastic lineage markers, such as CbfaI/Runx2, Collagen I and osteopontin, as 
previously described (Tropel et al. 2004). In particular, after osteoinduction EP, 
BF and M mBMSCs begin to express the well known transcription factor osterix, 
essential to osteogenic commitment of mBMSCs as well as late osteogenic 
markers, namely bone sialoprotein and osteocalcin, typically expressed in 
osteoblasts (Figure 26) (Karsenty et al. 2002). As N mBMSCs do not express 
bone sialoprotein, even in differentiation medium, Iconcluded that they are not 
able to fully differentiate in osteoblasts retaining a pre-osteoblastic-status. 
 
Figure 23 Osteogenic differentiation of mBMSCs. ALP expression 
ALP staining six days after osteogenic induction (panel A, magnification 10X). ALP 
activity was determined for each subculture after 7 and 14 days in osteogenic medium 
(panel B). 
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Table 7: Level of ALP activity of BMSCs, ANOVA result  
 
Matrix ANOVA  
result 
Control EP BMSCs vs control BF BMSCs  p< 0.001 
Diff. 7 days EP BMSCs vs Diff. 7 days BF BMSCs p> 0.05 
Diff. 14 days EP BMSCs vs Diff. 14 days BF BMSCs p> 0.05 
Control EP BMSCs vs control M BMSCs p< 0.05 
Diff. 7 days EP BMSCs vs Diff. 7 days M BMSCs p> 0.05 
Diff. 14 days EP BMSCs vs Diff. 14 days M BMSCs p> 0.05 
Control EP BMSCs vs control N BMSCs p> 0.05 
Diff. 7 days EP BMSCs vs Diff. 7 days N BMSCs p< 0.001 
Diff. 14 days EP BMSCs vs Diff. 14 days N BMSCs p< 0.01 
Control BF BMSCs vs control M BMSCs p< 0.001 
Diff. 7 days BF BMSCs vs Diff. 7 days M BMSCs p> 0.05 
Diff. 14 days BF BMSCs vs Diff. 14 days M BMSCs p> 0.05 
Control BF BMSCs vs control N BMSCs p< 0.001 
Diff. 7 days BF BMSCs vs Diff. 7 days N BMSCs p< 0.001 
Diff. 14 days BF BMSCs vs Diff. 14 days N BMSCs p< 0.01 
Control M BMSCs vs control N BMSCs p> 0.05 
Diff. 7 days M BMSCs vs Diff. 7 days N BMSCs p< 0.001 
Diff. 14 days M BMSCs vs Diff. 14 days N BMSCs p> 0.05 
 
Diff. 7 days: Cells kept in osteogenic medium for 7 days 
Diff. 14 days: Cells kept in osteogenic medium for 14 days 
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Figure 24 Osteogenic differentiation of mBMSCs. Bone nodule formation 
Alizarin red s staining 21 days after induction (panel A, magnification 10X). Calcium 
deposition was quantified as described in Chapter 4, section 4.11.2 (panel B). 
 
 
 
 
Figure 25 Osteogenic differentiation of mBMSCs. Von Kossa staining 
Von Kossa staining 21 days after induction (magnifications 4X). 
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Figure 26 Expression of osteoblast specific markers 
Analysis of the expression of osteoblast-specific markers by RT-PCR (panel A). 0, 3, 21: 
RNA from cells at day 0 or after 3 or 21 days in induction medium. Pc: positive control. 
The positive control is the RNA extracted from MC3T3. GAPDH is shown as a control for 
RNA sample quality. Schematic representation of osteogenic differentiation (panel B). 
 
5.6.2 Chondrogenesis 
I tested chondrogenic differentiation ability of mBMSC groups using a micro-
drop culture technique which mimics the prechondrogenic cellular condensation 
event that occurs in vivo (Denker et al. 1995; Mackay et al. 1998; Sun et al. 2003; 
Murdoch et al. 2007). Treatment of micro-drop cultures of mBMSC cells with 
chondrogenic medium resulted in aggregation of the cells into a three-dimensional 
spherical structure, as observed for EP, BF and M mBMSC groups. For the first 
12-24 h of culture, both treated and untreated micro-drop cultures appeared 
similar; after 72 hr there was a change in shape of the cells on the outer edge of 
the micro-drop culture. These cells acquired a more elongated/bipolar shape 
compared to their untreated counterparts. Then the cells just inside the periphery 
of the micro-drop culture piled upon each other to form a ridge-like structure that 
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was attached on one side to the dish. After twenty one days these spheroids 
accumulated sulphated proteoglycans as shown by Alcian Blue staining (Figure 
27). Different results were obtained for N mBMSC group; when I treated these 
cells with chondrogenic medium in micro-drop cultures, I did not observe 
spheroids formation but only a contraction of the remainder of the micro-drop 
culture into an opaque sheet of cells that was significantly smaller in diameter 
than the original culture, and detached from the surface of the dish except for the 
centre of the sheet-like structure, which remained attached and was positive to 
Alcian Blue; this data suggested that these cells have a delay or impairment in 
chondrogenic differentiation. 
Pellet cultures (Mackay et al. 1998) were used to obtain the RNA for the analysis 
of the expression of chondrogenic-specific markers before and after treatment 
with the inductive medium by RT-PCR (Figure 28). RT-PCR results confirmed 
that all analyzed mBMSC progenitors constitutively express Sox- 9, as previously 
described (Mackay et al. 1998; Murdoch et al. 2007; Figure 29). Following 
induction, BF and M mBMSCs began to express aggrecan and collagen XI, 
confirming a differentiation in chondroblasts. During the last phase of cartilage 
development, differentiating cells begin to express the collagen X, which is the 
only known hypertrophic chondrocyte-specific molecular marker. The appearance 
of this marker is accompanied to the peak of CbfaI/Runx 2 which, as occurs in 
vivo, appears at day 3 in a proliferation phase and after 14 days in a hypertrophic 
state (Ducy et al. 1997). Only EP and M mBMSCs were able to differentiate in 
hypertrophic chondrocyte as they express mRNA of collagen X and CbfaI/Runx2 
after 21 days of differentiation. I  was able to observe the expression of Sox9 and 
Collagen XI in N mBMSCs at time-point 0, in cells grown in monolayer, but not 
after three or twenty-one days in micro-pellet culture. As reported by Murdoch 
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there is a reduction in Collagen I and Sox9 expression from monolayer at time-
point 0 and micro-pellet at time-point 3, but these markers normally increase 
throughout the three weeks of differentiation (Murdoch et al. 2007). As N 
mBMSCs do not express any marker, even in differentiation medium, I concluded 
that they do not differentiate in chondroblasts, confirming my initial hypothesis, 
above discussed. 
 
Figure 27 Chondrogenic differentiation of mBMSCs micro-drops 
Alcian blue staining of micro-drops cultures of mBMSCs (magnification 10X). 
 
 
 
Figure 28 Chondrogenic differentiation of mBMSCs micro-pellet 
Alcian blue staining of micro pellet cultures of mBMSCs. 
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Figure 29 Expression of chondrogenic markers 
Expression of chondrocyte-specific markers by RT-PCR (panel A). 0: RNA from 
monolayer cells at day 0. 3, 21: RNA from micro pellets after 3 or 21 days in induction 
medium. Pc: positive control. The positive control is the RNA extracted from ATDC5. 
GAPDH is shown as a control for RNA sample quality. Schematic representation of 
chondrogenic differentiation (panel B). 
 
5.6.3 Adipogenesis 
I induced adipogenic differentiation in mBMSCs subpopulations, according to the 
protocol described in Chapter 4, section 4.10.3 (Reyes et al. 2001). After fourteen 
days of induction the cells were fixed and stained with Oil Red O (Figure 30). N 
mBMSCs  underwent a dramatic change in cellular morphology from spindle 
shaped to polygonal which was accompanied by a significant lipid droplets 
accumulation detectable just after 3-4 days of induction as shown by Oil Red O 
staining and confirmed by quantification of bound oil red (panel B). Conversely, 
EP, BF and M mBMSC subpopulations treated with adipogenic medium 
accumulated very few and small lipid droplets, even after 14 days of induction. To 
further confirm these data, I determined the expression of adipogenic specific 
markers before and after treatment with the inductive medium by RT-PCR.  These 
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data suggest that BF and M mBMSCs are able to become immature adipocytes, as 
they express lipoprotein lipase (LPL) and fatty acid binding protein-4 (FABP-4) 
after 14 days of induction (Figure 31). N mBMSCs express early adipogenic 
markers also before induction, suggesting that these cells are pre-adipocytes. 
Upon stimulation they can differentiate readily in adipocytes, as they express the 
transcription factor PPARγ2, essential to adipogenic commitment of mBMSCs 
and adipsin, a late adipogenic marker (Rosen et al. 2006), just three days after 
treatment with induction medium.  
 
Figure 30 Adipogenic differentiation of mBMSCs 
Oil Red O staining of mBMSCs (panel A, magnification 10X). Lipid accumulation was 
quantified as described in Chapter 4, section 4.11.5 (panel B). 
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Figure 31 Expression of adipogenic specific markers 
Expression of adipocyte-specific markers was analyzed by RT-PCR (panel A). 0, 3, 14: 
RNA from cells at day 0 or after 3 or 14 days in induction medium. Pc: positive control. 
The positive control is the RNA extracted from C3H10T1/2. Β actin is shown as a control 
for RNA sample quality. Schematic representation of adipogenic differentiation (panel B). 
 
5.7 Switching the N BMSC cells into standard growth medium 
does not rescue their osteogenic potential 
Using NIH3T3 conditioned medium, I obtained cells that showed impairment in 
osteogenic and chondrogenic differentiation, whereas retaining a very high 
adipogenic potential during passages. I hypothesized that this could be the result 
of NIH3T3 conditioned medium exposition. Therefore, in order to address this 
behaviour, I switched the N BMSC cells into standard growth medium for ten 
passages, a condition identified as N*BMSCs. I induced osteogenic differentiation 
of N BMSCs and N*BMSCs and I evaluated bone nodule formation and 
expression of osteoblast specific markers after 21 days. A slight increase in bone 
nodule formation was observed in N*BMSCs (Figure 32), whereas by RT-PCR I 
did not observe a dramatic change in the expression of osteogenic specific 
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markers (Figure 33). In order to better analyze if switching the N BMSC cells 
into standard growth medium rescue their osteogenic potential, I evaluated by 
Real-time PCR expression of osteocalcin, which is the only known specific 
osteogenic marker (Ducy et al. 1996; Karsenty et al. 2002; Figure 34). No 
statistically significant difference was observed in levels of osteocalcin mRNA 
between N and N* BMSCs, suggesting that this treatment is not sufficient to 
recover the osteogenic potential of these cells.  
 
 
Figure 32 Osteogenic differentiation of N*BMSCs 
Alizarin red s staining of BMSCs (panel A, magnification 10X). Calcium deposition was 
quantified as described in Chapter 4, section 4.11.2 (panel B). 
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Figure 33 Expression of osteogenic specific markers in N and N* BMSCs 
Analysis of the expression of osteogenic-specific markers by RT-PCR. 0, 3, 21: RNA from 
cells at day 0 or after 3 or 21 days in induction medium. Pc: positive control. The positive 
control is the RNA extracted from MC3T3. GAPDH is shown as a control for RNA 
sample quality. 
 
 
 
 
Figure 34 Osteocalcin expression in N and N* BMSCs 
Real Time-PCR analysis. mRNA levels were normalized with respect to GAPDH, chosen 
as an internal control. 0, 3, 21: RNA from cells at day 0 or after 3 or 21 days in induction 
medium. Pc: positive control.  Histograms show mean expression values (± SD, n=3; * p 
< 0.05; ** p < 0.01). 
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5.8 Expression of leukaemia inhibitory factor (LIF) in NIH3T3  
Switching N BMSCs to standard medium did not produce any significant 
recovery of osteogenic potential leading to the conclusion that this effect was not 
reversible. In the attempt to identify cytokines possibly responsible for this 
behaviour, I focused my attention on LIF (Metcalf 2003). 
It has been recently observed that LIF is responsible for blocking osteoblast 
maturation at late differentiation stages and redirect these cells toward the 
adipogenic pathway (Falconi et al. 2007; Falconi et al. 2007); I therefore analyzed 
LIF expression in NIH3T3 and MS-5 cell lines by RT-PCR to evaluate whether 
this cytokine was expressed and could constitute a potential determinant for the 
observed effect on differentiation ability. RT-PCR data demonstrated that LIF was 
expressed only in NIH3T3 cells (Figure 35). In order to verify the capacity of 
NIH3T3 to secrete bioactive LIF, I tested the capacity of NIH3T3 supernatant to 
support maintenance of undifferentiated state of pluripotent mES cells, as it is 
well known that it requires the presence of LIF or LIF-related factors (Ying et al. 
2003). Therefore, I plated mES cells in NIH3T3 supernatant supplemented with 
serum and after 6 days I determined the number of ALP- positive colonies, 
distinguishing among undifferentiated (ALP- positive), partially differentiated 
(ALP expression localized to a few discrete cells forming a colony) and 
differentiated colonies (ALP- negative) as ALP is a well known marker of 
undifferentiated mES cells (O'Connor et al. 2008). As shown in Figure 36, 
NIH3T3 conditioned medium supported the maintenance of undifferentiated state 
of mES cells. On the other hand, addition of an antagonist of LIF completely 
blocked this effect, supporting the production of bioactive LIF from NIH3T3 
cells. 
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Figure 35 Expression of LIF in NIH3T3 
LIF expression in NIH3T3 was determined by RT-PCR analysis. GAPDH is shown as a 
control for RNA sample quality. 
 
 
 
 
Figure 36 NIH3T3 secrete bioactive LIF 
ALP staining of mES cells (panel A, magnification 10X). Quantization of ALP-positive 
colonies (panel C). Positive control: cells maintained in ES complete medium. Negative 
control: cells maintained in ES complete medium without LIF. 
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Chapter 6 
Efficient non viral transfection of mBMSCs using 
Nucleofection technology 
 
6.1 Background 
Adult primary cells are, in general, difficult to transfect with DNA and BMSCs 
are no exception. Traditional techniques that give high transfection efficiencies 
throughout a range of cell lines are unable to transfer foreign DNA into BMSCs. 
Importantly, for in vitro analysis of BMSCs, the introduction of DNA has to be 
mediated by a technique that does not affect proliferation and differentiation.  
The use of cationic lipids complexed to DNA has been widely used for 
transfection assays in a range of cell lines and also in mES cells.  Lipofectamine 
2000 has proved useful for  plasmid DNA delivering in BMSCs (Hoelters et al. 
2005) and is the best reagent to transfect shRNA and siRNA in BMSCs and in 
mES cells (Parisi et al. 2008). In order to establish a quick and reliable 
transfection protocol for mBMSCs, I initially tested lipofectamine 2000 from 
Invitrogen and nucleofection buffer solution V from Amaxa. 
 
6.2 Testing BMSCs transfection efficiency with Lipofectamine 
2000  
To test whether mBMSCs could be transfected with Lipofectamine2000, I started 
with a set-up experiment in 96 well-plates, following the manufacturer’s 
instructions. Cells were seeded at 80% confluence the day before manipulation, 
and then transfected with pCMV-GFP plasmid at different DNA/lipofectamine 
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2000 ratio, ranging from 0.075-1.5 µl of lipofectamine 2000 and 0.05-0.4 µg of 
DNA. I observed a weak GFP signal in some of the wells, which I scaled-up in 6 
well-plates. After 24 h, the cells were monitored for, GFP expression, viability 
and changes in phenotype as compared to non transfected cells. 
Notably, transfection efficiency was very low and there was a significant change 
in morphology in transfected cells; not only the cells were bigger, containing 
visible vesicles in the cytoplasm, but there was also extensive cell death when 
compared to non transfected controls, as determined by a significant number of 
floating dead cells in the culture media (Figure 37). This adverse affect prompted 
me to examine other transfection protocols. 
 
 
 
Figure 37 Transfection efficiency with lipofectamine 2000 
mBMSCs were transfected with pCMV-GFP/lipofectamine at different ratio. After 24 
hours the phenotype was analyzed and compared to non transfected cells (panel A and 
B). Ratio 1:6 (7.8 μg DNA and 46 μl lipofectamine 2000) in panel C and D. Ratio 1:5 (9.3 
μg DNA and 46 μl lipofectamine 2000) in panel E and F. Ratio 1:4 (12.5 μg DNA and 46 
μl lipofectamine 2000) in panel G and H. Ratio 1:3 (9.3 μg DNA and 32.3 μl 
lipofectamine 2000) in panel I and L. Panel A, C, E, G, I, original magnification 10X, 
phase contrast microscopy. Panel B, D, F, H, L, original magnification 10X, fluorescence 
microscopy. 
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6.3 Testing BMSC transfection efficiency by using nucleofection 
technology 
The Nucleofector Technology is a new non viral transfection method, based on 
electroporation, specially designed for primary cells and hard to transfect cell 
lines, such as BMSCs (Lakshmipathy et al. 2004; Aluigi et al. 2006). I tested the 
efficacy of this method in mBMSCs transfection following the optimized protocol 
provided by the manufacturer. To this end I used 5x105 cells and 2 µg of 
pCMVGFP plasmid and the pulsing program U-23, specifically indicated for high 
transfection efficiency. As shown in Figure 38, 24 hours after nucleofection, GFP 
positive cells represented more than 40% of transfected mBMSCs, with no 
significant amount of cell debris or dead cells. Furthermore, significantly more 
GFP-positive cells were observed with optimized protocols, increasing the 
number of cells and the amount of DNA. Using 1x106 cells and 8 µg of 
pCMVGFP plasmid,  52.39% of cells  resulted GFP positive (Figure 39) with a 
mean cell viability of 97.3% and an overall recovery of 120% ± 30% for cell 
treated with no DNA and 88.4% ± 15.2% for cell treated with pCMV-GFP (n=5). 
These results can be considered extremely satisfactory compared to those obtained 
in BMSCs with lipofectamine 2000 (Hoelters et al. 2005) or standard 
electroporation (Helledie et al. 2008). 
 
 
Maria Teresa Esposito                                                                                                                                            PhD Thesis 
105 
 
Figure 38 Transfection efficiency with nucleofection technology. Fluorescence 
Microscopy 
mBMSCs were pulsed with U-23 program in the presence of different amount of pCMV-
GFP. After 24 hours phenotype was analyzed and compared to non transfected cells 
(panel A and B). 5x105 cells and 2 μg DNA in panel C and D. 1x106 cells and 4 μg DNA 
in panel E and F.1x106 cells and 8 μg DNA  in panel G and H. Panel A, C, E and G, 
original magnification 10X, phase contrast microscopy. Panel B, D, F and H, original 
magnification 10X, fluorescence microscopy. 
 
 
 
 
 
 
Figure 39 Transfection efficiency with nucleofection technology. FACS analysis 
Flow cytometry analysis of non transfected cells (panel A) and GFP transfected cells 
(panel B).   
 
 
A B
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6.4 Time course analysis of GFP expression in nucleofected 
mBMSCs  
To assess the stability of the nucleofection-based transfection, I performed a time 
course analysis over a period of one week. In accordance with the transient nature 
of plasmid-based transfection, GFP levels in mBMSCs declined over time. 
Afterward, although GFP expression decreased due to the dilution of the plasmid 
in culture, the percentage of GFP positive cells was still as high after one week 
(Figure 40), according to the hypothesis that as the DNA is delivered into the 
nucleus and is not retained in the cytoplasm after the transfection, it could be less 
subjected to degradation (Hamm et al. 2002). 
 
 
 
 
Figure 40 Time course analysis of GFP expression 
1x106 mBMSCs were pulsed with U-23 program in the presence of 8 μg pCMV-GFP. 
GFP expression was analyzed after 1 (panel A and B), 2 (panel C and D), 3 (panel E and 
F), 4 (panel G and H) and 5 (panel I and L) days after transfection. Original 
magnification 10X, panel A, C, E, G, I phase contrast microscopy; panel B, D, F, H and 
L, fluorescence microscopy. 
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6.5 Effect of nucleofection on cell proliferation  
In order to test whether nucleofected mBMSCs maintain their phenotype after 
transfection, I considered the effect on cell proliferation and senescence.  
Twenty-four hours after transfection, mBMSCs were seeded at 2500 cells each 
well of a 96-well plates, and after 2 days, cell numbers in nucleofected,  non 
transfected and mock (no DNA) transfected cells were determined from three 
wells of each culture, as described in Chapter 4, section 4.15. Notably, 
nucleofected cells yielded similar cell growth rates compared to both controls, 
indicating that nucleofection technology does not impair cell proliferation (Figure 
41). 
 
 
 
Figure 41 Nucleofection does not affect cell proliferation 
Cell number was evaluated using CellTiter-Glo Luminescent Cell Viability Assay from 
Promega. Blue line: non nucleofected mBMSCs; pink line: mBMSCs nucleofected with no 
DNA; yellow line: mBMSCs nucleofected with pCMV-GFP. 
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6.6 Effect of nucleofection on cellular senescence 
I evaluated the number of senescent cells in nucleofected cells compared to non 
transfected and mock (no DNA) transfected cells. Twenty-four hours after 
transfection, mBMSCs were seeded at 104 cells/cm2 in six-well plates, and after 3 
days, the cultures were assayed for SA- β- Galactosidase expression, as described 
in Chapter 4, section 4.6. Importantly, nucleofected cells gave similar results in 
terms of SA- β- Galactosidase positive cells compared to both controls (t-Test 
between untransfected and mock, p= 0.18; t-Test between untransfected and 
pCMVGFP, p=0.28; t-Test between mock and pCMVGFP, p=0.53) indicating that 
nucleofection technology does not induce cellular senescence (Figure 42). 
 
 
 
 
Figure 42 Nucleofection does not induce cellular senescence 
Β-gal-staining in mBMSC untransfected (panel A), transfected with no DNA (panel B) or 
with pCMVGFP (panel C) (original magnification 10x). Quantization of the number of 
SA-Beta-Gal positive cells (panel D). 
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6.7 Effect of nucleofection on cell migration  
I assessed whether nucleofection affect cell migration. The motility of BMSCs 
was examined in a migration chamber in which the migrating cells in the insert 
chamber went through the poles on the membrane. The cells landing in the lower 
chamber or attaching on the other side of the membrane were stained and 
quantified by counting several fields. The results showed that nucleofection does 
not impair cell migration (t-Test between untransfected and mock, p= 0.35; t-Test 
between untransfected and pCMVGFP, p=0.76; t-Test between mock and 
pCMVGFP p=0.80; Figure 43).  
 
 
Figure 43 Nucleofection does not affect cell migration 
Crystal violet staining of chamber slides of untransfected mBMSC (panel A), transfected 
with no DNA (panel B) or with pCMVGFP (panel C) (original magnification 10x). 
Quantization of the number of migrated cells (panel D). 
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Chapter 7  
Effect of Nanog over-expression and down-regulation in 
mBMSCs 
 
7.1 Background  
ES cells maintain pluripotency by a transcriptional program that suppresses 
differentiation; this property is regulated by a small number of ES cell specific 
transcription factors such as Nanog, Oct-4 and Sox-2, whose expression is down 
regulated early during embryogenesis (Boiani et al. 2005). 
Very recent papers showed the expression of Oct-4, Nanog and Sox2 in BMSCs 
(Jiang et al. 2002; Anjos-Afonso et al. 2007; Beltrami et al. 2007; Gonzalez et al. 
2007; Greco et al. 2007; Kobayashi et al. 2008). 
Although the role of Nanog, Oct4 and Sox2 in adult tissue stem cells remains 
unclear, it has been expected that it may be possible to use them to enhance the 
self-renewal of tissue stem cells, as it has recently been reported that pluripotent 
stem cells can be directly generated from mouse fibroblasts by the introduction of 
concomitant four transcription factors, Sox2, Oct4, KLF-4 and c-myc (Takahashi 
et al. 2006); Nanog is not one of the four genes, however, its functional 
importance is evident from the fact that up regulation of the Nanog gene seemed 
to be critical for reprogramming the cell (Okita et al. 2007). Very poor data are 
available about the role of Nanog in BMSCs. Studies of  Go et al. and Liu et al. 
showed an effect of Nanog on proliferation and osteogenic and chondrogenic 
abilities (Go et al. 2008; Liu et al. 2008), however, nobody of them tested the 
effect of Nanog in the balance between senescence, apoptosis and tumorigenesis 
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and in cell migration. The last part of this study was dedicated to start a project 
aimed to dissect the role of Nanog in these phenomena in collaboration with the 
group of Dr Nicole Horwood at the Kennedy Institute of Rheumatology, Imperial 
College of London. 
 
7.2 Stemness factors expression in B BMSCs  
For these studies, I used primary bone marrow stromal cells isolated from Balb/c 
mice (B mBMSCs) in the laboratory of Dr Nicole Horwood. Recent unpublished 
data from this laboratory confirm an immunophenotype compatible with 
mBMSCs (Lai et al. 1998; Deans et al. 2000) and tri- lineage differentiation 
potential (Pittenger et al. 1999). I evaluated the expression of Oct-4, Nanog and 
Sox-2, as well as done in my previous preparation of mBMSCs. As evidenced by 
real time-PCR, Nanog is highly expressed in B mBMSCs, whereas the expression 
of Sox-2 was ten times lower than Nanog and Oct4 was undetectable (Figure 44). 
These data are consistent with the previous results, obtained in EP, BF, M and N 
BMSCs and several published papers (Jiang et al. 2002; Anjos-Afonso et al. 2007; 
Beltrami et al. 2007; Gonzalez et al. 2007; Greco et al. 2007; Galderisi et al. 2008; 
Kobayashi et al. 2008). 
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Figure 44 Stemness factor expression in B BMSCs 
Real Time-PCR analysis. mRNA levels were normalized with respect to GAPDH, chosen 
as an internal control. Histograms show mean expression values (± SD, n=3; * p < 0.05; 
** p < 0.01). 
 
7.3 Transient over- expression and down-regulation of Nanog  
In order to obtain a transient over-expression or down-regulation of Nanog in 
BMSCs, I cloned the murine Nanog cDNA in sense and antisense direction in 
expression vectors carrying a CMV promoter and an IRES-GFP-WPRE sequence, 
so that expression of the construct would have been easily detectable during the 
cell culture. IRES sequence, the internal ribosome entry site, allows for translation 
initiation in the middle of a mRNA sequence as part of the greater process of 
protein synthesis. Usually, in eukaryotes, translation can only be initiated at the 5’ 
end of the mRNA molecule, since 5’ cap recognition is required for the assembly 
of the initiation complex. However, when an IRES segment is located between 
two open reading frames (ORFs) in a eukaryotic mRNA molecule, it can drive 
translation of the downstream protein coding region independently of the 5’-cap 
structure bound to the 5’ end of the mRNA molecule. In such a setup both 
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proteins are produced in the cell. The first reporter protein located in the first 
cistron is synthesized by the cap-dependent initiation approach while translation 
initiation of the second protein is directed by the IRES segment located in the 
intercistronic spacer region between the two reporter protein coding regions 
(Pelletier et al. 1988). The WPRE, woodchuck hepatitis virus post-transcriptional 
regulatory element, is a sequence which facilitates nucleocytoplasmic transport of 
RNA and therefore stimulates cDNA expression (Higashimoto et al. 2007).  
 
7.3.1 Over-expression of Nanog in 293 cell line  
In order to test the efficacy of the vector carrying Nanog cDNA, I initially 
transfected 293 cell line, using calcium-phosphate method, as described in 
Chapter 4, section 4.14.3. As shown in Figure 45, 48 hours after nucleofection, 
GFP positive cells represented more than 70% of pCMVIRES-GFP-WPRE and 
pCMVNanogIRES-GFP-WPRE transfected 293.  
Western Blot analysis confirms that Nanog protein is expressed at high levels in 
Nanog over-expressing cells, while is not expressed in untreated or pCMV-
IRESGFP-WPRE treated cells (Figure 46).    
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Figure 45 GFP expression in 293 transfected with Nanog vector 
293 cells were transfected with no DNA (panel A and B), 10 μg pCMVIRES-GFP-WPRE 
(panel C and D) or pCMVNanogIRES-GFP-WPRE (panel E and F). GFP expression was 
analyzed after 24 hr. (original magnification 10X; panel A, C and E phase contrast 
microscopy; panel B, D and F fluorescence microscopy). 
 
 
 
Figure 46 Nanog expression in 293 transfected with Nanog vector 
Western blot analysis of Nanog in 293. 1, 293; 2, mES; 3 293 transfected with 
pCMVIRES-GFP-WPRE; 4 293 transfected with pCMVNanogIRES-GFP-WPRE. The 
protein levels were normalized with respect to GAPDH, which was chosen as an internal 
control. 
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7.3.2 Down-regulation of Nanog in 293 cell line  
In order to test the efficacy of the vector expressing antisense sequence of Nanog 
to interfere with the expression of Nanog, I transfected this vector in 293 cell line, 
using calcium-phosphate method, as described in Chapter 4, section 4.13.3. As 
shown in Figure 47, 24  hours after transfection of pCMVIRES-GFP-WPRE, GFP 
positive cells represented more than 70%; a significant less number of GFP 
positive cells were observed in 293 transfected with pCMVantiNanogIRES-GFP-
WPRE transfected.  
293 cells do not express Nanog. So, in order to test the efficacy of the antisense to 
down regulate the expression of Nanog, I co-transfected pCMVNanogIRES-GFP-
WPRE and pCMVantiNanogIRES-GFP-WPRE at different ratio (Figure 48).  
Western Blot analysis confirms that antisense of Nanog is able to reduce the 
expression of Nanog protein to less than 25% when cotransfected with Nanog at 
ratio 1.1. Increasing ratios reduce Nanog protein to level undetectable by western 
blot (Figure 49). 
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Figure 47 GFP expression in 293 transfected with antiNanog vector 
293 cells were transfected with no DNA (panel A and B), 10 μg pCMVIRES-GFP-WPRE 
(panel C and D) or pCMVantiNanogIRES-GFP-WPRE (panel E and F).GFP expression 
was analyzed after 24 hr (original magnification 10x; panel A, C and E phase contrast 
microscopy; panel B, D and F fluorescence microscopy). 
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Figure 48 GFP expression in 293 co-transfected with Nanog and antiNanog vectors 
GFP expression was analyzed after 24 hr (original magnification 10x; upper panels 
phase contrast microscopy; lower panels fluorescence microscopy). 
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Figure 49 Down- regulation in Nanog expression in 293 co-transfected with Nanog 
and antiNanog vectors 
Western blot analysis of Nanog in 293. 1, 293 transfected with pCMVNanogIRES-GFP-
WPRE; 2, 75% sample 1; 3, 50% sample 1; 4 25% sample 1; 5, 293 co-transfected with 
pCMVNanogIRES-GFP-WPRE and pCMVantiNanogIRES-GFP-WPRE ratio 1.1; 6, 293 
co-transfected with pCMVNanogIRES-GFP-WPRE and pCMVantiNanogIRES-GFP-
WPRE ratio 1.2;  7, 293 co-transfected with pCMVNanogIRES-GFP-WPRE and 
pCMVantiNanogIRES-GFP-WPRE ratio 1.3;  8, 293 co-transfected with 
pCMVNanogIRES-GFP-WPRE and pCMVantiNanogIRES-GFP-WPRE ratio 1.4;   9, 
293; 10, 293  transfected with pCMVIRES-GFP-WPRE; 11,  293 transfected with 
pCMVantiNanogIRES-GFP-WPRE; 12, mES cells. The protein levels were normalized 
with respect to GAPDH, which was chosen as an internal control. 
 
7.3.3 Transfection efficiency, cell viability and cell recovery in 
mBMSCs nucleofected with pCMVNanogIRES-GFP-WPRE and 
pCMVantiNanogIRES-GFP-WPRE  
I transfected the vectors described above in B BMSCs, using the optimized 
nucleofection protocol described in the Chapter 4, section 4.14.2 and discussed in 
Chapter 6. As shown in Figure 50, 24 hours after nucleofection, GFP positive 
cells represented more than 70% of pCMV-GFP transfected mBMSCs; lower 
percentages of GFP positive cells were observed in cell nucleofected with 
pCMVIRES-GFP-WPRE, pCMVNanogIRES-GFP-WPRE and 
pCMVNanogIRES-GFP-WPRE. This difference in GFP expression was due to 
the presence of IRES element: as discussed above, in these constructs Nanog 
expression is driven by CMV promoter and protein is synthesized by the cap-
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dependent initiation approach while, translation initiation of the GFP protein is 
directed by the IRES segment located in the intercistronic spacer region between 
the two protein coding regions, so the efficiency is lower (Pelletier et al. 1988; Go 
et al. 2008). 
The transfected cells were also analyzed by fluorescence activated cell sorter 
(FACS) in order to quantify the results in terms of efficiency, viability and cell 
recovery. 
The flow cytometry analysis verified that nucleofection of pCMVIRES-GFP-
WPRE  resulted in 32.2% GFP positive cells, while the percentage of GFP 
positive cells obtained with nucleofection of pCMVNanogIRES-GFP-WPRE and 
pCMVantiNanogIRES-GFP-WPRE was 38,36% and 3,95%, respectively,  
confirming the results obtained with fluorescence microscopy (Figure 51).  
I observed a mean cell viability of 93.4%, 87.15%, 83.89 % and 90.72% for cell 
treated with no DNA, pCMVIRES-GFP-WPRE, pCMVNanog-IRES-GFP-WPRE 
or pCMVantiNanogIRES-GFP-WPRE respectively, confirming no particular 
difference in toxicity of different vectors (Figure 51). 
Cell recovery was  120% ± 30%, 88.4% ± 15.2%,  73.8% ± 9.49% and 61%± 
13.45%,  for cell treated with no DNA, pCMVIRES-GFP-WPRE,  pCMVNanog-
IRES-GFP-WPRE or pCMVantiNanogIRES-GFP-WPRE respectively. T-Test 
analysis confirm that the difference between no DNA and pCMVIRES-GFP-
WPRE, no DNA and pCMVNanogIRES-GFP-WPRE and pCMVIRES-GFP-
WPRE and pCMVNanogIRES-GFP-WPRE were not statistically significant (p= 
0.072; p=0.052; p= 0.10); whereas the difference between no DNA and 
pCMVantiNanogIRES-GFP-WPRE, and between pCMVIRES-GFP-WPRE and 
pCMVantiNanogIRES-GFP-WPRE were statistically significant (p= 0.021; 
p=0.042). 
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Figure 50 GFP expression in B BMSCs nucleofected with pCMVIRESGFP-WPRE 
vector. Fluorescence microscopy analysis 
1x106 mBMSCs were pulsed with U-23 program in the presence of no DNA (panel A and 
B), 8 μg pCMV-GFP (panel C and D),  pCMVIRES-GFP-WPRE (panel E and F), 
pCMVNanogIRES-GFP-WPRE (panel G and H) pCMVantiNanogIRES-GFP-WPRE 
(panel I and J) original magnification 10X; panel A, C, E, G and I phase contrast 
microscopy; panel B, D, F, H and J fluorescence microscopy). 
 
 
 
Figure 51 GFP expression in cell nucleofected with pCMVIRESGFP-WPRE vector. 
FACS analysis 
Flow cytometry analysis of BMSCs transfected with no DNA (panel A), pCMVIRES-GFP-
WPRE (panel B), pCMVNanogIRES-GFP-WPRE (panel C), pCMVantiNanogIRES-GFP-
WPRE (panel D). 
A B 
C D
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7.3.4 Over-expression of Nanog in mBMSCs  
In order to confirm that the nucleofection with pCMVNanogIRES-GFP-WPRE 
allows over expression of Nanog in B mBMSCs, I analyzed the expression of 
Nanog by Real time-PCR and Western Blot analysis. 
As showed in Figure 52, over expression of Nanog driven by CMV promoter 
leads to an increase in Nanog mRNA of 50 times, compared to mBMSCs treated 
with pCMVIRES-GFP-WPRE (p=6.23E-07), confirming the efficacy of the 
vector in driving Nanog expression in BMSCs. 
Western Blot analysis confirms that Nanog protein is expressed at high levels in 
Nanog over-expressing cells (Figure 53). I did not detect Nanog protein in control 
B mBMSCs by western blot analysis, even when I loaded 10-50 µg of proteins as 
also showed by several papers (Greco et al. 2007; Go et al. 2008; Liu et al. 2008). 
 
Figure 52 Nanog expression in BMSCs nucleofected with Nanog vector. Real time 
PCR 
 mRNA levels were normalized with respect to GAPDH, chosen as an internal control. 
The histogram shows the mean expression values expressed as 2^-Delta ct (± SD, n=3).  (* p 
< 0.05; ** p < 0.01). 
 
* 
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Figure 53 Nanog expression in BMSCs nucleofected with Nanog vector. Western-blot 
Western blot analysis of Nanog in B mBMSCs. 1, mES; 2, B mBMSCs; 3 B mBMSCs 
nucleofected with pCMVIRES-GFP-WPRE; 4 B mBMSCs nucleofected with 
pCMVNanogIRES-GFP-WPRE. The protein levels were normalized with respect to 
GAPDH, which was chosen as an internal control. 
 
7.4 Effect of over-expression and down-regulation of Nanog in 
mBMSCs  
I assessed whether over- expression or down- regulation of Nanog affect cell 
migration. The motility of BMSCs was examined in a migration chamber in 
which the migrating cells in the insert chamber went through the poles on the 
membrane. The cells landing in the lower chamber or attaching on the other side 
of the membrane were stained and quantified by counting several fields. The 
results show that Nanog does not affect cell migration (Figure 43;  p= 0.35 t-Test 
between untransfected and mock; p=0.76 t-Test between untransfected and 
pCMVGFP; p=0.80 t-Test between mock and pCMVGFP), whereas down 
regulation of Nanog enhances cell migration in a significant way. 
In order to rationalise the effect of down- regulation of Nanog in BMSCs 
migration, I analyzed by real- time PCR expression of CCL5 and CXCL10, two 
cytokines involved in BMSC migration (Honczarenko et al. 2006; Chamberlain et 
al. 2008; Lazennec et al. 2008). Real- time PCR data confirm that down- 
regulation of Nanog in BMSCs stimulates expression of these cytokines (t- Test 
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between pCMVIRES-GFP-WPRE and pCMVantiNanogIRES-GFP-WPRE p= 
0.01377 for CCL5; p= 0.022 for CXCL10), whereas Nanog over expression does 
not affect expression of these genes (t- Test between pCMVIRES-GFP-WPRE 
and pCMVNanogIRES-GFP-WPRE p= 0.258 for CCL5; p= 0.320 for CXCL10). 
 
 
 
Figure 54 Effect of over expression or down regulation of Nanog on cell migration 
Crystal violet staining of chamber slides of mBMSC transfected with pCMVIRES-GFP-
WPRE (panel A), transfected with pCMVNanogIRES-GFP-WPRE (panel B) or with 
pCMVantiNanogIRES-GFP-WPRE (panel C) (original magnification 10X). Quantization 
of the number of migrated cells (panel D). 
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Figure 55 CCL5 and CXCL10 expression in BMSCs 
mRNA levels were normalized with respect to GAPDH, chosen as an internal control. 
The histogram shows the mean expression values expressed as 2^-Delta ct (± SD, n=3) (* p 
< 0.05; ** p < 0.01). 
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DISCUSSION  
Chapter 8 
 
In the present study, I have provided a characterization of four mBMSC 
subpopulations enriched through distinct culture conditions and showing different 
immunophenotype, self-renewal ability and differentiation potential. 
In the recent years, BMSCs have generated a great deal of interest as potential 
source of cells for therapy as several papers have suggested a function in tissue 
repair by migration-differentiation (Bianco et al. 2001; Jiang et al. 2002; Anjos-
Afonso et al. 2004; Kawada et al. 2004; Lemoli et al. 2005), by fusion (Ferrari et 
al. 1998; Wagers et al. 2004), by provision of a stromal support network (Caplan 
et al. 2006; Schenk et al. 2007) or mediated by their immunosuppressive abilities 
(Aggarwal et al. 2005; Le Blanc et al. 2005; Uccelli et al. 2008). Indeed, 
involvement of BMSCs has been demonstrated in the regeneration of a number of 
organs and tissues including bone (Lieberman et al. 1998; Olmsted et al. 2001; 
Gafni et al. 2004), skin (Fu et al. 2009), liver (Khurana et al. 2007), kidney (Choi 
et al. 2008),  muscle (Ferrari et al. 1998; Gussoni et al. 1999; Ferrari et al. 2001) 
and infarcted myocardium (Orlic et al. 2001). 
These observations, together with the possibility to obtain these cells from 
biopsies, escaping the ethical issue concerning embryonic stem cells, make them 
one of the most promising therapeutic tools of this century (for a review of 
clinical trials employing BMSCs see Le Blanc et al. 2005; Giordano et al. 2007  
and www.clinicaltrial.gov).  
Nevertheless, the ability to move forward their use in therapy is impeded by the 
inability to definitively identify and characterize this population in a simple 
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mammalian model, such as the mouse and also by the lack of information 
regarding their biology, their in vivo role and factors involved in senescence and 
tumorigenic potential. BMSC, in fact is a cell type better studied and 
characterized in humans than in mouse and, although in the last few years 
numerous protocols have been developed to isolate these cells, some problems 
still remain (Baddoo et al. 2003; Meirelles Lda et al. 2003; Sun et al. 2003; Peister 
et al. 2004; Tropel et al. 2004; Wang et al. 2006)  most of the published papers 
lack optimization of culture conditions to obtain a high number of specific 
progenitors, maintaining the same characteristic for many passages without 
acquisition of tumorigenic potential (Serakinci et al. 2004; Rubio et al. 2005; 
Miura et al. 2006; Li et al. 2007; Tolar et al. 2007; Rubio et al. 2008). 
 
8.1 Culture expansion of mBMSCs from C57bl/6 mouse bone 
marrow 
In this work I described a protocol to isolate BMSCs from C57bl/6 mice, as this 
strain is frequently used to prepare transgenic mice. The yield in CFU-F obtained 
from C57bl/6 mice has already been reported to be very low compared to other 
strains such as Balb/c, FVB/N and DBA (Phinney et al. 1999; Peister et al. 2004). 
When I tried to isolate and expand mBMSC from C57Bl/6 mice using complete 
medium without any supplements, the few adherent cells obtained after the 
incubation period were not able to proliferate even when I sub-cultured them in 
another plate. Starting from the observation that use of bone fragment-conditioned 
medium favors BMSCs growth (Sun et al. 2003), I devised the conditions that 
selected the subpopulations described as BF and EP. As it is well known that 
mBMSCs expand very poorly (Baddoo et al. 2003; Meirelles Lda et al. 2003; Sun 
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et al. 2003; Peister et al. 2004; Tropel et al. 2004; Wang et al. 2006), after 2 weeks 
of culture, I cultured a part of these cells, named EP mBMSCs, in complete 
medium supplemented with EGF and PDGF-AA (Colter et al. 2001; Tropel et al. 
2004; Kratchmarova et al. 2005); on the other hand, I maintained BF mBMSCs in 
complete medium with no additional components. Surprisingly, in spite of the 
above cited considerations, I observed an expansion of BF mBMSCs. These 
results led us to hypothesize that a specific bone marrow derived 
microenvironment could be responsible for the selection and maintenance of 
mesenchymal progenitors. I therefore decided to evaluate whether conditioned 
media obtained from MS-5 (Issaad et al. 1993) and NIH3T3 cell lines (Burroughs 
et al. 1994) could mimic the properties of bone marrow microenvironment. To 
this aim, I grew MS-5 and NIH3T3 in the same medium (see Chapter 4, section 
4.2.2) in order to minimize any difference between the conditioned media 
harvested from these cell lines, that differ only in the molecules secreted from 
each individual line. Using the above-mentioned conditioned media I was able to 
efficiently culture mBMSC. I therefore hypothesized that one of the main 
determinant for a successful isolation and expansion of mouse mesenchymal 
progenitors were the growth supplement adopted for the isolation and expansion. 
Immunophenotypical characterization of BMSC subpopulations showed in each 
case profiles compatible with BMSCs (Lai et al. 1998; Deans et al. 2000). 
Interestingly, I observed differences in CD117, CD13 and H2-kb expression 
(Table 5). All cultures were positive to Sca I, the hallmark of hematopoietic and 
mesenchymal progenitor cells (Holmes et al. 2007) and CD44 which bridges the 
cells to hyaluronan and osteopontin (Avigdor et al. 2004) and is  involved in 
BMSC- T-cell interaction (Aggarwal et al. 2005; Uccelli et al. 2007; Uccelli et al. 
2008) (Figure 12). 
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Some papers have reported Sca I expression typical of haematopoietic stem cells 
(HSC) (Holmes et al. 2007) and higher in BMSCs from C57Bl/6 compared to 
Balb/c mice (Peister et al. 2004). As this antigen is trypsin sensitive (Meirelles 
Lda et al. 2003), this variability could be also associated to the type of treatment 
used to detach the cells. As also suggested by Mereilles (Meirelles Lda et al. 
2003) our data confirm that usage of accutase from Stemcell technology allows us 
to avoid the cleavage of this antigen from cell surface.  
EP mBMSCs showed two populations regarding CD13 expression (Figure 12); 
as mentioned in Chapter 4, section 4.2.1, EP mBMSCs were treated with EGF and 
PDGF, so it is likely that these cytokines contributed to this phenotype, as they 
expanded subpopulations of mBMSC which expressed EGF and PDGF receptors 
(Satomura et al. 1998; Colter et al. 2000; Colter et al. 2001).  
BF and M mBMSCs were negative to H-2kb, the major hystocompatibility 
complex of class I, so suggesting a typical feature of very early progenitors known 
as mMAPC (Jiang et al. 2002). 
After an initial lag phase of about 10-17 days (Figure 11), these cells started to 
proliferate showing different growth kinetics (Figure 12). Cell cycle analysis 
confirmed a small difference in the percentage of cells in G1, S or G2 phase 
among the four groups, according to the differences in doubling time (Figure 13, 
Figure 14).   
One of the most common observation in a large number of papers is that culture-
expanded hBMSC usually stop proliferating before or at 40 population doublings 
(PD's) (at least 60 for mBMSCs (Tropel et al. 2004)), at which time the cells lose 
spindle-shaped fibroblastic morphology, become bigger and more flattened and 
accumulate SA-β-Gal in cytoplasm (Bruder et al. 1997; Stenderup et al. 2003; Ito 
et al. 2007; Shibata et al. 2007; Ryu et al. 2008; Wagner et al. 2008).  A 
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phenomenon largely associated with senescence in vitro (Hayflick 1965; Dimri et 
al. 1995; Sethe et al. 2006). In contrast to these studies, during the observation 
period (30 passages) I did not observe any signs of cellular senescence such as 
absence of mitotic activity (Figure 13, Figure 14) accumulation of cellular 
debris or increase in expression of SA-β- galactosidase (Figure 15). These data 
were very surprising as an increase in the number of senescent cells, assessed by 
SA- β- Gal staining was reported both for human (Ito et al. 2007; Shibata et al. 
2007; Ryu et al. 2008; Wagner et al. 2008) and rat BMSCs (Galderisi et al. 2008). 
As the cellular senescence is one the tumor suppressor functions of normal cells 
(Sharpless et al. 2007), to further investigate the characteristics of these 
subcultures and exclude the acquisition of a tumorigenic potential, I analyzed their 
DNA content, the expression of telomerase and the ability to form tumor in mice 
after 30 passages in culture.  
Analysis of cell cycle after 30 passages showed a slight increase in the number of 
cells in G1 phase and a decrease in S phase for EP and BF mBMSCs (Figure 16, 
Figure 17). No differences in terms of cells in G1, S or G2 phase were observed 
between early (10-15) and late (35-40) passages in N BMSCs, suggesting that the 
NIH3T3 conditioned medium could contain cytokines involved in the suppression 
of cellular senescence and maintenance. One of this could be FGF-2. It has been 
already shown that NIH3T3 express FGF- 2 (Quarto et al. 2005). This cytokine 
has been considered one of the most important mitogens for human (Bianchi et al. 
2003; Choi et al. 2008) and murine BMSCs (Sun et al. 2003) because it is able to 
maintain the cells in an immature state during in vitro expansion; recently Ito et 
al. have also demonstrated that FGF-2 is able to suppress the cellular senescence 
through down-regulation of TGF-β2 (Ito et al. 2007).  
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Considering the results obtained for EP, BF and N BMSCs jointly, they confirm 
the maintenance of a euploid karyotype over a period of 30 passages. Different 
results were obtained with M BMSCs, which showed an aneuployd karyotype at 
late passages (Figure 16).  
Chromosomal alterations in BMSCs are very often associated with the activation 
of telomerase activity in vitro (Serakinci et al. 2004; Rubio et al. 2005; Miura et 
al. 2006; Rubio et al. 2008) and tumorigenic potential in vivo (Serakinci et al. 
2004; Rubio et al. 2005; Miura et al. 2006; Zhou et al. 2006; Rubio et al. 2008). 
For these reason I decided to analyze expression of telomerase in mBMSCs and 
their ability to form tumor in vivo. 
Telomerase activity has been found in almost all human tumors but not in normal 
cells (Kim et al. 1994) and maintenance of telomere stability is required for 
bypassing senescence and for the long-term proliferation of the cells. Indeed, 
ectopic expression of hTERT can immortalize hBMSCs, maintaining their 
proliferative and differentiation ability (Shi et al. 2002; Simonsen et al. 2002) and, 
in conjunction with additional events usually implying an oncogene deregulation 
such as KRAS (Serakinci et al. 2004) and c-myc, (Rubio et al. 2005; Miura et al. 
2006; Zhou et al. 2006; Tolar et al. 2007; Rubio et al. 2008), produce cell 
transformation (Serakinci et al. 2004; Rubio et al. 2005; Miura et al. 2006). 
TRAP assay did not show any significant telomerase expression in BMSCs 
(Figure 18) in accordance to some published papers (Simonsen et al. 2002; 
Stenderup et al. 2003). This finding confirms that BMSCs, even without showing 
dramatic changes in proliferative activity or cellular metabolism after 20 passages 
in vitro, do not activate telomerase expression. 
In order to exclude that these subpopulations contained transformed cells I tested 
their tumorigenicity in vivo. When mBMSCs were subcutaneously injected in 
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nude mice, no animals developed a tumour within 2 months, demonstrating that 
these BMSCs were free of transformed or tumorigenic cells. 
 
8.2 Culture condition select mBMSCs with different 
differentiation potential 
As for the differentiation potential,  in two of the four conditions, BF and M, cells 
showed tri-potential differentiation ability, giving rise to osteoblasts, chondrocytes 
and pre-adipocytes, whereas EP cells lost adipogenic potential, probably during 
the first passages (Digirolamo et al. 1999). Interestingly, we observed that the 
ability to differentiate in pre-adipocytes was typical of BF and M BMSCs, which 
are negative to the major histocompatibilty complex of class I (H2-kb), a typical 
characteristic of mMAPCs (Jiang et al. 2002). Moreover, the ability to 
differentiate in hypertrophic chondrocytes was typical of EP and M BMSCs, 
which showed lower expansion profiles than the other subpopulations (Figure 13). 
We speculate that this data could be partially due to the effect of EGF on these 
cells. The EGF, added directly to EP BMSCs and contained in MS-5 conditioned 
medium (Issaad et al. 1993) could act not only as mitogen in mesenchymal 
proliferation (Tropel et al. 2004), but also as a stimulator of osteogenic 
differentiation(Kratchmarova et al. 2005). This effect could account for the high 
condrogenic-osteogenic potential of these cells. 
On the other hand, using NIH3T3 conditioned medium, I obtained cells that 
showed impairment in osteogenic and chondrogenic differentiation, whereas 
retaining a very high adipogenic potential during passages. We hypothesized that 
this could be the result of NIH3T3 conditioned medium exposition. Therefore, in 
order to address this behavior, I switched the N BMSC cells into standard growth 
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medium for ten passages. I was not able to appreciate any significant recovery of 
osteogenic potential (Figure 32, Figure 33), which leads to the conclusion that 
this effect was not reversible. In the attempt to identify cytokines possibly 
responsible for this behaviour, we focused our attention on LIF (Falconi et al. 
2007). It has been recently observed that LIF is responsible for blocking 
osteoblast maturation at late differentiation stages and redirecting these cells 
toward the adipogenic pathway (Falconi et al. 2007; Falconi et al. 2007) I 
speculate that in N BMSC model, LIF could suppress the osteoblast maturation at 
late differentiation stages (Falconi et al. 2007; Falconi et al. 2007), contributing to 
the selection of adipogenic progenitors from bone marrow by stimulating the 
expression of proteins involved in PPARγ expression such as C/EBPβ and 
C/EBPδ (Hogan et al. 2005; Falconi et al. 2007).  
RT-PCR data  confirmed that the mBMSCs constitutively express some 
osteoblastic lineage markers such as CbfaI/Runx2, Collagen I and osteopontin 
(Figure 26) and  chondrogenic markers such as Sox-9 and Collagen XI (Figure 
29). Expression of these lineage markers in undifferentiated cells is not surprising 
(Mackay et al. 1998; Karsenty et al. 2002; Tropel et al. 2004; Goldring et al. 
2006; Rosen et al. 2006; Murdoch et al. 2007) and could be explained by two 
different hypotheses. In a classical model of differentiation, there could be a 
spontaneous and continuous generation of lineage restricted progenitors from 
stem cells (Dennis et al. 2002) (Figure 6, MSC compartment). Gene- lineage 
repression could be the common regulatory mechanism of mesenchymal lineage 
differentiation, so, according to this model, expression of the master regulatory 
genes  Cbfa I/Runx2, C/EBPα and PPARγ2  or Sox 9 could be  not sufficient to 
induce, respectively,  osteogenic, adipogenic and chondrogenic differentiation  of 
mBMSCs; factors of one lineage repress factors of the other lineages, thereby 
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maintaining the undifferentiated state (Hong et al. 2005). However, under 
appropriate conditions, the balance can be tipped leading to a cascade that 
promotes one cell fate while repressing other possible fates. Alternatively, these 
results could be explained by “the chiaroscuro model” described by Quesenberry 
et al. (Quesenberry et al. 2002) on available data concerning haematopoietic stem 
cell physiology. In this model, (Figure 6, differentiation compartment), cells from 
a wide stem cell compartment oscillate between different states of differentiation 
competencies. Consequently, a cell may express lineage-specific genes (similarly 
to a unipotent progenitor) and its progeny may present a stem cell phenotype. This 
model underlies great cell plasticity, which is a major BMSC property (Wagers et 
al. 2004; Lemoli et al. 2005). As an example, bone marrow adipocytes can 
dedifferentiate and re-differentiate towards adipocytic or osteoblastic pathways 
(Park et al. 1999).  
 
8.3 BMSCs express the homeodomain gene Nanog 
A very interesting feature of all the BMSC subpopulations isolated was the 
expression of a well-known marker of undifferentiated embryonic stem cells, 
Nanog (Chambers et al. 2003; Mitsui et al. 2003; Boiani et al. 2005) (Figure 
21Figure 22).   
Initially I analyzed Nanog expression by RT-PCR: at day 0 Nanog is expressed in 
all the BMSC groups. At day 21 I observed the expression of Nanog only in EP 
BMSCs. As BMSCs are able to spontaneously differentiate along mesenchymal 
lineages during the time in culture, I believe that at day 21 BF, M and N mBMSCs 
differentiate and lose expression of a stemness marker such as Nanog. The 
maintenance of the expression of Nanog in EP mBMSC at day 21 can be due to 
culture conditions used to expand these cells. As reported in Chapter 4, section 
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4.2.1, EP mBMSCs were treated with EGF and PDGF. Very recently, a link 
between PDGF and Nanog expression was elucidated:  PDGF induces 
phosphorilation of p68 that binds to β catenin, allowing its nuclear localization; in 
this way it can up-regulate the expression of Nanog (He 2006; Yang et al. 2006; 
Takao et al. 2007). Immunofluorescence data confirm the nuclear localization of 
Nanog in BMSCs (Figure 22).  
Although the role of Nanog in adult tissue stem cells remains unclear, it is 
possible that it enhances self-renewal of tissue stem cells. In the last two years, 
many papers have shown that the introduction of the transcription factors, Sox2, 
Oct4, KLF-4 and c-myc, into adult somatic cells resulted in the generation of 
induced pluripotent stem cells (iPS) (Takahashi et al. 2006). These results have 
suggested that the over-expression of these genes in BMSCs can improve the 
quality of these cells, in terms of stemness, or promote their proliferation. The 
homeodomain gene Nanog is not one of the four genes, however, its functional 
importance was evident by the fact that up regulation of the Nanog gene is critical 
for reprogramming the cell (Okita et al. 2007). 
Several groups (Anjos-Afonso et al. 2007; Battula et al. 2007; Beltrami et al. 
2007) have demonstrated expression of Nanog in BMSCs; however its role in 
these cells is still unknown. Very recent studies of Go et al. and Liu et al. have 
shown an effect of Nanog on proliferation and osteogenic and chondrogenic 
abilities (Go et al. 2008; Liu et al. 2008), however, nobody of them tested the 
effect of Nanog in cell migration and in the balance between senescence, 
apoptosis and tumorigenesis.  
During a six-month period as visitor in the lab of Dr Nicole Horwood I 
constructed and tested in BMSCs the efficacy of vectors expressing Nanog sense 
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and antisense to employ in experiments of Nanog over- expression and down- 
regulation in BMSCs.  
As strategy to mediate expression of Nanog in BMSCs, I used a non viral 
transfection method, the nucleofection technology of Amaxa System, which has 
been already used in BMSC transfection (Lakshmipathy et al. 2004; Aluigi et al. 
2006).  After 24 hours from transfection 52.39% of cells resulted GFP positive 
with mean cell viability of 97.3% and an overall recovery of 120% ± 30% for 
cells treated with no DNA and 88.4% ± 15.2% for cell treated with pCMV-GFP 
(Figure 39). These results are very satisfying compared to other transfection 
methods. Cell survival was reported to be less than  50%,  35-40% and  40%  with 
lipofectamine 2000 (Hoelters et al. 2005), electroporation (Helledie et al. 2008) or 
nucleofection (Aluigi et al. 2006) respectively,  whereas, with the same methods,   
transfection efficiency, measured as GFP positive cells,  was reported to be 50%, 
30% and 28%. Time course analysis confirms that GFP levels declined over time, 
according to the transient nature of plasmid-based transfection. Afterward, the 
introduction of DNA in BMSCs did not affect proliferation (Figure 41), 
senescence (Figure 42) and migration (Figure 43) and the percentage of GFP 
positive cells was still as high after one week (Figure 40), according to the 
hypothesis that as the DNA is delivered into the nucleus and is not retained in the 
cytoplasm after the transfection, it could be less subjected to degradation (Hamm 
et al. 2002). These results allowed me to perform some experiments which 
required just a transient over expression or down regulation of Nanog. 
Preliminary data suggest that down-regulation of Nanog enhances migration 
ability (Figure 54), and induces an increase in the expression of CCL5 (Rantes) 
and CXCL10 (IP10, interferon γ inducible protein-10) 
(
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Figure 55), which have been reported to enhance motility, invasion and metastasis 
of breast cancer cells (Karnoub et al. 2007) and to have a potent thymus-
dependent antitumoral effect (Luster et al. 1993). Very recent micro-array data 
gave some insights in specific Nanog target  genes  in BMSCs (Liu et al. 2008). 
According to these data, Nanog over expression induces 1.5 fold increase in 
CCL5 expression (Liu et al. 2008), in contrast with my results. Notably, CCl5 and 
CXCL10 have also shown to be direct targets inhibited by STAT-3 (McLoughlin 
et al. 2005) and activated by NF-Kβ (Yang et al. 2007); Nanog has been shown to 
be able to cooperate with NF-Kβ and STAT-3 by protein– protein interaction 
(Narayanan et al. 1993; Pan et al. 2005; Torres et al. 2008). So we hypothesize 
that the effect of Nanog on CCL5 and CXCL10 could be indirect and mediated by 
STAT3 or NF-Kβ (Figure 56).  
On the other hand, over-expression of Nanog does not affect cell proliferation 
(Figure 58) or  reduce the number of senescent cells (Figure 59),  however 
Nanog over-expressing cells show a decrease in p53 expression, a well known 
tumor-suppressor gene (Campisi et al. 2007; Serrano et al. 2007; Sharpless et al. 
2007) (Figure 60) and acquire the ability to grow in soft agar (Figure 61), an in 
vitro hallmark of tumorigenic cells (Freedman et al. 1974).  
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Several papers have elucidated expression of Nanog in different tumors, such as 
germ cell tumors, (Hart et al. 2005) breast tumors (Ezeh et al. 2005) and bone 
sarcomas, (Gibbs et al. 2005) leading to the identification of  tumor-stem- like 
cells expressing the key molecular machinery of embryonic stem cells. Indeed 
other two papers suggest a potential oncogenic role for Nanog in NIH3T3 and 
HSCs (Piestun et al. 2006; Tanaka et al. 2007).  
 
 
 
 
 
 
Figure 56 Model of interaction among Nanog, STAT3 and NF-Kb 
Interaction of Nanog with STAT-3 can activate this molecule in its activity as activator or 
repressor of specific target genes. Interaction of Nanog with NF-Kβ has a negative effect 
on the activity of this protein, which repress genes involved in ES self-renewal. 
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Figure 57 "Cancer stem cell hypothesis" for BMSCs 
Normal signalling influences the proliferation and renewal of stem cells (dark blue) 
during development of a variety of tissues. Different stressful stimuli such as telomere 
shortening, DNA damage, oncogene activation and epigenetic modifications can induce 
senescence or apoptosis. Uncontrolled signalling (dark blue arrow) can lead to 
constitutive renewal in spite of accumulated DNA damage, leading to aberrant expansion 
of the stem cell pool. These changes can, in turn, lead to formation of cancerous tissues.  
 
8.4 Conclusions and Future Perspectives 
The work described reports the isolation and the enrichment of specific 
progenitors from C57bl/6 mice bone marrow using cytokines, bone marrow 
derived fragment, MS5 and NIH3T3 conditioned medium. These data suggest that 
the use of appropriate conditioned media can determine the obtainment of a large 
number of desired cells for large scale transplantations or cell therapies. In the 
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near future the identification of growth factors regulating the survival rate, the 
self-renewal, the lineage differentiation will be crucial for the understanding of 
BMSCs biology and for their safe application in clinical settings. In the attempt to 
analyze potential factors involved in BMSC self-renewal I focused my attention 
on the homeodomain gene Nanog. Preliminary data concerning Nanog down 
regulation and over expression show a potential role for Nanog in migration and 
tumorigenesis. Data obtained by the transient transfection system of Amaxa did 
not allow me to observe a significant change in proliferative abilities of the cells, 
al already shown by Go et al. and Liu  et al. (Go et al. 2008; Liu et al. 2008), or in 
the number of senescent cells. Transgene expression declined over time and 
transfection efficiency did not reach 100%. We plan to use lentiviruses in order to 
obtain a long-lasting expression and high infection efficiency in BMSCs (Zhang 
et al. 2002; Zhang et al. 2004; Ricks et al. 2008). I have already cloned Nanog 
cDNA in sense and antisense orientation in a vector containing the backbone of a 
self-inactivating lentiviral vector (Zhang et al. 2002; Zhang et al. 2004; Ricks et 
al. 2008). Lentivirus work will allow us to better investigate the effects of Nanog 
in BMSCs both in vitro than in vivo, unravelling the role of Nanog in the balance 
between apoptosis, senescence and tumorigenesis (Figure 57).  This work is vital 
for our understanding of how levels of Nanog affect BMSC properties as these 
cells are being widely used in clinical trials for the treatment of GVHD, 
myocardial infarction and cartilage degeneration (Giordano et al. 2007). 
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Appendix  
Chapter 9 
 Effect of Nanog over-expression on BMSC tumorigenesis 
9.1 Effect of Nanog over expression on cell proliferation 
I tested the proliferation of BMSCs over expressing Nanog compared to mock (no 
DNA) and pCMVIRES-GFP-WPRE transfected cells. Twenty-four hours after 
transfection, mBMSCs were seeded at 1x104 cells each well of a 6 well- plates 
and after 3, 6 and 10 days, cell numbers were determined from three wells of each 
culture, as described in Chapter 4, section 4.16. No effects were observed during 
the time course. The results indicated that Nanog over expressing cells have no 
advantage in cell proliferation compared to cells transfected with no DNA or with 
the mock vector (Figure 58). 
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Figure 58 Growth kinetic of BMSCs over expressing Nanog 
Cell number was evaluated by counting cells with a hematometer in triplicates. Blue line: 
mBMSCs nucleofected with no DNA; pink line: mBMSCs nucleofected with 
pCMVIRESGFP-WPRE; yellow line: mBMSCs nucleofected with pCMVNanogIRES-
GFP-WPRE. 
9.2 Effect of Nanog over-expression on cellular senescence  
I evaluated the effect of over expression of Nanog on cellular senescence. 
Twenty-four hours after transfection, mBMSCs were seeded at 104cell/cm2 in six-
well plates, and after 3 days, the cultures were assayed for SA- β- Galactosidase 
expression, as described in Chapter 4, section 4.6. As shown in Figure 59, Nanog 
over expressing cells gave similar results in terms of SA-β- Galactosidase positive 
cells compared to both controls (cells transfected with no DNA and pCMVIRES-
GFP-WPRE), indicating that the over expression of Nanog does not have an effect 
on cellular senescence.  
In order to better analyze the behaviour of Nanog over expressing cells I analyzed 
by real time PCR expression of p53 and pRB, which are the principal mediators of 
senescence and apoptosis (Campisi et al. 2007; Serrano et al. 2007; Sharpless et 
al. 2007). Real time data show a statistically significant slight reduction in p53 
expression of BMSCs over expressing Nanog (p= 0.0008), whereas pRB is not 
affected (p= 0.304) (Figure 60). 
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Figure 59 Effect of over expression of Nanog on cellular senescence 
B gal staining of BMSCs transfected with no DNA (panel A) pCMVIRES-GFP-WPRE 
BMSCs (panel B) and pCMVNanogIRES-GFP-WPRE (panel C). Original magnifications 
10X. Quantization of β gal positive cells (panel D). 
 
 
 
Figure 60 Nanog effect on p53 and pRB expression 
Real Time-PCR analysis. mRNA levels were normalized with respect to GAPDH, chosen 
as an internal control. Histograms show mean expression values (± SD, n=3; * p < 0.05; 
** p < 0.01). 
 
**
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9.3 Effect of Nanog over-expression on acquisition of tumorigenic 
ability  
p53 is a well known tumor suppressor and a crucial mediator of cellular responses 
to DNA damage, including the senescence response (Campisi et al. 2007; Serrano 
et al. 2007; Sharpless et al. 2007). A reduction in p53 level could be extremely 
dangerous for cells, because it can provide the cells with the ability to escape from 
senescence and apoptosis, leading to a tumorigenic transformation (Pelicci 2004; 
Sharpless et al. 2004; Rubio et al. 2005; Rubio et al. 2008). For this reason I 
decide to investigate the effect of Nanog over expression on BMSCs 
tumorigenesis. As readout of acquisition of tumorigenic ability, I assessed colony 
formation in soft agar (Freedman et al. 1974). A549, lung adenocarcinoma cell 
line was used as positive control (Sithanandam et al. 2005). A549 cells, Nanog 
over expressing BMSCs, mock (no DNA) and pCMVIRES-GFP-WPRE 
transfected BMSCs were suspended in medium containing 0.3% low melting 
agarose at a density of 105cells/dish and layered on medium contaning 0.5% 
agarose. After two weeks I analyzed the number of colonies. As expected A549 
cells formed a huge number of big colonies, whereas no colony formation was 
observed in mock (no DNA) and pCMVIRES-GFP-WPRE transfected BMSCS 
(Figure 61). Notably, over-expression of Nanog in BMSCs induced acquisition 
of ability to grow in soft agar (Figure 61). This result confirms the hypothesis 
that Nanog could transform BMSCs. 
Nanog is able to up-regulate expression of Sox2 and Oct4 in ES cells (Boiani et 
al. 2005). Aberrant expression of these pluripotency-associated genes has been 
shown to be closely associated with aggressive cancer progression (Ezeh et al. 
2005; Gibbs et al. 2005; Bourguignon et al. 2008). I decided to investigate 
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expression of these genes in Nanog over expressing cells by Real time PCR. As 
shown in figure there is no significant increase in Oct4 (p= 0.102) and Sox2 (p= 
0.078) mRNA in response to Nanog over expression (Figure 62), leading to the 
hypothesis that these promoters could be no accessible to Nanog in BMSCs. 
To further analyze the potential tumorigenic role of Nanog in BMSCs, I analyzed 
by real time PCR expression of two genes commonly associated with BMSCs 
tumorigenicity such as c-myc (Rubio et al. 2005; Miura et al. 2006; Zhou et al. 
2006; Tolar et al. 2007; Rubio et al. 2008) and TERT (Kim et al. 1994; Serakinci 
et al. 2004; Rubio et al. 2005; Miura et al. 2006; Serakinci et al. 2006). Real time 
data show no difference in the expression of c-myc (p= 0.054) and TERT 
(p=0.067) in control and Nanog over expressing cells (Figure 62). 
 
 
Figure 61 Anchorage independent-growth of BMSCs over-expressing Nanog 
Crystal violet staining of BMSCs transfected with no DNA (panel A), pCMVIRES-GFP-
WPRE (panel B) and pCMVNanogIRES-GFP-WPRE (panel C). Quantification of 
colonies (panel B; * p < 0.05; ** p < 0.01). 
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Figure 62 Expression of Sox-2, Oct4, c-myc and TERT in BMSCs 
Real Time-PCR analysis. mRNA levels were normalized with respect to GAPDH, chosen 
as an internal control. Histograms show mean expression values (± SD, n=3; * p < 0.05; 
** p < 0.01). 
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Culture Conditions Allow Selection of Different Mesenchymal
Progenitors from Adult Mouse Bone Marrow
Maria Teresa Esposito, B.Sc.,1,2 Rosa Di Noto, B.Sc.,1,3 Peppino Mirabelli, Ph.D.,1,3 Marisa Gorrese, B.Sc.,1,3
Silvia Parisi, Ph.D.,1,2 Donatella Montanaro, B.Sc.,1 Luigi Del Vecchio, M.D.,1,3 and Lucio Pastore, M.D., Ph.D.1,2,3
The use of adult stem cells in tissue engineering approaches will benefit from the establishment of culture
conditions that allow the expansion and maintenance of cells with stem cell–like activity and high differentiation
potential. In the field of adult stem cells, bone marrow stromal cells (BMSCs) are promising candidates. In the
present study, we define, for the first time, conditions for optimizing the yields of cultures enriched for specific
progenitors of bone marrow. Using four distinct culture conditions, supernatants from culture of bone frag-
ments, marrow stroma cell line MS-5, embryonic fibroblast cell line NIH3T3, and a cocktail of epidermal growth
factor (EGF) and platelet-derived growth factor (PDGF), we isolated four different sub-populations of murine
BMSCs (mBMSCs). These cells express a well-known marker of undifferentiated embryonic stem cells (Nanog)
and show interesting features in immunophenotype, self-renewal ability, and differentiation potency. In par-
ticular, using NIH3T3 conditioned medium, we obtained cells that showed impairment in osteogenic and
chondrogenic differentiation while retaining high adipogenic potential during passages. Our results indicate that
the choice of the medium used for isolation and expansion of mBMSCs is important for enriching the culture of
desired specific progenitors.
Introduction
The use of bone marrow stromal cells (BMSCs) for ap-plications such as tissue engineering and gene therapy is
one of the major challenges of regenerative medicine. The
ability to move forward the use of these cells in therapy
depends on the setting up of mammalian models, necessary
to evaluate pre-clinical efficacy and standardize procedures.
In particular, characterization of murine BMSCs (mBMSCs)
is a major breakthrough that can benefit from numerous
established genetic models of human diseases now available
in this organism.1–3
However, the BMSC is a cell type better studied and
characterized in humans than inmice, and although in the last
few years, numerous protocols have been developed to isolate
these cells, some problems remain.4–11 The standard method,
widely used for the purification of human BMSCs, based on
adherence to plastic substrate, does not allow the isolation of
homogeneous populations of mBMSCs. Using alternative
methods based on immunodepletion6 or centrifugation,4,9,12
different populations of mBMSCs have been isolated; how-
ever, they expand poorly, probably because of the loss of
relevant cell–cell contacts or the absence of specific cytokines
necessary in the early phases of expansion. Moreover, no data
are available concerning an exhaustive characterization of the
stemness, differentiation potential, and acquisition of trans-
formed phenotype of the isolated cells during passages.
Starting from the observation that use of bone fragment–
conditionedmedium favors BMSC growth,8 we hypothesized
that specific conditioned media, obtained from different
microenvironments, might contribute to the self-renewal of
BMSCs and could be critical in the early phases of mBMSC
expansion. Therefore, the aim of this work was to compare
supernatants from cultures of bone fragments, mouse mar-
row stroma cell line MS-5, mouse embryonic fibroblast cell
line NIH3T3, and a cocktail of epidermal growth factor (EGF)
and platelet-derived growth factor (PDGF) to identify culture
conditions that would enable us to expand and maintain
BMSCs with stem cell-like activity and high differentiation
potential, also at late passages.
Materials and Methods
Mice
C57BL=6 (H-2Kb) and nude (Foxn1nu=Foxn1) mice were
obtained from Harlan Sprague Dawley, Inc., Indianapolis,
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Indiana. All of the experiments in this study were performed
following all regulations protecting animals used for re-
search purposes, including those of the DL 116=92.
mBMSC isolation and expansion
C57Bl=6 mice were euthanized with carbon dioxide va-
pors. The cells were isolated as described by Mereilles et al.7
We initially seeded 2106 nucleated cells=cm2 in complete
medium (alpha minimum essential medium (a-MEM; Cam-
brex Bio Science Verviers, Verviers, Belgium) with 10% se-
lected fetal bovine serum (FBS) (HyClone, Logan, Utah),
2mM L-glutamine (Gibco, Invitrogen, San Giuliano Milanese
(Mi), Italy) and 10U=mL penicillin–10 mg=mL streptomycin
(Gibco, Invitrogen) without any supplements. After 3 days,
we removed the nonadherent cells and waited for a
subconfluent culture. Unfortunately, the cells failed to reach
confluence and formed a single small colony. We tried to
subculture this colony, but the cells did not expand in this
condition. We then decided to start with another culture,
using Dulbecco’s modified Eagle medium (DMEM), and Is-
cove’s modified Dulbecco’s medium (IMDM). In both con-
ditions, we obtained larger colonies, although when we tried
to subculture these colonies, the cells were not able to ex-
pand. After these unsuccessful attempts, we decided to add
20% bone marrow–conditioned medium to the complete
medium, as reported by Sun et al., and the cells became
confluent in 10 to 17 days.8 At that time, they were washed
twice with Ca2þMg2þ-free phosphate buffered saline (PBS)
(Gibco, Invitrogen), detached with Accutase (Innovative Cell
Technologies, San Diego, California) at 378C for 10min and
then suspended in 50% culture supernatant and 50% com-
plete medium with the addition of (a) 20% bone marrow–
conditioned medium8 (BF mBMSC), (b) 20 ng=mL murine
EGF and 20ng=mL PDGF-AA (Sigma-Aldrich, Milano,
Italy) after 2 weeks of culture in condition (a) (EP mBMSC),
(c) 20% MS5-conditioned medium13 (M mBMSC), or (d)
20% NIH3T3 conditioned medium14 (N mBMSC). The
resulting suspensions were split 1:3. Half of the culture
medium was changed every 3 to 4 days until the cultures
became confluent, at which point they were washed twice
with Ca2þMg2þ-free PBS, detached, and split 1:2.
Preparation of bone marrow–conditioned medium
The bone marrow–conditioned medium has been pre-
pared following the procedure described in Sun et al.8 Briefly,
after flushing the bone marrow out of femurs and tibiae,
fragments from these bones were cultured in a-MEM (Cam-
brex Bio Science) supplemented with 20% selected FBS
(HyClone) at 378C in humidified atmosphere containing
5% carbon dioxide (CO2) for 3 days. Then the incubation
medium was collected using centrifugation at 2500 rpm for
10min and filtered through a 0.22-mm filter.
MS-5 and NIH3T3 cell lines, obtained from DSMZ
(Braunschweig, Germany), were cultured in a-MEM (Cam-
brex Bio Science) supplemented with 10% selected FBS (Hy-
Clone), 2mM L-Glutamine (Gibco, Invitrogen), and 10U=mL
penicillin–10 mg=mL streptomycin (Gibco, Invitrogen) at 378C
in humidified atmosphere containing 5% CO2. Cells were
subcultured every 3 to 4 days, and conditioned media were
collected from each cell line, centrifuged at 2500 rpm for
10min, and filtered through a 0.22-mm filter.
Flow cytometry analysis
mBMSCs were analyzed using flow cytometry with FACS
Canto II (BD Biosciences, Buccinasco (Mi), Italy). Monoclonal
antibodies directly coupled with phycoerythrin or fluores-
cein isothiocyanate including Ly-1 (CD5), CD19, Ly-5 (CD45),
and CD34 were obtained from Santa Cruz Biotechnology,
and monoclonal antibodies against Ly-24 (CD44), CD117
(c-kit), CD13, Ly-6A=E (Sca I), and MHC-I (H2-kb) were
obtained from BD Biosciences.
In vivo tumorigenicity: transplantation of mBMSCs
into nude mice
mBMSCs (2106) were resuspended in a 1:1 mixture of PBS
and injected subcutaneously into five nude mice (Foxn1nu=
Foxn1þ, 6 to 8 weeks of age from Harlan Sprague Dawley).
As a positive control for tumors induction, five mice subcu-
taneously received murine embryonic stem cells E14 tg2A
(Bay Genomics, San Francisco, California) at a concentration
of 2106 cells per site. The mice that received murine em-
bryonic stem cells (mESCs) were sacrificed 4 weeks post-
transplantation, because at that time, they had formed a
visible tumor in the injection site. The mice treated with the
different BMSC subpopulations were sacrificed 10 weeks
post-transplantation. Sites of injection were analyzed macro-
scopically and histologically using hematoxylin and eosin
staining.
Immunofluorescence for Nanog detection
Cells were fixed in 4% paraformaldehyde and permeabi-
lized with 0.2% TX-100 in 10% normal goat serum=1% bo-
vine serum albumin (Sigma-Aldrich) in PBS for 15min at
room temperature. The samples were incubated with pri-
mary antibody goat anti-murine Nanog (1:100 dilution, R&D
Systems, Minneapolis, USA) and then with an anti-goat im-
munoglobulin G conjugated with Alexa Fluor 488 (Mole-
cular Probes, Eugene, Oregon). Images were captured using
an inverted microscope (DMI4000, Leica Microsystems,
Milano, Italy).
Differentiation assays
For osteogenic and adipogenic differentiations, cells were
allowed to grow to 70% to 90% confluence and then cultured
in osteogenic5 or adipogenic15 medium for 3 and 2 weeks,
respectively. Cells were induced to chondrogenic differenti-
ation using the micro-drops and micro-pellet techniques
as described.8,16
Reverse transcription polymerase chain reaction
Total RNAwas extracted frommBMSCs cultured in control
or inductive media at different time points using TriReagent
(Sigma-Aldrich) and then treated with DNase I (Ambion,
Monza, Italy). Reverse transcription polymerase chain reac-
tion (RT-PCR) was performed using M-MuLV Reverse Tran-
scriptase (New England BioLabs, Beverly, Massachussets). A
25-fold dilution of each sample was PCR amplified using
primers and conditions listed in the supplementary materials
(Supplemental Table S1, available online at www.liebert
online.com/ten). Amplified DNA fragments were separated
on a 1% agarose gel containing 0.1 mg=mL ethidium bromide
and visualized under ultraviolet light.
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Alizarin red S staining
Cells were washed with PBS and fixed in 10% formalde-
hyde (Sigma-Aldrich) for 1 h; after rinsing with distilled
water, they were incubated with 2% alizarin red S (Sigma-
Aldrich) at pH 4.1 with gentle agitation for 10min. After
removal of excess staining using PBS, presence of minerali-
zation was examined as described previously.17 After visual
examination, the mineralized depot-bound dye was extracted
using overnight incubation with 4M guanidine–hydrochloric
acid (Sigma-Aldrich) at room temperature. Absorbance at
490 nm of a 10-times dilution of the resulting supernatant
was used for quantitative calcium determination.
Alcian blue staining
Cells were fixed with 4% paraformaldehyde (Sigma-
Aldrich) for 15min at room temperature. After being rinsed
with PBS, cells were stained with 1% Alcian blue (Sigma-
Aldrich) in 0.1N HCl at pH 1.0 (Carlo Erba Reagenti, Milano,
Italy) overnight. Cells were then dried, washed with 0.1MHCl
for 5min to remove excess staining, and then washed with
distilled water.18
Oil red-O staining
Cells were washed with PBS and fixed in 10% formal-
dehyde for 10min. After being rinsed with distilled water,
they were stained with 0.5% Oil red-o working solution
prepared by vigorously mixing three parts of a stock solu-
tion (0.5% Oil red-O in isopropanol) (Sigma-Aldrich) with
two parts of water for 5min and filtering through a 0.4-mm
filter. Excess staining was removed using PBS. Cells were
then counterstained with hematoxylin (Bio-Optica, Milano,
Italy) for 3min and then washed with distilled water.17 After
visual examination, the lipid-bound dye was extracted using
isopropanol incubation for 15min at room temperature.
Quantitative assessment was obtained by measuring absor-
bance of a ten-times dilution of the extracted dye at 550 nm.
Alkaline phosphatase staining
Briefly, the cells were washed with PBS and fixed in 10%
cold neutral formalin buffer (10% formalin, 0.1M Na2HPO4,
0.029M NaH2PO4.H2O) (Sigma-Aldrich) for 15min. After
being rinsed with distilled water, cells were stained
with substrate solution [2.4104 M naphthol AS MX-PO4
FIG 1. Morphology of mu-
rine bone marrow stromal
cells (mBMSCs) varies ac-
cording to culture condition.
Morphology of BMSCs 72 h
after plating (A) and after 10
to 17 days of culture (B). Cells
were subdivided and cultured
in complete medium with 20%
bone marrow–conditioned
medium and, subsequently, in
complete medium with
20 ng=mL murine epidermal
growth factor and 20 ng=mLof
platelet-derived growth
factor-AA (mBMSC EP, C);
complete medium with 20%
bone marrow–conditioned
medium (mBMSC BF, D);
complete medium with 20%
MS5-conditioned medium
(mBMSC M, E), and com-
plete medium with 20%
NIH3T3-conditioned
medium (mBMSC N, F).
Magnification 10.
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(Sigma-Aldrich), 0.4% N,N dimethylformamide (Sigma-
Aldrich), 1.6mM red violet LB salt (Sigma-Aldrich) in 0.2M
Tris-HCl pH 8.3 (Carlo Erba Reagenti)] for 45min. Excess
staining was removed by washing twice with distilled water
and then with 2.5% silver nitrate (Sigma-Aldrich) for 30min.
Excess silver nitrate staining was removed with distilled
water.
Alkaline phosphatase assay
Determination of the activity of alkaline phosphatase (ALP)
was performed as previously described.19 Briefly, the cells
were washed twice with Tyrode’s balanced salt solution
(50mM Tris-HCl pH 7.4, 0.15M sodium chloride) and
thenincubated with 5mM p-nitrophenylphosphate (Sigma-
Aldrich) in 50mM glycine (Sigma-Aldrich), 1mMmagnesium
chloride (Carlo Erba Reagenti) pH 10.5 at 378C for 5 to 20min.
The reaction was stopped by adding 3M sodium hydroxide to
each well. Optical density (OD) was measured at 405 nm.
Culture of mESCs
mESC line E14 tg 2A (BayGenomics) was maintained
in Glasgow Minimum Essential Medium (GMEM) (Sigma-
Aldrich) supplemented with 10% fetal bovine serum
(HyClone), 0.1mM b-mercaptoethanol (Sigma-Aldrich),
1mM sodium pyruvate (Invitrogen), 1non essential amino
acids (Invitrogen), 2mM glutamine (Invitrogen), 10U=mL
penicillin–10 mg=mL streptomycin (Gibco, Invitrogen), and
103 U=mL leukemia inhibitory factor (LIF) (Chemicon Inter-
national, Vimodrone (MI), Italy) (ES complete medium).
ESCs were routinely split every 2 days, and the medium was
changed on alternate days. To analyze the expression of LIF
in NIH3T3 supernatant, we plated mESCs at 10 cells=cm2 in
ES complete medium. After 24 h, we changed the medium
and maintained cells in ES complete medium (positive con-
trol); in ES complete medium without LIF (negative control);
and in supernatant NIH3T3 supplemented with 10% fetal
bovine serum, 0.1mM b-mercaptoethanol, 1mM sodium
pyruvate, 1non essential amino acids, 2mM glutamine, and
10U=mL penicillin–10 mg=mL streptomycin in the absence or
presence of blocking anti-LIF antibody (Chemicon Interna-
tional), according to the manufacture’s instructions. The
medium was changed every day. After 6 days, we analyzed
the formation of ALP-positive colonies.
Culture of MC3T3, C3H10T1=2, and ATDC5 cell lines
MC3T3-E1 sub4 and C3H10T1=2 cell lines were obtained
from American Type Culture Collection (Sesto San Giovanni,
Milano, Italy) ATDC5 cell line were obtained from European
Collection of Cell Culture (Milano, Italy). MC3T3-E1 sub4
cell line was cultured in IMDM (Sigma-Aldrich) supple-
mented with 10% selected FBS, 2mM L-glutamine, and
1mM sodium pyruvate at 378C in a humidified atmosphere
containing 5% CO2. For osteogenic differentiation, cells
were plated at 2104 cell=cm2 and cultured in a-MEM sup-
plemented with 10% selected FBS, 2mM L-glutamine,
0.05mM ascorbic acid 2-phosphate, and 10mM b-glycer-
ophosphate, and the medium was changed every 3 days
for 10 days.20
C3H10T1=2 cell line was cultured in a-MEM supple-
mented with 10% selected FBS and 2mM L-glutamine at
378C in a humidified atmosphere containing 5% CO2. For
adipogenic differentiation, cells were allowed to reach 90%
confluence and then cultured in a-MEM supplemented with
10% selected FBS, 2mM L-glutamine, 106 M dexametha-
sone, 5mg=mL insulin, 0.5 mM 3-isobutyl-1-methylxanthine,
and 50mM indomethacin, and the medium was changed
every 3 to 4 days for 14 days.21
ATDC-5 cell line was cultured in DMEM=HamF12 sup-
plemented with 5% selected FBS and 2mM L-glutamine at
378C in a humidified atmosphere containing 5% CO2.
22
Total RNA from MC3T3-E1, C3H10T1=2, and ATDC-5 was
extracted from the cells using TriReagent as described above.
Statistical analysis
All the experiments were analyzed using two-way Student
t-Test. P-values less than 0.05 were considered statistically
significant.
Results
Mesenchymal progenitors
Our initial cultures were heterogeneous, presenting round,
flattened, or spindle-shaped morphologies, and underwent
an initial lag phase of approximately 10 to 17 days (Fig. 1A,
B); then the colonies started to proliferate, became confluent,
and were split in four different conditions, as reported in
Materials and Methods (Fig. 1C–F).
Table 1. Variations in Culture Conditions Allow Selection of Different Mesenchymal Progenitors
Antigen
20 ng=mL Murine Epidermal
Growth Factor and 20 ng=mL
Platelet-Derived Growth
Factor-AA
20% Bone
Marrow–Conditioned
Medium
20%
MS5-Conditioned
Medium
20%
NIH3T3-Conditioned
Medium
CD 45    
CD 34    
CD 5    
CD19    
CD 117 (ckit) þ   þ
ScaI þþ þ þ þ
CD 44 þþþ þþ þþ þþþ
CD 13 þ  þ þ
H2kb þ   þ
 indicates that murine bone marrow stromal cell type does not express the specific antigen. þ, þþ, and þþþ indicate a partial
overlapping, no overlapping, and a large difference between the plot of isotype control and the plot of staining profile, respectively.
4 ESPOSITO ET AL.
FIG 3. Mesenchymal progenitors
express Nanog. Expression of stemness
markers was analyzed using reverse
transcription polymerase chain reaction
(RT-PCR) immediately after cell purifi-
cation (0) and after 21 days in the dif-
ferent culture conditions (A).
Expression of Nanog was confirmed
in all the subpopulations using im-
munostaining with an anti-Nanog an-
tibody conjugated with fluorescein
isothiocyanate counterstained with
4’,6-diamidino-2-phenylindole (B,
magnification 63) and quantified as
percentage of Nanog-positive cells at
early and late passages (C).
FIG 2. Selected mesenchymal progeni-
tors exhibit different self-renewal char-
acteristics. Cumulative population
doublingswere calculated from the initial
number of mBMSCs at the first detach-
ment from plastic tissue culture and the
number of mBMSCs harvested at the
following passage. This procedure was
repeated for each passage, providing a
theoretical growth curve that is directly
proportional to the cell number. Different
culture conditions are indicated as
follows:& EP, ^ BF,~M, and * N
mBMSCs (A). All the described subpop-
ulations after 35 passages showed no
tumor formation when transplanted
into immunocompromised mice (EP
mBMSCs B and F, BFmBMSCsC andG,
M mBMSCs D and H, N mBMSCs
E and I; magnification 2.5 for B-E, 10
for F-I; hematoxylin and eosin staining).
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After 5 to 10 passages, we analyzed the four mBMSC
subpopulations using flow cytometry (Table 1). In all cases,
the immunophenotype showed a marker profile strictly
compatible with BMSCs,23 without the expression of any
hematopoietic cell markers, such as CD45, CD34, CD5, and
CD19. In addition, although the EP mBMSCs presented a
subset of cells highly positive to CD13, the BF and MmBMSC
subpopulations were negative to the major histocompatibil-
ity complex of class I (H2-kb), suggesting a typical feature of
early multipotent bone marrow progenitors known as mul-
tipotent adult progenitor cells (MAPCs).24
Mesenchymal progenitors exhibit different
self-renewal abilities
We were able to subculture all four BMSC subpopulations
for more than 30 passages without observing any signs of
cellular senescence such as absence of mitotic activity, ac-
cumulation of cellular debris, total degeneration of the cul-
ture or aneuploidy, as evidenced by the diploid DNA
content of our subcultures (data not shown). So to evaluate
self-renewal ability of the different isolated progenitors, we
determined their doubling time that resulted 58 h for the EP,
40 h for the BF, 57 h for the M, and 44 h for the N groups, as
confirmed also according to cell cycle analysis (data not
shown). These data accounted for the different numbers of
cumulative duplication numbers reached after 30 passages.
As reported in Figure 2A, cumulative duplication numbers
were 83, 109, 70, and 90 for the EP, BF, M and N groups,
respectively.
To exclude that our subpopulations contained transformed
cells with abnormal proliferative characteristics, we first cul-
tured them without serum. In these conditions, the cells
showed signs of cellular senescence and died in few days
(data not shown). Subsequently, we tested their tumorige-
nicity in vivo in immunodeficient mice, by subcutaneous in-
jection of 2106mBMSCs, for each subpopulation.We did not
observe any tumor formation, as determined by macroscopic
and histological analysis 10 weeks after inoculum (n¼ 5; Fig
2B-I), confirming that our subpopulations were essentially
free of tumorigenic cells. As a positive control for tumor for-
mation, five mice received mESCs (2106 cells=site) at the
same site. All animals inoculated with mESCs developed
large tumors (1,28 0,49 cm in diameter) at the injected sites
within 3 to 4 weeks (data not shown).
We then evaluated whether transcription factors essential
for pluripotency and self-renewal in mESCs, such as Oct 4,
Nanog, Sox-2, and Rex-1, were present in our progenitors
and could account for the differences in proliferative ability
observed. Of the above-mentioned transcription factors,
only Nanog was expressed in our sub-cultures, as evidenced
by RT-PCR, at time 0 and after 21 days of culture in EP
mBMSCs and at time 0 in BF, M, and N mBMSCs (Fig. 3A).
Immunofluorescence data confirmed the localization of
Nanog in the nucleus of mBMSCs EP (71.8% 16.6%), BF
(61.0% 20.0%), M (48.4% 19.2%) and N (47.9% 17.5%),
as shown in Figure 3B. T-test analysis showed that the dif-
ferences in percentage of Nanog expressing cells between EP
and M BMSCs or EP and N BMSCs were statistically signif-
icant (Supplemental Table S2, available online at www
.liebertonline.com/ten). Because Nanog is a stemness mar-
ker for mESCs, and its expression is usually lost as soon as
the cells begin to differentiate and lose self-renewal poten-
tial,25 we determined its expression also in mBMSCs at high
passage number. After 30 to 40 passages, the percentage of
Nanog-positive cells was reduced for mBMSCs EP (71.8%
16.6% to 31.0% 19.1%), mBMSCs BF (61.0% 20.0% to
24.0% 20.0%) and M (48.4% 19.2% to 28.3% 22.7%). On
the contrary, the reduction in percentage of Nanog-positive
cells was not significant for mBMSCs N (47.9% 17.5% to
42.6% 11.0%) (Fig. 3C). T-test analysis suggested that the
differences in Nanog-expressing cells between the four cul-
ture conditions used were significant only in the early pha-
ses of expansion and that this percentage reached the same
value after a high number of passages (Table S2).
Differentiation abilities of mesenchymal progenitors
To further characterize the isolated subpopulations, we
evaluated their differentiation potency, performing osteo-
genic, chondrogenic, and adipogenic differentiation assays.
Osteogenesis
After 6 days of osteogenic induction, 80% of EP, M, and BF
mBMSCs underwent a dramatic change in cellular mor-
phology and were ALP-positive (Fig. 4A). Control cultures in
regular growth media expressed a variable and significant
background level of ALP-positive staining (Supplemental
Table S3, available online at www.liebertonline.com/ten), in
agreement with previously described results in human26 and
murine BMSCs.27 In fact, in the conditions studied, EP and BF
subpopulations seemed to express ALP at time 0, suggesting
that several osteogenic patterns might already be active. ALP
activity of differentiated cells increased during the first week
of induction for EP, BF, and M mBMSCs (Fig. 4B), reaching a
plateau phase, a phenomenon correlated with the increased
extensive mineralization that occurred throughout the differ-
entiated cultures.26 On the other hand, the ALP activity of
differentiated N mBMSCs increased during the time, but it
did not reach the level of the other subpopulations, suggest-
ing a delay or an impairment in osteogenic differentiation
(Fig. 4B). Alizarin red S staining confirmed that EP, BF, and M
subpopulations, grown with osteogenic medium for 21 days,
produce a well-mineralized matrix (Fig. 4C). As expected, the
mineralization pattern of N mBMSCs was localized to a few
discrete foci, rather than throughout the culture dish, as re-
ported for EP, BF, and MmBMSCs (Fig. 4C). The extraction of
bound Alizarin red S allowed us to quantify mineralization
deposits elaborated from the cells (Fig. 4D).
To confirm the differentiation status of our subcultures,
we analyzed expression of osteoblast-specific markers using
RT-PCR. Our results confirmed that the mBMSCs constitu-
tively express some osteoblastic lineage markers, such as
core-binding factor alpha 1=runt-related transcription factor
2 (Cbfa 1=Runx2), collagen I, and osteopontin, as previously
described.10 In particular, after osteoinduction, EP, BF, and
M mBMSCs begin to express the well-known transcription
factor osterix, which is essential to osteogenic commitment of
mBMSCs, as well as late osteogenic markers, namely bone
sialoprotein and osteocalcin, typically expressed in osteo-
blasts (Fig. 4E).28 Because N mBMSCs do not express bone
sialoprotein, even in differentiation medium, we concluded
that they are not able to fully differentiate in osteoblasts re-
taining a pre-osteoblastic status.
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FIG 4. Osteogenic differentia-
tion of mBMSC subpopulations.
Alkaline phosphatase (ALP)
staining was performed 6 days
after osteogenic induction (A,
magnification 10). ALP activity
was determined for each subcul-
ture. The ALP activity of differ-
entiated cells increased during
the first week of induction for EP,
BF, and M mBMSCs, reaching a
plateau after 6 days; a slight in-
crease in ALP-positive cells was
observed in the N subpopulation
during the entire period of in-
duction (B). Alizarin red S stain-
ing was performed 21 days after
induction. EP, BF, and M BMSCs
exhibit calcium deposition in the
extracellular matrix; a lower level
of calcium deposition was ob-
served for the subpopulation N
(C, magnification 10). Calcium
deposition was quantified as de-
scribed in Materials and Methods
(D). Expression of osteoblast-
specific markers was determined
using RT-PCR (E) at 0, 3, and 21
days after induction. Pc, a posi-
tive control constituted by RNA
extracted from MC3T3. Glycer-
aldehyde 3 phosphate dehydro-
genase (GAPDH) is shown as a
control for RNA sample quality.
FIG 5. Chondrogenic differentiation
of mBMSC subpopulations. Micromass
cultures of the different mBMSC sub-
populations were treated with control
or chondrogenic medium. All of the
cultures were fixed after 21 days and
stained with Alcian blue (A, magnifi-
cation 10). Expression of chondrocyte-
specific markers was determined using
RT-PCR (B). RNA was extracted from
cells induced in monolayer at day 0 and
from micropellets after 3 or 21 days in
induction medium. Pc, positive control
constituted by RNA extracted from
ATDC5 cells. GAPDH is shown as a
control for RNA sample quality.
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Chondrogenesis
Treatment of micro-mass cultures of EP, BF, and M
mBMSCs with chondrogenic medium resulted in aggrega-
tion of the cells into a three-dimensional spherical structure
that accumulated sulphated proteoglycans, as shown using
Alcian blue staining (Fig. 5A).16,18,29 When we treated N
mBMSCs with chondrogenic medium in micro-mass cul-
tures, we did not observe spheroid formation but only a
contraction of the micro- mass culture into an opaque sheet
of cells smaller in diameter than the original culture, and
weakly positive to Alcian blue (Fig. 5A); these data sug-
gested to us that these cells have a delay or impairment in
chondrogenic differentiation.
To corroborate this hypothesis, we analyzed the ex-
pression of specific markers using RT-PCR in our four sub-
populations. The results confirmed that all analyzed mBMSC
progenitors constitutively express Sox-9.16,29 After induction,
BF and M mBMSCs began to express aggrecan and collagen
XI, confirming a differentiation in chondroblasts. Only EP
and M mBMSCs were able to differentiate in hypertrophic
chondrocyte because they express mRNA of collagen X and
Cbfa 1=Runx2 after 21 days of differentiation (Fig. 5B).30 We
were able to observe the expression of Sox9 and collagen
XI in N mBMSCs at time-point 0 in cells grown in mono-
layer, but not after 3 or 21 days in micropellet culture. As
reported by Murdoch et al., there is a reduction in collagen
I and Sox9 expression from monolayer at time-point 0 and
micropellet at time-point 3, but these markers normally in-
crease throughout the 3 weeks of differentiation.29 Because
N mBMSCs do not express any marker, even in differentia-
tion medium, we concluded that they do not differentiate in
chondroblasts, confirming our initial hypothesis, discussed
above.
Adipogenesis
After adipo-induction, we observed full adipogenic dif-
ferentiation only in N mBMSCs, with small lipid droplets
detectable after 3 to 4 days of induction as shown using Oil
red O staining and confirmed using quantification of bound
Oil red (Fig. 6A, B). Conversely, EP, BF, and M mBMSC
subpopulations treated with adipogenic medium did not
accumulate lipid droplets, even after 14 days of induction
(Fig. 5A, B). To further corroborate these data, we deter-
mined the expression of adipogenic-specific markers using
RT-PCR. Our data suggest that BF and M mBMSCs are able
to become immature adipocytes, because they express lipo-
protein lipase and fatty acid binding protein-4 after 14 days
of induction (Fig. 6C). N mBMSCs also express early adi-
pogenic markers before induction, suggesting that these cells
are pre-adipocytes. Upon stimulation, they can differentiate
readily into adipocytes, because they express the transcrip-
tion factor peroxisome proliferator-activated receptor gam-
ma 2, essential to adipogenic commitment of mBMSCs and
adipsin, a late adipogenic marker,31 just 3 days after treat-
ment with induction medium (Fig. 6C).
Expression of LIF in NIH3T3-conditioned medium
We hypothesized that the different results, in terms of
adipogenic differentiation abilities, were due to the compo-
sition of the medium used for isolation and expansion of
mBMSCs. It has been recently observed that LIF is respon-
sible for blocking osteoblast maturation at late differentiation
stages and redirecting these cells toward the adipogenic
pathway;32,33 we therefore analyzed LIF expression in
NIH3T3 and MS-5 cell lines using RT-PCR, demonstrating
that LIF was expressed only in NIH3T3 cells (Fig. 7A). To
further investigate the ability of NIH3T3 to secrete bioactive
LIF, we tested whether NIH3T3 supernatant could support
maintenance of the undifferentiated state of mESCs, because
it is well known that the maintenance of the undifferentiated
state of mESCs requires the presence of LIF or LIF-related
factors.34 Therefore, we plated mESCs in NIH3T3 superna-
tant supplemented with serum, and after 6 days we deter-
mined the number of ALP-positive colonies, because ALP is a
well-known marker of undifferentiated mESCs.35 As shown
in Figure 7B–D, NIH3T3-conditioned medium supported
the maintenance of the undifferentiated state of mESCs. On
the other hand, addition of an antagonist of LIF completely
blocked this effect, supporting the production of bioactive
LIF from NIH3T3 cells.
Discussion
In the present study, we have provided a characterization
of four mBMSC subpopulations enriched through distinct
culture conditions and showing different immunopheno-
types, self-renewal abilities, and differentiation potentials.
In the recent years, BMSCs have generated a great deal of
interest as a potential source of cells for therapy because of
their interesting differentiation, trophic, and immunosup-
pressive abilities.3,36–38 Nevertheless, the inability to defini-
tively identify and characterize this population in a simple
mammalian model, such as the mouse, impeded the ability
to move their use forward in therapy. mBMSCs have been
partially characterized,4–11 and although some studies have
been done to demonstrate their in vivo contribution24,39 or the
in vivo potential for tissue regeneration and gene delivery,1–3
most of them lacked optimization of culture conditions to
obtain a high number of specific progenitors, maintaining the
same characteristic for many passages without acquisition of
tumorigenic potential.40
We tried to obtain mMSCs using complete medium with-
out any supplements. However, the few adherent cells ob-
tained after the incubation period were not able to proliferate
even when we sub-cultured them in another plate. Starting
from the observation that use of bone fragment–conditioned
medium favors BMSC growth,8 we devised the conditions
that selected the subpopulations described as BF and EP.
Because it is well known that mBMSCs expand poorly,4–11
after 2 weeks of culture, we cultured a part of these cells
(EP mBMSCs) in complete medium supplemented with EGF
and PDGF-AA,10,41,42 whereas we maintained BF mBMSCs
in complete medium with no additional components. Sur-
prisingly, in spite of the above-cited considerations, we ob-
served an expansion of BF mBMSCs. These results led us to
hypothesize that a specific bone marrow–derived microen-
vironment could be responsible for the selection and main-
tenance of mesenchymal progenitors. We therefore decided to
evaluate whether conditioned media obtained from MS-513
and NIH3T3 cell lines14 could mimic the properties of the
bonemarrowmicroenvironment. With this aim, we grewMS-
5 and NIH3T3 cells in the same medium (see Materials and
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FIG 6. Adipogenic differentiation of
mBMSC subpopulations. The different
BMSC subpopulations were incubated in
adipogenic medium as described in Materi-
als and Methods. Fourteen days after in-
duction, the cells were fixed and stained
with Oil red O. The N mBMSC subpopula-
tion underwent a dramatic change in cellu-
lar morphology from spindle-shaped to
polygonal, which was accompanied by a
significant lipid accumulation; to the con-
trary, EP, BF, and M mBMSC subpopula-
tions showed absence of lipid droplets
(A, magnification 10). Lipid accumulation
was also quantified as described in Materials
and Methods (B). Expression of adipocyte-
specific markers was analyzed using RT-
PCR (C) from RNA extracted at day 0 or
after 3 or 14 days in induction medium. Pc,
positive control constituted by RNA ex-
tracted from C3H10T1=2 cells. B-actin is
shown as a control for RNA sample quality.
FIG 7. NIH3T3 cells secrete bioactive leu-
kemia inhibitory factor (LIF). LIF expression
in NIH3T3 cells was determined using RT-
PCR analysis (A). GAPDH is shown as a
control for RNA sample quality. ALP stain-
ing of murine embryonic stem cells (mESCs)
plated in NIH3T3 supernatant in the ab-
sence or presence of blocking anti-LIF anti-
body (B and C at 10magnification). We
distinguished between undifferentiated
(ALP-positive), partially differentiated (ALP
expression localized to a few discrete cells
forming a colony), and differentiated (ALP-
negative) colonies. ALP-positive colonies
were also quantified (D). The positive con-
trol in all the experiments was constituted
by cells maintained in ES complete medium,
whereas as negative control, we used cells
maintained in ES complete medium without
LIF.
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Methods) to minimize any difference between the condi-
tionedmedia harvested from these cell lines, which differ only
in the molecules secreted from each individual line. Using the
above-mentioned conditioned media, we were able to effi-
ciently culture mBMSCs. We therefore hypothesized that one
of the main determinants of successful isolation and expan-
sion of mouse mesenchymal progenitors was the growth
supplement used for isolation and expansion.
Immunophenotypical characterization of our four BMSC
subpopulations showed in each case profiles compatible
with BMSCs. We observed differences in CD117, CD13, and
H2-kb expression (Table 1). Moreover, these progenitors have
different growth kinetics, and after an initial lag phase of
approximately 10 to 17 days, they started to proliferate, after
30 passages reaching different numbers of cumulative du-
plications (Fig. 2A).
An interesting feature of all of the BMSC subpopulations
isolated was the expression of a well-known marker of un-
differentiated embryonic stem cells: Nanog (Fig. 3).
Although the role of Nanog in adult tissue stem cells re-
mains unclear, it is possible that it enhances self-renewal of
tissue stem cells. In a recent paper, Go et al., observed that
Nanog-over-expressing human BMSCs showed much higher
expansion potential and osteogenic differentiation abilities
than control cells.43 So it is possible to argue that the ex-
pression of Nanog, strictly correlated to proliferation ability,
could play a key role in quality of specific markers for the
selection of BMSC progenitors to employ in cell therapy
protocols.
About the differentiation potential, in two of the four
conditions (BF and M), cells showed tri-potential differenti-
ation ability, giving rise to osteoblasts, chondrocytes, and
pre-adipocytes, whereas EP cells lost adipogenic potential,
probably during the first passages.17 We observed that the
ability to differentiate in pre-adipocytes was typical of BF
and M BMSCs, which are negative to H2-kb, a typical char-
acteristic of mMAPCs.24 Moreover, the ability to differentiate
in hypertrophic chondrocytes was typical of EP and M
BMSCs, which showed lower expansion profiles than the
other subpopulations. We speculate that this could be par-
tially due to the effect of EGF on these cells. The EGF, added
directly to EP BMSCs and contained in MS-5–conditioned
medium,13 could act not only as mitogen in mesenchymal
proliferation,10 but also as a stimulator of osteogenic differ-
entiation.42 This effect could account for the high chondro-
genic and osteogenic potential of these cells.
On the other hand, using NIH3T3-conditioned medium,
we obtained cells that showed impairment in osteogenic and
chondrogenic differentiation while retaining a high adipo-
genic potential during passages. We hypothesized that this
could be the result of NIH3T3-conditioned medium exposi-
tion. Therefore, with the aim of addressing this behavior, we
switched the N BMSCs into standard growth medium for 10
passages. We were not able to appreciate any significant
recovery of osteogenic potential (data not shown), leading to
the conclusion that this effect was not reversible. In the at-
tempt to identify cytokines possibly responsible for this be-
havior, we focused our attention on LIF.32 It has been
recently observed that LIF is responsible for blocking oste-
oblast maturation at late differentiation stages and redirect-
ing these cells toward the adipogenic pathway.32,33 We
speculate that, in our N BMSCs model, LIF could suppress
the osteoblast maturation at late differentiation stages32,33
contributing to selection of adipogenic progenitors from
bone marrow.32,44,45
Our differentiation data, which include tissue-specific
staining and RT-PCR results, are aimed only at confirming the
differentiation process, based on the presence or the absence
of markers;16,28,29,31 analysis of the kinetics of the process may
produce further indications on the effect of specific factors on
BMSCs and may constitute object of future research.
To our knowledge, this is the first article that reports the
enrichment of specific progenitors from murine bone mar-
row using MS5- and NIH3T3-conditioned medium. Our data
suggest that the use of appropriate conditioned media can
determine the obtainment of a large number of desired cells
for large-scale transplantations or cell therapies. In the near
future, we believe that the identification of growth factors
regulating survival rate, self-renewal, and lineage differen-
tiation will be crucial for the understanding of MSC biology
and for their application in clinical settings.
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